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Abstract 
Background: Impaired arterial structure and stiffness are strong predictors of cardiovascular 
events and mortality. These subclinical signs of impairment can be used to identify early 
stages of cardiovascular disease. Improved understanding of their determinants may enable 
earlier interventions to reduce cardiovascular risk. 
Aim: This research aimed to study the associations of fatness, fitness, physical activity and 
sedentary behaviour with arterial structure and stiffness. 
Methods: Data were from four large population-based studies: the Burnie Take Heart (BTH), 
Can Tho (CT), Childhood Determinants of Adult Health (CDAH), and Cardiovascular Risk in 
Young Finns (Young Finns) studies. The subjects for BTH (n=832 Australians aged 25–64 
years in 1998–99), CT (n=1978 Vietnamese aged 25–64 years in 2005), CDAH (n=2328 
Australians aged 7–15 years in 1985 and when aged 26–36 years in 2004–06) and Young 
Finns (n=2175 Finns aged 30–45 years in 2007) were all drawn from population-based 
samples.  Measurements included anthropometry, blood pressure, resting heart rate (RHR), 
physical activity and fitness, sedentary behaviours, blood biochemistry, and arterial structure 
and stiffness assessed using carotid ultrasound. 
Results: First, body mass index was positively associated with pulse pressure (an indicator of 
large artery stiffness) among adult Caucasians, but with both systolic and diastolic pressure 
among adult Asians. Second, adult carotid artery stiffness was exclusively dependent on adult 
body size and fatness, whereas adult carotid artery structure (assessed as intima-media 
thickness) was associated with childhood body size and fatness independently of attained 
adult values. Cross-sectional data showed that adult carotid artery stiffness was associated 
thirdly with physical fitness and fourthly with vigorous activity, each independently of current 
body size/fatness and with each association mediated by RHR. Fifth, carotid artery stiffness 
was positively associated with sitting time, independently of physical activity and fitness, 
body size/fatness, RHR, or metabolic syndrome. 
Conclusions: For the first time, our findings suggest a different pathophysiology related to 
obesity-induced hypertension among Caucasians (increased arterial stiffness phenotype) and 
Asians (essential hypertension phenotype). Adult arterial stiffness was primarily influenced 
by attained adult body size and fatness, whereas adult arterial structure was influenced by 
body size and fatness in both childhood and adulthood. Independently of fatness, young adults 
may reduce stiffening of large arteries by doing vigorous activity and improving their fitness, 
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and by minimising sedentary behaviours. For the first time, our findings attribute a key 
intermediary role to RHR in the relationship of arterial stiffness with physical activity and 
fitness, and identify a positive relationship between arterial stiffness and sitting time 
independent of measurements of physical activity and fitness. These findings strengthen the 
case for lifestyle interventions to reduce obesity, encourage participation in vigorous activity 
and reduce prolonged sitting periods to reduce cardiovascular risk.
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Chapter 1. Introduction 
Epidemiology of cardiovascular disease (CVD) 
What is CVD? 
The term CVD refers to any disease of the heart or blood vessels. It includes conditions such 
as coronary heart disease (or ischaemic heart disease), cerebrovascular disease (stroke), heart 
failure, rheumatic heart disease and other peripheral vascular diseases. 
Global burden of CVD and “the epidemiologic transition” 
Over the last century, CVD has shifted from a disease with low burden to a disease with very 
high burden that has replaced infectious disease as the leading cause of death and disability 
worldwide.
1
 It was estimated that 17.3 million people died from CVD in 2008, accounting for 
48% of deaths from non-communicable disease and 30% of total deaths.
2
 Coronary heart 
disease and stroke are the two most common causes of CVD deaths and were the two leading 
causes of death worldwide in 2011, accounting for 7 million and 6.2 million deaths 
respectively.
3
 The top ten leading causes of death worldwide are shown in Figure 1.1. In 
terms of total burden of disability-adjusted life years (DALY) loss that accounts for years of 
life lost due to premature death and years lived with disability, coronary heart disease and 
stroke have increased by 29% and 19% respectively over the last two decades.
4
 In 2010, 
coronary heart disease and stroke were the leading causes of DALY loss worldwide, up from 
the fourth and fifth leading causes in 1990.
4
 According to World Health Organization (WHO) 
estimates, by 2030 the number of deaths from CVD will have increased to 25 million per 
annum, and CVD will remain the single leading cause of death not only in high- and middle-
income countries, but also in low-income countries.
5
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Figure 1.1. The top 10 leading causes of death worldwide in 2011. Figure reproduced 
from data reported by the WHO
3
 
The shift in burden from communicable to non-communicable diseases has been termed “the 
epidemiologic transition”. Omran originally identified three stages in this transition (Age of 
pestilence and famine, Age of receding pandemics, and Age of degenerative and man-made 
diseases).
6
 A fourth (Age of delayed degenerative diseases) and fifth (Age of health 
regression and social upheaval) stage were recently added by Olshansky et al
7
 and Yusuf et 
al.
8
 The mortality burden of CVD is lowest in stage 1, increases in stage 2, peaks in stage 3, 
and tapers off in stage 4. Yusuf et al have predicted increases in CVD of infectious aetiology 
(rheumatic heart disease) in stage 5, together with increases in ischaemic and hypertensive 
diseases among the young.
8
 This transition is characterised by reduced proportions of 
communicable disease and increased proportions of chronic disease (including CVD) and 
injuries. One of the major factors driving this change has been the improvements in public 
health and medical care that have resulted in an increase in average life expectancy. Because 
CVD is more common in older ages, improved life expectancy increases the proportion of 
people who survive to older ages when CVD is most prevalent. Another major factor that is 
attributable to “the epidemiologic transition” is increased prevalence of “lifestyle” CVD risk 
factors such as smoking, unhealthy (energy-rich) diet and a sedentary lifestyle. At any given 
0 1 2 3 4 5 6 7 8
Prematurity
Road injury
Diabetes
Lung cancer
HIV/AIDS
Diarrhoeal diseases
COPD
Lower respiratory infections
Stroke
Ischaemic heart disease
Number of deaths (in millions) 
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time, countries and regions are going through different stages of the transition. Two examples 
of this are discussed in the following sections. 
Burden of CVD in Australia 
Similarly to other countries with established market economies, Australia is likely to be in the 
fourth stage of the transition (Age of delayed degenerative diseases).
7
 In this stage, deaths 
from CVD have begun to decline after reaching a peak in the third stage (Age of degenerative 
and man-made diseases) due to public health interventions such as those to reduce smoking, 
improved treatment, extensive primary and secondary prevention efforts, and major 
technological advances. Indeed, from 2002 to 2011, the number of CVD deaths in Australia 
fell by 9.3%.
9
 However, as reported by the National Heart Foundation, CVD remains the 
largest cause of mortality in Australia, accounting for 34% of deaths among males and 39% of 
deaths among females.
10
 Stroke and ischaemic heart disease are the leading causes of CVD 
burden for Australian men and women of all ages.
10 
Burden of CVD in Vietnam 
In this section, Vietnam is highlighted as an example of a developing country because, in 
Chapter 3, the associations of body size and fatness with blood pressure among Australian 
adults are compared with those of Vietnamese adults. Developing countries such as Vietnam 
are likely to be in the second stage of the transition (Age of receding pandemics), in which 
rising incomes, better nutrition and improved living conditions result in reduced malnutrition 
and abatement of infectious diseases. This results in lower infant and child mortality rates, 
and substantially improved life expectancy. However, urbanisation and changing of lifestyles 
and diet also lead to higher levels of CVD risk factors such as obesity, hypertension, diabetes 
and hypercholesterolemia. These factors, together with longer lifespans, result in a steep 
increase of CVD burden in developing countries.
11
 In Vietnam, even though infectious 
diseases still contribute significantly to the total years of life lost, CVD was the leading cause 
of deaths in 2008, accounting for 24% of deaths among men and 31% among women.
12 
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Major risk factors for CVD 
There are many risk factors that are associated with CVD including those that are modifiable 
(such as smoking, obesity, physical inactivity, hypertension, diabetes, and 
hypercholesterolemia) and those that are non-modifiable (such as increasing age, male sex, 
race, and family history). Primary and secondary prevention efforts have focused on 
modifiable risk factors in order to reduce CVD risk. Extensive epidemiological research has 
attributed significant contribution of these risk factors – particularly hypertension,13 
smoking,
14
 diabetes,
15
 and hypercholesterolemia
16
 – to the development of future 
cardiovascular events. Intervention studies have shown that treatment or reduction of these 
four risk factors reduces CVD risk markedly.
14, 17, 18
 Thus, smoking, hypertension, diabetes, 
and hypercholesterolemia are usually referred to as the major or traditional CVD risk 
factors.
19
 
In the past, the prevailing belief was that traditional CVD risk factors were present among at 
most one-half of people with CVD.
20-23
 However, more recent data from major clinical trials 
and cohort studies have demonstrated that CVD is very uncommon in the absence of 
traditional CVD risk factors.
24, 25
 These studies used data from 14 clinical trials and three 
large prospective cohorts, and together included more than half a million subjects. The 
findings showed that 80% to 90% of patients with significant coronary heart disease, and 
more than 95% of patients with fatal coronary events, had been exposed to at least one major 
CVD risk factor. Indeed, according to findings from five large cohort studies including over 
350,000 men and women aged 18 to 59 years at baseline in the United States, those without 
any major CVD risk factor had 72% to 85% lower risk of cardiovascular mortality and 40% to 
58% lower risk of all-cause mortality than those with at least one major CVD risk factor.
26
 In 
addition, findings from the INTERHEART study – an international, standardised, case-
control study with approximately 15,000 cases and 15,000 controls from 52 countries across 
all geographic regions and ethnic groups of the world – showed that hypertension, smoking, 
diabetes, abnormal lipids, obesity, physical inactivity, psychosocial factors, lack of 
consumption of fruit and vegetable, and regular alcohol consumption accounted for 90% 
(men) and 94% (women) of risk of acute myocardial infarction worldwide.
27
 These important 
results convincingly challenge the theory that at most one-half of CVD events are attributable 
to the traditional CVD risk factors and more importantly, emphasise the importance of 
identifying and controlling major CVD risk factors to reduce CVD burden. 
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Hypertension 
The most recent classification of blood pressure (as in Table 1.1) for adults aged 18 years or 
older was introduced in 2003 by the Joint National Committee in their seventh report.
28
 This 
classification differed from their sixth report by adding a new category (prehypertension), and 
combining stage 2 and 3 hypertension. 
Table 1.1. Classification of blood pressure for adults aged 18 years or older
28
 
Blood pressure classification SBP (mmHg)  DBP (mmHg) 
Normal < 120 and < 80 
Prehypertension 120 - 139 or 80 - 89 
Stage 1 hypertension 140 - 159 or 90 - 99 
Stage 2 hypertension ≥ 160 or ≥ 100 
Abbreviations: SBP (systolic blood pressure); DBP (diastolic blood pressure). 
Hypertension is the leading cause of CVD worldwide and contributes to 13% of total deaths.
29
 
Data from the Framingham Heart Study suggest that normotensive individuals at the age of 55 
years have 90% lifetime risk of developing hypertension.
30
 For individuals classified as 
prehypertensive, anti-hypertensive medication is not yet indicated unless co-morbidity such as 
chronic kidney disease or diabetes is present, but lifestyle modifications are recommended 
because affected individuals have around two-fold higher risk of developing hypertension,
31
 
and of developing CVD,
32
 than those with normal blood pressure.  
Some individuals may develop high systolic pressure (≥ 140mmHg), but have low or normal 
diastolic pressure. This usually happens in older adults, and results in high pulse pressure that 
is calculated as the difference between systolic and diastolic pressure.
33
 This phenomenon is 
called isolated systolic hypertension, and it is associated with higher CVD risk.
34, 35
 This is 
possibly because a greater gap between systolic and diastolic pressure (i.e. higher pulse 
pressure) is usually referred to as an indicator of increased arterial stiffness in older adults (i.e. 
those aged over 50 years).
33
 Increased arterial stiffness predicts cardiovascular events and 
mortality independently of blood pressure.
36
  
To investigate the direct and continuous relationship between blood pressure and CVD risk, a 
systematic meta-analysis of one million adults without pre-existing vascular disease was 
performed using data from 61 prospective studies that had not selected participants on a basis 
of a history of stroke or heart disease.
37
 The findings showed that an increment of 20 mmHg 
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in systolic blood pressure or 10 mmHg in diastolic blood pressure doubled the risk of 
cardiovascular mortality, even in individuals with blood pressure as low as 115/75 mmHg.
37
 
In addition, data from randomised controlled trials show that using anti-hypertensive therapies 
to lower blood pressure reduces the risk of stroke, coronary heart disease, myocardial 
infarction and mortality among hypertensive patients.
38-40
 Collectively, these findings 
demonstrate the importance of preventing or reducing elevated levels of blood pressure as a 
means of reducing CVD risk. 
Tobacco smoking 
Smoking is the second leading cause of CVD worldwide and accounts for 9% of total 
deaths.
29
 It is estimated that there are currently one billion smokers in the world.
29
 The causal 
relationship of smoking or tobacco use with many types of CVD across various racial and 
ethnic groups, and also with many other diseases, are strongly dose-related and well 
established
14
 in terms of biological plausibility and the other criteria of Bradford Hill.
41
  
Smoking has been found to be associated with endothelial dysfunction – broadly defined as an 
imbalance between vasodilating and vasoconstricting substances produced by (or acting on) 
endothelial cells
42
 – by various mechanisms.43-45 Atherosclerotic plaques among smokers are 
more frequently complicated by mural thrombosis on arterial walls than those from non-
smokers.
46
 This is probably due to disturbance of the coagulation-fibrinolytic system, which 
may lead to vascular occlusion by thrombotic fragments and sudden cardiac death.
47
 Smoking 
also leads to increased inflammation
48, 49
 and an adverse lipid profile.
50
 It detrimentally 
influences cardiac function by: increasing oxygen demand of the myocardium;
51
 decreasing 
oxygen supply by reducing coronary blood flow;
52
 and diminishing the capacity of red blood 
cells to carry oxygen.
53
 Acute and episodic increases in blood pressure observed in smokers 
expose the arterial wall to greater mechanical load.
54
 Collectively, these pathways accelerate 
the adverse progression of atherosclerosis and cardiac events in individuals who smoke 
tobacco.  
In relation to other CVD risk factors, smoking may act synergistically to increase 
substantially the CVD risk associated with other risk factors.
55
 It is estimated that smoking 
may shift forward the onset of premature coronary heart disease by a decade.
24
 The adverse 
effects of smoking on cardiovascular health appear to be similar for both men and women.
56, 
57
 Smoking is also a strong risk factor for myocardial infarction even among women less than 
50 years of age, for whom the absolute risk of cardiovascular events is very low.
58, 59
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Given the high CVD risk associated with tobacco use, it is encouraging to smokers that their 
risk due to smoking is substantially decreased within a few years after cessation of smoking, 
and may return to that of a non-smoker within 15 years of quitting.
60
 This beneficial effect can 
be seen even among those who have been heavy smokers for many years.
60
 For individuals 
who have already developed coronary heart disease, smoking cessation also substantially 
reduces the risk of recurrent myocardial infarction, stroke or mortality by at least 50%.
61, 62
 
Given this evidence, there is little doubt that smoking cessation would reduce the risk of CVD 
for smokers. 
Diabetes 
Diabetes is a metabolic disease primarily defined by hyperglycaemia resulting from defects in 
insulin secretion, insulin action or both, and contributing to both microvascular and 
macrovascular diseases. It is estimated that diabetes affected 246 million people worldwide in 
2007, and will affect 380 million in the year 2025.
63
 In Australia, it is estimated that one in 
four adults aged 25 years or older has diabetes or impaired glucose metabolism (consisting of 
impaired fasting glucose or impaired glucose tolerance).
64
 The classification of blood glucose 
tolerance status based on fasting and/or 2-hour postprandial blood glucose is presented in 
Table 1.2. 
Table 1.2. Classification of blood glucose tolerance status
65
  
 Plasma glucose (mmol/L) 
 Fasting  2-hour postprandial 
Diabetes ≥ 7.0 or ≥ 11.1 
Impaired glucose tolerance < 7.0 and 7.8 – 11.0 
Impaired fasting glucose 6.1 - 6.9 and < 7.8 
Normal < 6.1 and < 7.8 
Diabetes is strongly related to CVD and regarded as a traditional CVD risk factor.
19
 There are 
two types of diabetes: type 1 diabetes (formerly called insulin-dependent diabetes, in which 
the pancreas fails to produce insulin) and type 2 diabetes (formerly called noninsulin-
dependent diabetes, which is a metabolic disorder characterised by high blood glucose due to 
insulin resistance and relative insulin deficiency). Both type 1 and type 2 diabetes are 
associated with greater CVD risk.
66, 67
 Indeed, CVD is responsible for at least 50% of deaths 
in people with diabetes.
63, 68
 Diabetes may even be considered as a “cardiovascular disease” 
because most diabetic patients have coexisting CVD risk factors. Compared with people with 
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normal blood glucose tolerance, those who have diabetes are much more likely to have 
hypertension, hypercholesterolemia, and obesity.
64
 This may explain why the absolute risk of 
diabetic patients is usually higher than the Framingham score calculated for hyperglycaemia, 
and is as high as that of patients with previous myocardial infarction.
69
 Diabetic patients are 
also at higher risk of developing specific CVD such as coronary heart disease, diabetic 
cardiomyopathy and stroke;
70
 once having developed CVD, they have a poor prognosis.
71
 
This renders diabetic patients a special case in CVD risk assessment and classifies them as 
high-risk category that requires comprehensive management of all CVD risk factors.
19 
Hypercholesterolemia 
Cholesterol is a fat-like substance that is transported in the blood in particles called 
lipoproteins. There are three major types of lipoproteins, including high density lipoprotein 
(also called “good” cholesterol), low density lipoprotein (also called “bad” cholesterol), and 
very low density lipoprotein (a triglyceride-rich lipoprotein). Among these lipoproteins, low 
density lipoproteins make up 60% to 70% of total blood cholesterol. They are regarded as the 
major atherogenic lipoprotein and are the primary target for cholesterol lowering therapy.
72
 
Hypercholesterolemia is defined as having total cholesterol equal to or greater than 6.2 
mmol/L (or 240 mg/dL).
72
  
The causal relationship of hypercholesterolemia with CVD has been well documented by 
major population studies including the Framingham Heart Study,
67, 73
 the Multiple Risk Factor 
Intervention Trial,
74
 and the Lipid Research Clinics trial.
75, 76
 The strong association of 
hypercholesterolemia with CVD is also clearly demonstrated among individuals with genetic 
hypercholesterolemia who commonly develop premature coronary heart disease even in the 
absence of other risk factors.
77
 In addition, findings from clinical trials of cholesterol lowering 
therapies, particularly those using HMG CoA reductase inhibitors (statins), have provided 
convincing evidence of significant reduction not only in coronary events, but also in 
cardiovascular and total mortality.
78
 The benefits of lowering cholesterol are observed across 
a wide range of cholesterol levels in different subgroups of patients, among those with or 
without established CVD, in smokers or non-smokers, and among those with or without 
hypertension or diabetes.
79, 80
  
To estimate by how much and how quickly a given reduction of serum cholesterol 
concentration may reduce the risk of ischaemic heart disease, an analysis used data from ten 
large cohort studies (each of which had recorded at least 350 coronary events), three 
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international studies (for comparison among participants in different communities in 25 
countries totally), and 28 randomised controlled trials.
81
 The findings showed that 
interventions to reduce serum cholesterol earlier in life rather than later may result in lower 
risk of ischaemic heart disease, and that the full effect of reduction in risk is achieved by five 
years.
81
 These findings emphasise the importance of long-term prevention of CVD and the 
need to understand risk factors in younger people and how they may influence CVD risk later 
in life. 
Obesity 
The prevalence of overweight and obesity has been consistently increasing in many countries 
over several decades, and is a major public health concern because obesity is a major risk 
factor for many chronic diseases.
82, 83
  It is estimated that approximately one in four adult 
Australians and one in three adult Americans are obese.
82, 83
 Overweight or obese individuals 
have higher risk of cardiovascular events and mortality.
84, 85
 In the past, the link between 
obesity and CVD was usually referred to as an indirect relationship mediated through 
subsequent increases in other CVD risk factors among obese people. That is, obese people are 
more likely to develop hypertension, diabetes and hypercholesterolemia,
86
 which will increase 
their risk of developing CVD. However, there is evidence that changes in cardiac structure 
and function may occur in obese individuals even in the absence of other risk factors,
87
 and 
that the magnitude of these changes may be related to the severity of obesity.
88
 In addition, 
major long-term longitudinal studies have shown that obesity strongly predicts cardiovascular 
events and mortality independently of other risk factors.
84, 85, 89
 For this reason, obesity has 
now been designated as a major CVD risk factor.
90
  
In both clinical and research work, overweight and obesity are often defined using body mass 
index (BMI), which is calculated by dividing weight in kilograms by height in squared 
meters. In Australia, the proportion of men and women who are overweight (BMI 25 – 29.9 
kg/m
2) or obese (BMI ≥ 30 kg/m2) generally increases with age, and most significantly so for 
adults from 18-24 years of age to 45-54 years of age.
83
 Between 1985 and 2011-12, young 
Australian adults had the most substantial increases in overweight and obesity, including men 
aged 25-34 years (increased by 7%), men aged 35-44 years (increased by 8%), women aged 
18-24 years (increased by 9%), and women aged 35-44 years (increased by 10%).
83
 This trend 
of increasing overweight and obesity among young adults also exists in other populations,
82
 
and may be mainly responsible for elevated risk factors observed among young adults in those 
countries. The Coronary Artery Risk Development in Young Adults Study collected data on 
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young black and white adults aged 18–30 years at baseline (stratified by age, sex, race and 
education) and followed-up for 15 years.
91
 Findings from this study showed that young adults 
who maintained stable BMI over 15 years had unchanged levels of metabolic syndrome 
components, regardless of baseline BMI, whereas those with increased BMI had adverse 
progression of risk factors and greater incidence of metabolic syndrome.
91
 These 
unfavourable trends of risk factors in younger adults may explain why mortality rates in older 
adults continues to decline significantly, whilst rates among younger adults have declined 
minimally or even increased.
92, 93
 This adverse trend in mortality experienced for younger 
adults, despite advanced development of medical and interventional therapies, again 
underlines the need for long-term studies of CVD risk factors – particularly obesity – among 
young people and their long-term consequences for health. 
Physical activity and fitness 
In Australia, physical inactivity causes 7% of total disease burden and is the second leading 
risk factor contributing to total disease burden, following tobacco use.
94
 Similarly, lack of 
physical activity is the second leading behavioural cause of death in the United States, 
following tobacco use.
95
 It is now widely accepted that physical activity plays a role in both 
primary and secondary prevention of CVD.
96-98
 Indeed, physical inactivity has been reported 
to independently predict the development of coronary heart disease.
99, 100
 Unless otherwise 
contraindicated,  regular physical activity can increase cardiovascular functional capacity (by 
reducing resting heart rate and increasing maximal cardiac output) and reduce myocardial 
oxygen demand (by increasing the ability of myocardium to extract and use oxygen delivered 
by red blood cells) not only among apparently healthy individuals, but also among CVD 
patients.
96
 To maintain these cardio-protective effects, individuals need to undertake exercise 
training habitually.
96
  
The direct causal relationship between physical activity and mortality has been documented in 
many studies. A systematic review and meta-analysis in 2007 including 33 cohort studies with 
nearly 900,000 apparently healthy participants who were followed-up for at least three years 
showed 35% and 33% reduction respectively in cardiovascular and all-cause mortality among 
those who were physically active.
101
 For individuals with established CVD, a Cochrane 
systematic review in 2011 including 47 randomised controlled trials showed that regular 
exercise training reduced total mortality among patients by 13% and cardiovascular mortality 
by 26% across all ages.
102
 For these patients, regular exercise also reduced the risk of hospital 
readmission within 12 months by 31%.
102
 In relation to other CVD risk factors, physical 
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activity also reduces both systolic and diastolic blood pressure, particularly for people with 
hypertension,
103
 reduces triglyceride levels and increases high-density lipoprotein levels,
104
 
and reduces insulin resistance and glucose intolerance.
105
 Based on the evidence of the many 
beneficial effects that participation in physical activity provides, physical inactivity has now 
been designated as a major CVD risk factor.
96
  
In relation to the role of physical activity in producing weight loss, a systematic review in 
2007 including 16 prospective, randomised controlled trials of at least four months in duration 
demonstrated that substantial weight loss may be achieved by physical activity alone, but 
requires large amount of exercise to be prescribed and sustained.
106
 This is in line with 
findings from another systematic review of both epidemiological studies and clinical trials 
that compared the benefits of physical activity at different intensities.
107
 These findings 
showed greater cardioprotective benefits (including reduction in blood pressure and glucose, 
and increase in aerobic capacity) produced by vigorous physical activity compared with those 
produced by light-to-moderate physical activity, given that the total energy expenditure from 
the two types of exercise was held constant.
107
 This evidence suggests that participation in 
vigorous physical activity may provide benefits that are beyond those provided by light-to-
moderate physical activity, but the underlying mechanisms are unclear at present. 
Cardiorespiratory fitness (CRF) refers to the ability of the circulatory and respiratory systems 
to supply oxygen to skeletal muscles during sustained physical activity. CRF measures the 
capacity of an individual to perform physical activity and can be improved by regular exercise 
training. The American Heart Association has recently recognised CRF as an important 
cardiovascular health metric and recommends routine assessment in clinical practice.
108
 This 
official statement was based on strong evidence that CRF independently predicts various 
health outcomes including cardiovascular and all-cause mortality.
109-111
 A recent systematic 
meta-analysis of 33 cohort studies on apparently healthy participants showed that those with 
low CRF had 47% and 56% greater risk of  developing cardiovascular events than those with 
intermediate and high CRF respectively.
112
 This meta-analysis also showed that participants 
with low CRF had 40% and 70% greater risk of all-cause mortality than those with 
intermediate and high CRF respectively.
112
 More importantly, unfit individuals (with or 
without chronic diseases) who improve their CRF may reduce their risk of death,
113, 114
 
regardless of changes in BMI.
115
 This evidence not only shows the importance of CRF in 
prevention of CVD, but also suggests that – regardless of weight loss – individuals who 
participate in physical activity may improve their CRF, and thereby, reduce CVD risk. This 
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again implicates the potential importance of vigorous physical activity in prevention of CVD 
because previous studies have demonstrated that the higher the exercise intensity, the greater 
the increase in CRF.
107, 116
 
Most of the findings on the relationship of physical activity and fitness with CVD are based 
on data from older adults and thus, less is known for younger adults. This is possibly due to 
low prevalence of cardiovascular events at younger age. However, given that CVD mortality 
rates among younger adults do not appear to have declined as they have among older adults,
83, 
84
 additional research is needed to better understand how these risk factors may influence the 
early stages of CVD among young people. This is critical for long-term prevention of CVD 
because it may enable early interventions to reduce CVD risk. As discussed in the preceding 
text, weight gain appears to be mainly responsible for elevated risk factors observed in young 
people.
91
 Thus, reducing obesity among young people is obviously crucial. However, obesity 
has many behavioural and genetic components that are not easily addressed. For overweight 
and obese people who experience difficulties with losing weight, increasing physical activity 
and improving CRF appears to be a good alternative because they are associated with lower 
risk of CVD mortality independent of BMI changes.
114, 115
 Although some participants as 
young as 20 years of age were included in the aforementioned studies, these findings were 
primarily based on data from older adults because death from CVD is rare among young 
adults. Therefore, the impact of physical activity and greater CRF on the early stages of CVD 
remains less certain and needs to be examined among young people, which is one of the aims 
of this research.  
Sedentary behaviours 
Sedentary behaviours such as sitting, watching television and using a computer are ubiquitous 
in contemporary society and have become a new focus for research in physical activity and 
health. They are defined by both their posture (sitting or reclining) and their low levels of 
energy expenditure (typically in the range of 1.0 to 1.5 multiples of the basal metabolic 
rate).
117
 In the past, it was a common belief that adverse health consequences of being 
sedentary were due to lack of physical activity. However, recent findings suggest that 
sedentary behaviours should not be viewed as equivalent to physical inactivity, but as an 
independent risk factor.
118
  
Over the past few years, several studies have reported detrimental relationships of sedentary 
behaviours – including self-reported sitting time119, 120 and television viewing time121-123 – 
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with cardiovascular and all-cause mortality, after adjustment for physical activity and BMI. 
Among older men, time spent riding in a car was also reported to be associated with CVD-
related mortality.
124
 In line with these findings, sedentary behaviours were found to be 
associated with a number of CVD risk factors, such as obesity, and elevated blood glucose 
and cholesterol,
125, 126
 which may act as possible pathways leading to a higher risk of 
mortality. Strengthening this evidence, data from accelerometers showed that objectively-
measured sedentary time was associated with waist circumference, blood glucose, insulin and 
lipids.
127, 128
 More importantly, these data also demonstrated that individuals who had more 
“breaks” during sedentary periods (in other words, interrupted their sedentary behaviours 
more frequently) had better cardiometabolic profile than those who did not, independent of 
total sedentary time and time spent doing moderate-to-vigorous physical activity. 
Collectively, these findings suggest a causal relationship between being sedentary and 
mortality risk. 
Despite all the evidence presented above, there has never been a study that examines the 
relationship between sedentary behaviour and vascular health, an important predictor of 
cardiovascular events and mortality.
36, 129
 Novel information in relation to this relationship 
may advance our knowledge in the field, and shed some light on the possible mechanisms 
involved in the relationship of sedentary behaviour with mortality, which still remains poorly 
understood at present. 
Advanced imaging techniques and vascular measures as 
subclinical markers of CVD 
The evidence presented in the preceding text underlines the need to study CVD risk factors 
among young people and to understand how these risk factors may influence the early stages 
of developing atherosclerosis (the underlying cause of most CVD). This is essential not only 
because of the adverse trend in cardiovascular mortality observed among contemporary 
younger adults,
83, 84
 but also because controlling risk factors associated with early stages of 
atherosclerosis may help prevent, or delay, the clinical manifestations of CVD and thereby, 
reduce CVD burden. However, because cardiovascular events are rare among the young, 
studying early stages of CVD or atherosclerosis in the past have relied on either autopsy 
studies, which was performed by the Bogalusa Heart Study
130
 and the PDAY Study,
131
 or the 
use of invasive techniques that leave a great burden on participants and are not feasible for 
large population studies.  
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The advancement of novel non-invasive imaging techniques during the 1990s opened a new 
era for studying subclinical markers of CVD among young and apparently healthy people. 
These markers are feasible for large population-based studies because they are relatively 
inexpensive, highly reproducible and can be repeated frequently without incurring risk for 
participants.
132-134
 These markers, including the structure (intima-media thickness – IMT) and 
stiffness of an artery, provide information regarding health of the arterial vasculature and may 
reflect early stages of atherosclerosis. IMT is constituted by thickness of the tunica intima and 
tunica media – the two innermost layers of the arterial wall − and is usually measured in the 
carotid artery because the carotid artery wall has a very thin smooth muscle layer and carotid 
atherosclerosis is strongly associated with coronary and peripheral atherosclerosis. In 
particular, carotid IMT is a strong predictor of future cardiovascular events, including 
myocardial infarction and stroke.
129
 Arterial stiffness is also commonly measured in the 
carotid artery (and in the aorta) because stiffening of these large arteries independently 
predicts future cardiovascular events and all-cause mortality.
135-137
 Other subclinical markers 
of CVD that have been used in previous studies include: flow-mediated dilation (an 
endothelium-dependent process facilitating the relaxation of an artery in response to increased 
shear stress
138
), pulse wave velocity (a measure of arterial stiffness
139
) and coronary 
calcification.
140
 
Since the reproducibility and prognostic values of the carotid IMT and carotid artery stiffness 
were established,
36, 141
 these subclinical markers of vascular health have been widely used as 
the main outcomes of interest in many studies that examine the effects of lifestyle risk factors 
– including fatness, and physical activity and fitness – and the effects of interventions to 
reduce these risk factors. However, most of these studies have targeted older adults, used 
small samples, or compared sedentary persons with highly trained athletes. In addition, 
although the association of physical activity and fitness with vascular health has been 
examined in several studies, there has never been a study that specifically investigates the 
possible mechanisms involved in this relationship. Large population-based studies that have 
measured carotid IMT and/or carotid artery stiffness among young people are summarised in 
Table 1.3. All of these studies are on-going longitudinal studies and collected 
anthropometrical measures of participants. Of these studies, only the Childhood Determinants 
of Adult Health (CDAH) Study and Cardiovascular Risk in Young Finns (Young Finns) 
Study collected objectively-measured physical activity, together with information on physical 
activity that were self-reported using a questionnaire. Of these two studies, only the CDAH 
study has objectively-measured CRF on participants. 
 Table 1.3. Summary of large population-based longitudinal studies that have measured carotid intima-media thickness (IMT) and/or 
carotid artery stiffness among young people 
Study Country Commenced in Population at baseline Vascular outcomes measured in adulthood 
The Muscatine Study
142
 USA 1971 N=4829, aged 8–18 years Carotid IMT, measured at 33–42 years of age 
The Bogalusa Heart Study
143, 144
 USA 1973 N=3525, aged 5–14 years Carotid IMT, measured at 20–43 years of age 
The Amsterdam Growth and 
Health Longitudinal Study
145, 146
 
Netherlands 1977 N=450, aged 13 years Carotid IMT and carotid artery stiffness, 
measured at 36 years of age 
The Cardiovascular Risk in Young 
Finns Study
147, 148
 
Finland 1980 N=3596, aged 3–18 years Carotid IMT and carotid artery stiffness, 
measured at 24–39 and at 30–45 years of age 
The Childhood Determinants of 
Adult Health Study
149, 150
 
Australia 1985 N=8498, aged 7–15 years Carotid IMT and carotid artery stiffness, 
measured at 26–36 years of age 
The Atherosclerosis Risk in Young 
Adults Study
151
 
Netherlands 1999–2000 N=750, aged 12–16 years Carotid IMT, measured at 27–30 years of age 
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Childhood origins of CVD 
Although the major manifestations of CVD typically do not present until older ages, the 
antecedents of CVD (notably atherosclerosis) appear earlier in life.
152
 The process of 
atherosclerosis is slow and involves the development of fatty streaks in blood vessels during 
childhood, which may accumulate more lipid deposition in subsequent years to form a fibrous 
plaque. In early stages, there are no symptoms. However, with time, these lesions may enlarge 
and result in complications such as calcification, haemorrhage, rupture or thrombosis. The 
natural history of atherosclerosis is illustrated in Figure 1.2, which was reproduced from 
McGill et al.
153
 The magnitude of the consequences from lesions depends on which artery is 
affected. For example, a lesion in the coronary artery or cerebral artery may result in 
myocardial infarction or stroke, leading to death or severe disability. Conversely, a lesion in a 
small artery might result in minor consequences.  
The first evidence of atherosclerosis beginning in childhood was provided in the late 1950s 
and early 1960s.
154-156
 The authors in these studies demonstrated that fatty streaks were 
present in aortas of children as young as three years of age and that these fatty streaks 
progressed to fibrous plaques by young adulthood. As an extension of their work, these 
authors compared early aortic atherosclerotic lesions among individuals between one and 40 
years of age in New Orleans, Guatemala and Costa Rica.
157
 A similar pattern of the early 
development of fatty streaks was found among these individuals, despite their wide racial and 
environmental differences.
157
 However, the progress from fatty streaks to fibrous plagues was 
different among populations, and these differences were well correlated with the incidence of 
clinical manifestations of atherosclerosis in these populations.
157
 These findings suggest that 
the origin of atherosclerosis begins very early in childhood, and factors (perhaps during late 
childhood and early adulthood) that influence the development of atherosclerosis may be 
important in determining CVD risk at older ages. More recently, autopsy data from the 
Bogalusa Heart Study
130, 158, 159
 and the Pathobiological Determinants of Atherosclerosis in 
Youth (PDAY) Study
131, 160
 respectively showed positive associations of antemortem and 
postmortem CVD risk factors (such as smoking, hypertension, obesity, dyslipidaemia and 
elevated blood glucose) with the extent and severity of atherosclerosis in aortas and coronary 
arteries of young individuals (aged two to 39 years) who died principally from trauma and 
other external causes. Collectively, these findings suggest that control of CVD risk factors 
early in life may delay the development of atherosclerosis. 
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Taking benefits from the advancement of novel non-invasive imaging techniques, many 
cohort studies have now focused on investigating the relationship of CVD risk factors in 
childhood with subclinical markers of CVD in adulthood. These studies are briefly 
summarised in Table 1.4. Although several studies have found a positive association of body 
size and fatness in childhood with carotid IMT and stiffness in adulthood, their findings in 
relation to whether body size and fatness in childhood may influence adult vascular health 
independently of adult body size and fatness are inconsistent. In addition, most of these 
studies relied upon BMI as their sole measure of body size and fatness in childhood. Although 
BMI is commonly used in research and clinical practice, it is not clear whether BMI is 
superior to other practical measures of body size and fatness in respect of predicting long-
term CVD risk.
161, 162
  
 
Figure 1.2. Natural history of atherosclerosis by years of age. 
Reproduced from McGill et al
153
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Table 1.4. Summary of cohort studies investigating the associations of childhood risk 
factors with vascular health in adulthood 
Childhood risk factors Study Vascular health in adulthood Association* 
Body size and fatness BHS
143, 144
 
ARYA
151
 
YFS
147, 148, 163
 
TFC
164
 
MS
165 
AGHL
145, 166
 
Carotid IMT 
Carotid IMT 
Carotid IMT and stiffness 
Carotid IMT 
Coronary calcification 
Carotid IMT and stiffness 
(+) 
(+) 
(+) 
Null 
(+) 
(+) 
Physical activity AGHL
167 
AGHL
168
 
Carotid stiffness 
Brachial and femoral 
compliance 
(−) 
(+) 
CRF AGHL
146, 166
 Carotid IMT 
 
Carotid stiffness 
Male (−) 
Female (Null) 
Null 
Blood lipids BHS
169-171 
MS
142, 165 
YFS
147, 172, 173 
YFS
173 
YFS
174 
AGHL
166 
CDAH
175
 
Carotid IMT 
Carotid IMT 
Carotid IMT and stiffness 
Brachial FMD 
Coronary calcification 
Carotid stiffness 
Carotid IMT 
(+) 
(+) 
(+) 
(−) 
(+) 
(+) 
(+) 
Blood pressure BHS
142, 169 
BHS
176 
YFS
147, 148 
YFS
177 
YFS
174 
AGHL
166
 
Carotid IMT  
Brachial-ankle PWV 
Carotid IMT and stiffness 
Brachial FMD 
Coronary calcification 
Carotid stiffness 
(+) 
(+) 
(+) 
(−) 
(+) 
(+) 
Active smoking YFS
147 
 
 
NIYHP
178
 
Carotid IMT 
Carotid stiffness, brachial FMD 
and coronary calcification 
Aorto-iliac PWV 
(+) 
Null 
 
(+) 
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Passive smoking YFS, CDAH
179
 Brachial FMD (+) 
Unhealthy diet YFS
180, 181
 
YFS
182 
AGHL
183, 184
 
Carotid IMT 
Arterial PWV 
Carotid stiffness 
(+) 
(+) 
(+) 
*(+) indicates a positive association, (−) indicates a negative association, and “Null” indicates 
no association. 
Abbreviations: BHS (the Bogalusa Heart study), ARYA (the Atherosclerosis Risk in Young 
Adults study), YFS (the Cardiovascular Risk in Young Finns study), TFC (Thousand 
Families cohort study), MS (the Muscatine study), AGHL (the Amsterdam Growth and 
Health Longitudinal study), CDAH (the Childhood Determinants of Adult Health study), 
NIYHP (the Northern Ireland Young Hearts Project), CRF (cardiorespiratory fitness), IMT 
(intima-media thickness), FMD (flow-mediated dilation), and PWV (pulse wave velocity). 
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Aims of this thesis 
This research has been designed to help to fill the evidence gaps and produce novel 
information to extend our current knowledge in the field. The main aims are to study the 
relationships of fatness, fitness, physical activity and sedentary behaviour with vascular health 
among younger adults to better understand how these lifestyle risk factors are associated with 
early stages of CVD and to investigate the possible mechanisms involved. In order to do that, 
the novel studies presented in this thesis aim to: 
 Compare the associations of body size and fatness with blood pressure using 
Australian and Vietnamese population-based samples to better understand the 
relationship between fatness and vascular health. 
 Determine whether child fatness predicts adult vascular health, and whether it does so 
independently of adult fatness. 
 Examine the relationship of physical fitness with arterial stiffness, and to investigate 
the possible mechanisms underlying any association. 
 Examine the relationship of different types of physical activity with arterial stiffness, 
and to investigate the possible mechanisms underlying any association. 
 Examine the relationship of sedentary behaviour assessed by sitting time with arterial 
stiffness, and to investigate the possible mechanisms underlying any association. 
Sources of data used in this thesis 
To address the aims of this thesis, data from four large population-based studies were used for 
analyses: the Burnie Take Heart (BTH), Can Tho (CT), CDAH, and Young Finns studies. In 
an attempt to better understand the associations of body size and fatness with blood pressure 
(an important component of cardiovascular health), these associations were compared using a 
sample predominantly containing Caucasians (the BTH study, Australia) and another sample 
predominantly containing Asians (the CT study, Vietnam), which is presented in Chapter 3 of 
this thesis. The findings from this chapter provide some insights into cardiovascular health. 
Thereafter, the associations of fatness, fitness, physical activity and sedentary behaviour with 
vascular health were examined among younger adults. These studies, which are presented in 
Chapters 4, 5, 6 and 7 of this thesis, used data from the CDAH study and the Young Finns 
study, both of which are member cohorts of the International Childhood Cardiovascular 
Cohort (i3C) Consortium. 
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Structure of this thesis 
Chapter 1: Introduction 
Chapter 2: Methods 
Chapter 3: Blood pressure and body mass index: a comparison of the associations in 
Caucasian and Asian populations. 
Chapter 4: Relative contributions of adiposity in childhood and adulthood to vascular health 
in young adults. 
Chapter 5: Resting heart rate and the association of physical fitness with carotid artery 
stiffness. 
Chapter 6: Vigorous physical activity and carotid distensibility in young and mid-aged adults. 
Chapter 7: The association of sitting time with carotid artery stiffness in young adults. 
Chapter 8: Summary, implications, future directions and conclusions 
Concluding remarks 
This chapter provides an overview of CVD burden and risk factors. The evidence from studies 
reviewed in the preceding text of this chapter points out that (1) the development of CVD is a 
long process and has origins from early stages of life, (2) long-term prevention of CVD may 
contribute to reduce CVD burden, and (3) improving lifestyle risk factors including fatness, 
fitness, physical activity and sedentary behaviour may reduce CVD risk, but their 
relationships with early stages of CVD are less clear and need to be examined among younger 
adults. This research aims to examine the relationships of these lifestyle risk factors with early 
stages of CVD assessed by subclinical markers of vascular health among younger adults to 
help to fill the current evidence gaps. The novel findings produced by this research may 
advance our knowledge in the field. 
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Postscript 
The next chapter will describe the participants and methods of the four population-based 
samples used in this thesis.  
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Chapter 2. Methods 
Preface 
This thesis aims to examine the relationship of fatness, fitness, physical activity and sedentary 
behaviour with vascular health and to investigate the possible mechanisms involved using an 
epidemiological approach. The data used for these analyses were from four large population-
based samples, including those from the Burnie Take Heart project (Chapter 3), the Can Tho 
survey (Chapter 3), the Childhood Determinants of Adult Health study (Chapter 4, 5, 6, and 
7), and the Cardiovascular Risk in Young Finns study (Chapter 6). This chapter briefly 
describes the participants and the methods of these samples that are relevant to this research. 
More details related to a specific sample can be found in the respective studies that are 
presented in the following Chapters 3–7. Data from all samples included in this thesis were 
approved by appropriate ethics committees. 
The Burnie Take Heart (BTH) project 
The BTH project was originally an initiative of the National Heart Foundation of Australia as 
an intervention to improve cardiovascular health in the community. The BTH project 
conducted two major surveys, pre- and post-intervention. The pre-intervention (baseline) 
survey was conducted between 1996 and 1997, followed by community-based promotions of 
public health with a focus on nutrition and physical activity. The post-intervention survey was 
conducted between 1998 and 1999. The study in Chapter 3 of this thesis used data from the 
post-intervention survey of the BTH project,
1
 which is described in this section. This project 
was approved by the Ethics Committee of the University of Tasmania. 
Study design 
The BTH project included two cross-sectional surveys conducted during 1996-97 and 
repeated during 1998-99. 
Sampling and participants 
Participants aged 25-64 years were selected by age- and sex-stratified random sampling from 
among those on the Electoral Roll of registered voters in Tasmania (Australia) who had an 
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address within the Burnie municipalities, located in the north west of Tasmania as in Figure 
2.1. The overall response rate was 69% (832/1205). The response rate of women (73%; 
439/600) was greater than men (65%; 393/605). The age-specific participation was 66% (25-
34 years), 67% (35-44 years), 71% (45-54 years) and 73% (55-64 years). Due to low response 
of younger persons in the pre-intervention survey, they were marginally oversampled in the 
post-intervention survey during 1998-99 to provide similar numbers of participants in each 
age group. 
 
Figure 2.1. Location of Burnie in the north west Tasmania, Australia. 
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Measurements 
Physical measurements of participants, including blood pressure and anthropometry, were 
obtained by trained field staff. 
Blood pressure 
Blood pressure was measured using a Dinamap Vital Signs Monitor 1846SX (Critikon 
Company, Tampa, FL, USA). This device was calibrated against a standard mercury 
sphygmomanometer before each week of clinic use. Correct cuff sizes were determined for 
the right upper arm before measuring blood pressure. Three readings of blood pressure were 
taken in an upright sitting position after the participants had rested for at least 10 minutes.  
Anthropometry 
This includes weight, height, and waist and hip circumference. Each participant’s weight was 
measured to the nearest 0.1 kg, in bare feet without heavy clothing, using digital scales. 
Height was measured to the nearest 0.1 cm, in bare feet without headwear, using a 
stadiometer. Waist circumference at the narrowest point between the lower costal border and 
the iliac crest, and hip circumference at the greatest posterior protuberance of the buttocks, 
were measured to the nearest 0.1 cm. The mean was calculated from two waist and hip 
circumferences. If there was a difference greater than 2 cm (waist circumference) or 1.4 cm 
(hip circumference), a third measure was taken. A median of the three measures would then 
be calculated and used. 
Other measurements 
14 ml of blood taken from 9-hour fasting participants were sent to the same accredited 
teaching hospital laboratory to measure total cholesterol and plasma glucose. Level of 
education, type of employment, smoking (never smoker, ex-smoker, or current smoker), 
frequency of alcohol consumption, diet and physical activity were obtained from self-reported 
questionnaire. The questionnaire used in this survey was developed using questions from 
various standardised resources, including the National Heart Foundation Risk Factor 
Prevalence study (Survey No 3, 1989),
2
 the short fat questionnaire,
3
 the self-efficacy scales 
for exercise behaviours,
4
 and the 1996 Tasmanian Food and Nutrition study.
5
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The Can Tho survey 
Can Tho is the largest city of the Mekong Delta – literally called “the Nine Dragon River 
Delta” – and locates in the far southern region of Vietnam as illustrated in Figure 2.2. While 
being the main food production area for the country, health services for the Mekong Delta 
were reported to be below the country average.
6
 The Can Tho survey was conducted in 2005 
and aimed to study risk factors for non-communicable diseases among residents living in this 
area. Ethics approval was provided by the Can Tho University of Medicine and Pharmacy. 
Study design 
The Can Tho survey was designed as a cross-sectional survey following the World Health 
Organization STEPwise approach to surveillance of non-communicable disease (STEPS).
7
 
Sampling and participants 
The Can Tho survey was conducted among Can Tho adult residents aged 25-64 years. 
Participants were selected by multi-stage random sampling with age, sex and urban/rural 
stratification.
8-10
 Briefly, the sampling process included 3 stages. Stage 1 was the selection of 
urban/rural-classified communes with probability proportional to size and with replacement. 
Stage 2 was the selection of health volunteers within each commune who were responsible for 
providing basic health services for residents living in their local areas. These health volunteers 
maintain and update the list of local residents regularly. Stage 3 was the selection of persons 
from lists of residents kept by health volunteers with stratification by sex and age group (25-
34, 35-44, 45-54 and 55-64 years). 2683 persons were eligible. Of these, 73.7% (1978/2683) 
participated in the survey. Data collection was carried out from July to November 2005. 
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Figure 2.2. Location of Can Tho in the far south of Vietnam. 
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Measurements 
Physical measurements of participants, including blood pressure and anthropometry, were 
obtained by trained field staff. 
Blood pressure 
Blood pressure was measured on the right upper arm using an Omron T9P digital automatic 
blood pressure monitor after the participants had rested for at least five minutes. This device 
was calibrated against a standard mercury sphygmomanometer before each day of clinic use. 
Two readings of blood pressure were taken for all participants. A third reading was taken for 
24 men because there was a difference of greater than 25 mmHg for systolic blood pressure or 
15 mmHg for diastolic blood pressure, following the STEPS protocols in 2005.
7
 A mean of all 
three readings was used for analysis. 
Anthropometry 
Weight was measured in bare feet without heavy clothing using a Seca 767 digital scale. 
Height was measured in bare feet without headwear using a Seca 220 stadiometer. Waist 
circumference was measured at the narrowest point between the lower costal border and the 
iliac crest using a constant tension tape. Hip circumference was measured at the greatest 
posterior protuberance of the buttocks. 
Other measurements 
Total cholesterol and plasma glucose were measured in capillary blood of participants who 
had fasted for at least 12 hours using a Roche Diagnostics Accutrend Glucometer (Roche 
Group, Basel, Switzerland). Level of education, type of employment, smoking (never smoker, 
ex-smoker, or current smoker), frequency of alcohol consumption, fruit and vegetable 
consumption, and physical activity were recorded using the STEPS questionnaire.
7
 Some 
locally relevant questions and response options were added to the questionnaire to suit the 
local needs (for example, types of work that were specific to the local area). These 
modifications were added in accordance to the STEPS protocols.
7
 The questionnaire was 
translated to Vietnamese and back translated to English by independent translators to ensure 
the integrity of the original meaning of each question. 
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The Childhood Determinants of Adult Health (CDAH) study 
The CDAH study (conducted during 2004-2006) is a 20-year follow-up of the 1985 
Australian Schools Health and Fitness Survey (ASHFS), which collected an extensive range 
of lifestyle, physical and biological measures on a nationally representative sample of 8498 
Australian schoolchildren aged 7-15 years. The CDAH study aims to determine the 
contribution of childhood risk factors to the development of cardio-metabolic diseases in 
adulthood. It is a member cohort of the International Childhood Cardiovascular Cohort (i3C) 
consortium, which contains several similar longitudinal studies in the world with the same 
principal aim as the CDAH’s.  
The 1985 ASHFS was approved by the State Directors General of Education. The CDAH 
follow-up study was approved by the Southern Tasmania Health and Medical Research Ethics 
Committee. 
Study design 
This study was designed as a cohort study. 
Baseline data (the 1985 ASHFS) 
Sampling and participants 
The 1985 ASHFS was conducted on a nationally representative sample of 8498 Australian 
schoolchildren aged 7-15 years. The sampling procedure was reported elsewhere.
11
 Briefly, 
these children were selected using two-stage random sampling. Stage 1 was the selection of 
schools with a probability proportional to enrolment numbers. Schools with total enrolment of 
less than 200 students (9.9% of primary schools and 3.1% of secondary schools) were 
excluded. Of the 121 schools selected, 90.1% (109/121) agreed to participate. The distribution 
of participating schools is shown in Figure 2.3. Stage 2 was the selection of children within 
each school with age and sex stratification. The study aimed for 500 boys and 500 girls from 
each year of age. Of the 12578 schoolchildren invited, 8498 (67.5%) children participated in 
the study. The detailed school and individual participant flow is described in Figure 2.4.  
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Figure 2.3. Distribution of schools participating in the 1985 ASHFS indicated by the 
green dots. 
Measurements 
In the 1985 ASHFS, measurements included a wide range of physical and biological 
parameters, including anthropometric measures (weight, height, waist circumference, hip 
circumference, and skinfolds), blood pressure, and fasting blood glucose and cholesterol. 
Height and weight were measured in bare feet without headwear and heavy clothing to the 
nearest 0.1 cm and 0.5 kg, respectively. Waist circumference was measured at the level of 
umbilicus. Hip circumference was measured at the level of the greatest posterior protuberance 
of the buttocks. Biceps, triceps, subscapular and suprailiac skinfolds were measured to the 
nearest 0.1 mm using Holtain Calipers (Holtain, Crymych, UK) only for those then aged 9, 12 
and 15 years. Blood pressure (using a standard mercury sphygmomanometer) and blood test 
(using a Technicon Auto Analyzer II, Technicon Instrument corp, New York, USA) were 
measured only in those who were aged 9, 12 and 15 years. All measurements were done in 
clinics by trained field staff. Blood samples were taken by qualified nurses. Children aged 
nine years and older also completed a questionnaire on demographics, diet, physical activity 
and other lifestyle behaviours in small supervised groups. Data on parental highest education 
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was obtained by self-administered questionnaire. Socio-economic status based on residential 
postcodes was derived using the Australian Bureau of Statistics Index of Relative 
Socioeconomic Disadvantage that was constructed using information from the Australian 
population census.
12
 The socio-economic status in childhood was determined using the 1981 
census data. 
Follow-up data (the CDAH study 2004-06) 
Participants 
During 2001–04, 80.5% (6840/8498) of the original participants were traced through the 
Australian Electoral Commission and the Australian National Death Index, and through 
school and family networks. Of these, 5170 (60.8% of the original participants) agreed to 
enrol in the CDAH study, and 2410 (28.4% of the original participants) attended one of the 34 
clinics held across Australia during 2004–06. The detailed school and individual participant 
flow in the 1985 ASHFS and the CDAH study is described in Figure 2.4.  
Study clinics 
Clinics were held during 2004–06 in each state and territory of Australia, including New 
South Wales/Australian Capital Territory (nine clinics, 720 participants), Victoria (eight 
clinics, 705 participants), Queensland (eight clinics, 497 participants), Western Australia 
(three clinics, 205 participants), South Australia (three clinics, 190 participants), Tasmania 
(two clinics, 55 participants) and Northern Territory (one clinic, 38 participants). The clinic 
locations were chosen to maximise the proportion of enrolled participants living within a 10 
km radius. These locations included community centres, schools, church halls or similar 
venues. 
Two weeks before the clinic, participants were sent three questionnaires (general, diet and 
physical activity). They were asked to complete the questionnaires and bring them to the 
clinic. The data collection teams included ten data collectors, one field co-ordinator and a 
trained venipuncturist. Training for each test was provided by the same person for each state 
and territory. Clinics took approximately three hours to complete. Participants were required 
to fast for 12 hours before their clinic appointment. At the clinic, anthropometric 
measurements, blood pressure, vascular ultrasound examination and blood test were done 
before participants were provided breakfast. After breakfast, participants completed other 
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examinations including cardiorespiratory fitness and muscular strength, and were issued a 
pedometer. Those participants who enrolled in the CDAH study but refused or were unable to 
attend a clinic (n=2760) were asked to complete a full or short questionnaire, or visit local 
pathology centre for a blood collection. Because full data are not available for these 
participants, they were not included in the analyses used for this thesis. 
 
Figure 2.4. School and individual participant flow in the 1985 ASHFS and the CDAH 
study. 
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Measurements 
Blood pressure 
Blood pressure was measured supine during the ultrasound examination using an Omron M4 
Digital Automatic Blood Pressure Monitor (Omron Corporation, Kyoto, Japan). A correct 
cuff for the right upper arm was chosen before measurements. A mean of two readings, which 
were measured at least one minute apart, was used for analysis.  
Carotid intima-media thickness (IMT) 
B-mode ultrasound studies of the left common carotid artery were performed using a portable 
Acuson Cypress (Siemens Medical Solutions USA Inc., Mountainview, CA) ultrasound 
machine with a 7.0 MHz linear-array transducer (as illustrated in Figure 2.5). Because the 
nature of clinical data collection for the CDAH study required an ultrasound machine to be 
moved around 34 clinics across Australia during 2004–06, the Acuson Cypress was identified 
as the only suitable portable system that incorporated ECG monitoring (necessary to ensure 
vascular measurements were collected at standardised phases in the cardiac cycle). Before its 
inclusion in the CDAH study, the measures of arterial structure and function derived from the 
portable Acuson Cypress were validated against those from a routinely-used clinic-based 
ultrasound machine like that used in the Cardiovascular Risk in Young Finns study (Acuson 
Sequoia 512, Siemens Medical Solutions USA Inc., Mountainview, CA).
13
 All the ultrasound 
examinations were done by a single technician who travelled to each of the clinics. 
 
Figure 2.5. A carotid ultrasound examination in the CDAH study. 
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The B-mode ultrasound studies of carotid IMT followed a previously reported standardised 
protocol.
14
 Briefly, the left common carotid artery and left carotid bifurcation were traced 
longitudinally so that the distal 10–30 mm of the artery was imaged with focus on the 
posterior (far) wall. A real-time image of three consecutive cardiac cycles was recorded. From 
the best-quality cardiac cycle, a total of 12 measurements at two positions were taken 
approximately 10 mm proximal from the bulb at the end-diastolic phase (coinciding with the 
R-wave on a continuously recorded ECG). All images were stored in digital format for off-
line analysis using the Image Pro Plus version 5.02 (Media Cybernetics, Inc., Silver Spring, 
MA, USA). An ultrasound image of the carotid artery is shown in Figure 2.6. The mean and 
maximum of each of six measurements were calculated, and they were averaged to derive 
mean and maximum IMT. The measurements of IMT were made by three readers, blinded to 
participants’ details. The mean maximum IMT measurements of the three readers were 0.588 
mm ± 0.093 (n=769), 0.595 mm ± 0.103 (n=702), and 0.590 mm ± 0.074 (n=512). The 
measurements of the three readers were calibrated to have the same mean adjusted for factors 
that differed between the groups of subjects measured by each reader. This procedure is 
necessary to preserve the associations of IMT with the same independent variables used in the 
main analysis. For example, the association of maximum IMT with childhood weight z-scores 
adjusted for age and sex was 𝑟=0.080 (pre-calibration) and 𝑟=0.079 (post-calibration). Intra-
reader reproducibility was assessed in a random subsample of 30 participants. The average 
absolute difference and standard deviation for replicate IMT measurements was 0.02 mm ± 
0.04.
15
 
 
Figure 2.6. An ultrasound image of the carotid artery (IMT – intima-media thickness). 
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Arterial stiffness 
The end-systolic and end-diastolic phases were determined based on the continuously 
recorded ECG (using end T-wave and R-peak). The end-systolic and end-diastolic carotid 
diameters, which were the maximum and minimum diameters during a cardiac cycle, were 
taken 10 mm proximal from the carotid bulb. These values, together with concomitant blood 
pressure measures, were used to calculate three indices of arterial stiffness as follows: 
CD = ([Dsbp−Ddbp]/Ddbp)/(SBP−DBP) 
SI = ln(SBP/DBP)/([Dsbp−Ddbp]/Ddbp) 
YEM = ([SBP−DBP)Ddbp)/([Dsbp−Ddbp]/IMT) 
where Dsbp is the end-systolic diameter, Ddbp is the end-diastolic diameter, SBP is brachial 
systolic blood pressure, and DBP is brachial diastolic blood pressure. Carotid distensibility 
(CD) measures passive expansion and contraction of the arterial wall with changes in 
pressure. Stiffness index (SI) is a measure of arterial stiffness designed to be relatively 
independent of blood pressure. Young’s elastic modulus (YEM) is an estimate of arterial 
stiffness per mm of IMT.  
Resting heart rate 
Resting heart rate was measured while sitting using an Omron HEM907 Digital Automatic 
Blood Pressure Monitor (Omron Corporation, Kyoto, Japan) after resting for at least five 
minutes. A mean of three readings, taking approximately one minute for each reading, was 
used for analysis. Resting heart rate was also measured from the ECG during the ultrasound 
examination. Analyses using this value of resting heart rate provided the same results as using 
the resting heart rate recorded from the blood pressure monitor.  
Anthropometry 
Height and weight were measured in bare feet and light clothes, and without headwear, to the 
nearest 0.1 cm and 0.1 kg, respectively. Body mass index was calculated as weight (kg) 
divided by height in squared meter (m
2
). Waist circumference was measured at the narrowest 
point between the lower costal border and iliac crest. Hip circumference was measured at the 
level of the greatest posterior protuberance of the buttocks. Skinfolds were measured to the 
nearest 0.5 mm at the bicep, tricep, iliac crest and supraspinale. Measures of skinfolds greater 
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than 40 mm were truncated due to caliper limitations and estimated values were imputed from 
body mass index and waist circumference using Tobit Regression.
16
 The sum of four 
skinfolds was used for analysis. 
Physical activity and sedentary behaviour 
Data on physical activity in the CDAH study were self-reported using the long version of the 
International Physical Activity Questionnaire,
17
 and was objectively measured using 
pedometers. The International Physical Activity Questionnaire has been shown to have 
acceptable reproducibility (one week test-retest intra-class correlation in the range of 0.74 to 
0.89) and comparative validity (rank correlation with accelerometer counts range of 0.20 to 
0.51),
17
 and is presented in Appendix 9.  
For self-reported physical activity, participants recorded total hours and minutes of the last 
seven days that were spent on four domains of physical activity including work-related, 
domestic, transport and leisure-time. The intensity (moderate or vigorous) was also recorded 
for work-related, domestic and leisure-time physical activity. Vigorous physical activities 
were defined as those that required hard physical effort and made the participants breathe 
much harder than normal. Moderate activities were defined as those that made the participants 
breathe somewhat harder than normal. Active transport was classified as moderate intensity. 
The minutes spent on the four domains were summed to obtain the total time spent on 
moderate-to-vigorous physical activity for the last seven days. These were weighted by their 
moderate and vigorous intensity – by assigning metabolic equivalent of task values of four 
and eight respectively – to obtain total energy expenditure. 
Participants also reported how much time (hours and minutes) they spent on sitting on a 
weekday (Monday to Friday) and weekend day (Saturday and Sunday) during the last seven 
days using the International Physical Activity Questionnaire.
17
 Time spent watching 
television, using a computer and playing video games were also recorded in the same manner. 
This item has also been shown to have good reproducibility (one week test-retest intra-class 
correlation of 0.82) and comparative validity (rank correlation with three day sedentary 
behavior log of 0.3).
18
 
For objectively-measured physical activity, participants wore Yamax Digiwalker SW-200 
pedometers to record daily steps over seven consecutive days. Of the 16,085 daily records 
collected, 328 records (2%) were excluded because the pedometers were worn for less than 
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eight hours, which was unlikely to represent a complete day. Another 11 records (0.07%) 
were also excluded because  more than 60,000 steps per day were recorded, which were likely 
to be erroneous.
1
 Average steps per day was calculated for participants who wore pedometers 
for at least four days, consistent with other studies;
19
 25 participants did not meet this 
criterion.    
Cardiorespiratory fitness 
Cardiorespiratory fitness was estimated as physical work capacity at a heart rate of 170 bpm 
(PWC170). PWC170 was estimated using a bicycle ergometer (Monark Exercise AB, Vansbro, 
Sweden) pedaled at 60 rpm.
20
 Participants pedaled continuously for 12 minutes at 60 rpm, 
which included three 4-minute periods where workload was increased at the end of every 
fourth minute. The workload increases were regulated so that heart rate achieved by the 
participants at the end of the first, the second, and the third period were greater than 115, 130 
and 145 respectively. Steady state heart rate was recorded in the last 15 seconds of each 
period. Heart rate measurements were then plotted against mechanical power, and the data 
points were used to extrapolate to heart rate 170 bpm where the corresponding power estimate 
would represent the PWC170. The greater values of PWC170 mean greater fitness. Because the 
absolute workload achieved is a function of muscle mass,
21
 cardiorespiratory fitness was 
calculated as PWC170 adjusted for lean body mass to create an index uncorrelated with lean 
body mass. Formulas that were used to calculate lean body mass are presented in Appendix 
5.A of Chapter 5, in which the association of cardiorespiratory fitness with vascular health is 
examined. Participants were asked not to exercise vigorously or eat a heavy meal two hours 
before testing, not to drink tea or coffee three hours before testing, and not to smoke one hour 
before testing. Participants with the following conditions were excluded from the test: body 
weight greater than 160 kg, being pregnant for more than three months, having current or past 
severe injuries or having hip or knee replacement, having resting blood pressure greater than 
180 mmHg or having resting heart rate greater than 100 bpm. Of the 2410 participants 
attending clinic, 1960 (81.3%) completed this test. 
Muscular strength 
Five measures of strength were measured in different types of large muscles using hand-grip, 
shoulder-arm and leg-back dynamometers (Smedley’s Dynamometer, TTM, Tokyo, Japan). 
Each measure was repeated twice with at least 1-minute rest apart. The maximum of the two 
attempts was used in analysis. Grip strength (left and right) was measured as participants held 
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the dynamometer with one hand, supported it on the opposite shoulder, and gripped with 
maximum force. Shoulder strength (pull and push) was measured as participants held the 
dynamometer in front of their chest so that their arms and elbows were parallel to the ground, 
and then pulled or pushed with maximum force. For leg strength, participants were asked to 
stand on the dynamometer with a straight back, flat against the wall, holding a hand bar with 
an overhand grip. Knees were flexed until an angle of 115º was obtained, at which position 
the bar was attached to the dynamometer by a chain. Participants then pulled the bar upward 
as far as possible. Other than leg strength that was measured to the nearest 1kg, the other four 
measures of muscular strength were measured to the nearest 0.5kg. Before testing in each 
Australian state or territory, the dynamometers were calibrated by either a private company 
accredited by the National Association of Testing Authorities, Australia, or by a hospital-
based biomedical engineering department, through the entire range of measurement of the 
device.  
Other measurements 
Data on highest level of education, socio-economic status, smoking, alcohol consumption and 
female reproductive characteristics (including menstrual cycle regularity, age at menarche, 
parity and hormonal contraceptive use) were obtained using a self-administered questionnaire. 
Socio-economic status based on residential postcodes was derived using the Australian 
Bureau of Statistics Index of Relative Socioeconomic Disadvantage.
22
 Smoking status was 
classified as never-smoker, ex-smoker, less than weekly, weekly or daily current-smoker. 
Alcohol consumption was calculated using a frequency grid.
23
 All the blood tests were done 
in a single laboratory. High-density lipoprotein cholesterol (HDL-C) and triglycerides 
concentrations were measured in 12-hour overnight fasting blood samples using an Olympus 
AU5400 automated analyzer (Olympus Optical, Tokyo, Japan). Low-density lipoprotein 
cholesterol (LDL-C) concentration was calculated using the Friedewald formula.
24
 Fasting 
plasma insulin was measured by a microparticle enzyme immunoassay kit (AxSYM, Abbot 
Laboratories, Abbot Park, IL, USA) and by electrochemiluminescence immunoassay (Elecsys 
Modular Analystics E170; Roche Diagnostics, Manheim, Switzerland) with interassay 
standardization.
16
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The Cardiovascular Risk in Young Finns (Young Finns) study 
The Young Finns study is an on-going five-centre prospective cohort study (as shown in 
Figure 2.7) that collected baseline data in 1980 when the participants were aged 3–18 years. 
Thereafter, follow-up studies were done every three years up until 1992 to collect data on 
anthropometry, and physical and biological measurements. Ultrasound studies of the carotid 
artery were performed in the 21-year follow-up in 2001 and the 27-year follow-up in 2007 
when the participants were aged 24–39 years and 30–45 years, respectively. The follow-up 
study in 2007 also measured average steps per day of the participants by using pedometers. 
These data in 2007 were used for analyses in Chapter 6 of this thesis, and are described in the 
following section. The study was conducted according to the guidelines of the Declaration of 
Helsinki, and was approved by local ethics committees. Similar to the CDAH study, the 
Young Finns study is also a member cohort of the i3C consortium. 
 
Figure 2.7. The five centres of data collection in the Young Finns study. 
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Study design 
This study was designed as a cohort study. 
Sampling and participants 
In 1980, 4320 Finnish children and adolescents were randomly selected from the Finnish 
Social Insurance Institution’s national population register, stratified by sex and age groups 
(including 3, 6, 12, 15 and 18 year-old). The population register covers the entire population 
in Finland and is regularly updated. Of the 4320 invited, 3596 boys and girls (83.1%) agreed 
to participate in the study in 1980. Of the 3596 participants at baseline, 2204 (61.3%) agreed 
to continue participating in the 27-year follow-up in 2007. The detailed participant flow in the 
Young Finns study is described in Figure 2.8.  
 
Figure 2.8. Participant flow in the Young Finns study. 
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Measurements 
Blood pressure  
In 2007, brachial blood pressure was measured on the right upper arm using a random-zero 
sphygmomanometer (Hawksley & Sons Ltd, Lancin, UK) after resting for at least five 
minutes. A correct cuff for the right upper arm was chosen before measurements. Systolic 
blood pressure was recorded using the first Korotkoff phase. Diastolic blood pressure at both 
the fourth and fifth Korotkoff phases was recorded. The value of diastolic pressure at the fifth 
Korotkoff phase was used for analysis. Readings were made to the nearest even number of 
mmHg. A mean of three readings was used for analysis. 
Arterial stiffness 
The ultrasound studies of the carotid artery (using Sequoia 512 ultrasound mainframes 
(Acuson, USA) with 13.0MHz linear-array transducers) followed the same standardised 
protocol that was used in the CDAH study.
14
 All the ultrasound measurements were also 
made offline using stored digital images by one reader, blinded to participants’ details. Again, 
similar to the CDAH study, the end-systolic and end-diastolic carotid diameters were used 
together with concomitant brachial blood pressure to calculate the three indices of arterial 
stiffness that were used in the CDAH study. To assess the reproducibility, re-examination of 
57 randomly selected participants three months after the initial examination showed between-
visits coefficients of variations of 6.4% for carotid intima-media thickness, and 14.3% for 
arterial stiffness. 
Resting heart rate 
Resting heart rate was measured by ECG during the ultrasound examination. All participants 
had rested for at least five minutes before the examination was conducted. 
Anthropometry 
Weight was measured in light clothes and bare feet to the nearest 0.1 kg using a digital scale. 
Height was measured in bare feet and without headwear to the nearest 0.5 cm using a wall-
mounted stadiometer. Body mass index was calculated by weight (kg) divided by height in 
squared meter (m
2
). 
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Physical activity 
Similar to the CDAH study, physical activity in the Young Finns study was self-reported 
using a questionnaire and objectively-measured using pedometers. For self-reported physical 
activity, the amount of time per usual week that was spent on two domains of physical 
activity (leisure-time and transport) was recorded.
25
 Participants reported leisure-time 
vigorous physical activity – which made the participants breathe much harder than normal or 
have shortness of breath – per usual week by choosing one of the following answer options: 
“none”, “approximately 30 minutes”, “1 hour”, “2-3 hours”, “4-6 hours” and “7 hours or 
more”. The validity of this questionnaire was tested by an experimental study and showed 
comparable validity against accelerometers (correlation coefficients ranging from 0.26 to 
0.40) and pedometers (correlation coefficients ranging from 0.30 to 0.39).
25
 For objectively-
measured physical activity, participants wore Omron Walking Style One (HJ-152R-E) 
pedometers for seven days.
26
 Average number of steps per day was calculated for participants 
wearing pedometers at least eight hours per day for four days, consistent with other studies 
including CDAH.
19, 27
 
Other measurements 
Cardiorespiratory fitness was estimated in a random subsample of 538 participants (47.8% 
male) by a bicycle ergometer using hypothetical maximal workload sustainable for six 
minutes measured on the basis of age, sex, height, and weight.
28
 Level of education, smoking 
and alcohol consumption were reported using a questionnaire. 12-hour overnight fasting 
concentrations of high density lipoprotein cholesterol and triglycerides were determined 
enzymatically in a clinical chemistry analyzer (AU400, Olympus Optical, Mishima, Japan). 
Low density lipoprotein cholesterol concentration was calculated using the Friedewald 
formula.
24
 Insulin was measured by microparticle enzyme immunoassay kit (Abbott 
Laboratories, Diagnostic Division, Dainabot). Glucose concentrations were analyzed 
enzymatically (glucose dehydrogenase, Olympus Diagnostica GmbH). 
Statistical analyses 
All statistical analyses were performed using STATA 12 (Statacorp, College Station, Texas, 
USA). Statistical significance was set at a two-tailed p-value ≤ 0.05. The statistical methods 
used to address the research aims of this thesis are reported in details in the corresponding 
chapter. Chapter 3 included older adults many of whom had developed hypertension and were 
on anti-hypertensive medication. Therefore, they were excluded from analyses of the 
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relationship between BMI and blood pressure. Chapters 4–7 included only younger adults of 
whom very small proportions were on medication for hypertension or diabetes or had 
developed symptomatic cardiovascular disease. Excluding these participants made no material 
difference to the results.  
Loss to follow-up of the ASHFS sample is selective, with those who participated in CDAH 
having poorer socio-economic status, lower school performance, greater BMI, and lower 
cardiorespiratory fitness (p<0.05) in childhood in 1985 than those who participated in CDAH. 
In consequence, the missing data for ASHFS subjects who did not participate in CDAH are 
not missing completely at random (MCAR), which requires the probability of dropout to be 
unrelated to the outcomes and covariates whether observed or not. In other words, MCAR 
requires the probability of dropout to be unrelated to every characteristic of the subject. If 
instead the probability of dropout is related to the covariates and to pre-dropout (observed) 
values of the outcomes, but not to the missing (unobserved) values of the response variables, 
the missing data would be missing at random (MAR). Whether missing data that are not 
MCAR are nevertheless MAR cannot be established from the observed data, because the data 
on the response variables for drop-outs are missing and therefore not available to test whether 
they are independent of the probability of dropout.  
The distinction is important because if the missing data were MCAR, a complete case 
analysis of the data as has been undertaken in this thesis – using frequentist statistical 
procedures such as analysis of variance and linear regression – would be unbiased. If the 
missing data were MAR but not MCAR, ignoring the missing data would produce bias if 
participants with complete data differ from non-participants with incomplete data. Doing so 
would also reduce precision and study power. There are three general methods of dealing with 
missing data. They are (a) multiple imputation of the missing data with a correctly-specified 
imputation model, (b) modelling the relationship between the mean response and the 
probability of missingness using correctly-specified statistical models as part of the estimation 
process, and (c) the assignment of statistical weights to the participants. The third approach 
has been argued by Höfler et al
29
 to be the most appropriate method for missing data due to 
dropout, when entire sets of data on responses and covariates are missing. In particular, the 
inverse probability weighting (IPW) of the non-missing data was employed. This involves 
modelling the probability of missingness as a function of covariates and pre-dropout 
responses. If the probabilities are estimated from a correctly-specified probability model, the 
bias (if any) would be removed if the missing data were MAR but not MCAR. This approach 
was not guaranteed to remove the bias due to missing data (if any) in the analyses undertaken 
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in the thesis because it could not be guaranteed that the missing data were MAR, though there 
was no reason to suspect otherwise. Nevertheless, analyses reported in the thesis were 
repeated using IPW as an attempt to gain insights into the extent of the bias (if any). In every 
instance, the change in the estimated associations was minor relative to the reported measure 
of association. This does not confirm the absence of bias because this procedure involved 
comparing a possibly biased measure of association with a possibly biased weighted measure 
of association in circumstances that the biases (if any) may be positively correlated. However, 
it provided some limited reassurance that the bias (if any) was unlikely to be substantial. 
We outline below the calculation of the IPW weights and the IPW results for the analyses 
reported in Chapter 7. These analyses were chosen because – at the request of a reviewer of 
the manuscript reproduced in Chapter 7 – specific comment is made there about the results of 
the IPW analyses. In the interest of brevity, the calculation of IPW weights and the IPW 
results are not reported for analyses in Chapters 4–6. In each set of analyses, the results and 
conclusions were similar to those of Chapter 7. 
Firstly, the weights were calculated from a logistic regression of a binary indicator for non-
missingness on factors related to non-missingness for which data were available for all 
ASHFS subjects. These factors were socio-economic status, school academic performance, 
BMI and cardiorespiratory fitness measured by time to finish 1.6 km run. The results of the 
regression model are shown in the following Table 2.1. The weights used in the IPW analyses 
were the inverse of the predicted probabilities for each of the ASHFS subjects who 
participated in the CDAH follow-up. Among ASHFS subjects who are similar in the factors 
that predict non-missingess, the data for CDAH participants are used to represent the data for 
CDAH non-participants. The CDAH participants with high weights (low predicted 
probabilities of non-missingness) represent a relatively large number of CDAH non-
participants similar to them in ASHFS factors that predict non-missingness, whereas those 
with low weights represent the missing data of relatively few of their similar CDAH non-
participants. The following Table 2.2 shows the reported and IPW results for the major 
associations estimated in Chapter 7. It is readily seen that the estimates of association are in 
most cases almost unchanged, and changed by less than 5% in every case. 
In the Young Finns study, there was no significant difference in anthropometry and 
demography at baseline in 1980 between the participants who attended clinic in 2007 and 
those who did not. 
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Table 2.1. Logistic regression model used to calculate the inverse probability weights 
in the CDAH study 
Covariates β (SE) [95% CI] 
Male    
Socio-economic status −0.14 (0.04) [−0.23, −0.06] 
School academic performance −0.33 (0.04) [−0.41, −0.24] 
BMI −0.12 (0.04) [−0.19, −0.03] 
Cardiorespiratory fitness −0.08 (0.04) [−0.17, −0.00] 
Constant −0.18 (0.16) [−0.49, 0.13] 
Female    
Socio-economic status −0.15 (0.04) [−0.23, −0.06] 
School academic performance −0.36 (0.04) [−0.45, −0.28] 
BMI −0.10 (0.04) [−0.18, −0.02] 
Cardiorespiratory fitness −0.10 (0.04) [−0.19, −0.02] 
Constant 0.05 (0.14) [−0.22, 0.32] 
 
 
Table 2.2. The associations of sitting time with health outcomes in CDAH study 
before and after inverse probability weighting 
 Before inverse probability 
weighting 
After inverse probability 
weighting 
 β 95% CI β 95% CI 
Men     
Carotid distensibility −0.02 (−0.03, −0.01) −0.02 (−0.04, −0.01) 
Resting heart rate 0.37 (0.17, 0.56) 0.39 (0.20, 0.59) 
Skinfolds 0.67 (0.13, 1.20) 0.70 (0.12, 1.29) 
cMetS* 0.02 (0.01, 0.03) 0.02 (0.01, 0.03) 
Women     
Carotid distensibility −0.01 (−0.02, −0.00) −0.01 (−0.02, −0.01) 
Resting heart rate 0.10 (−0.08, 0.29) 0.10 (−0.12, 0.33) 
Skinfolds 0.93 (0.38, 1.56) 0.90 (0.11, 1.65) 
cMetS* 0.02 (0.00, 0.04) 0.02 (0.00, 0.04) 
*continuous metabolic syndrome score 
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Postscript 
The following chapters present studies that used data from the aforementioned samples to 
address the aims of this research. Specifically, Chapter 3 utilised data from the BTH project 
and the Can Tho survey to compare the associations of fatness with blood pressure between 
Caucasians and Asians; Chapter 4 utilised data from the 1985 ASHFS and the CDAH study to 
investigate the relative contribution of fatness in childhood and adulthood to adult vascular 
health; Chapter 5 utilised data from the CDAH study to examine the associations of physical 
fitness with vascular health and to investigate the possible mechanisms; Chapter 6 utilised 
data from the CDAH study and the Young Finns study to investigate the associations of 
different types of physical activity with vascular health; and Chapter 7 utilised data from the 
CDAH study to examine the associations of sitting time with vascular health. 
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Chapter 3. Blood pressure and body mass index: a 
comparison of the associations in Caucasian and Asian 
populations 
Preface 
In an attempt to better understand the associations of body size and fatness with vascular 
health, this chapter aims to compare the associations of body size and fatness with blood 
pressure in a population-based sample predominantly containing Caucasians (Burnie Take 
Heart project, Australia) to those in another population-based sample predominantly 
containing Asians (Can Tho survey, Vietnam). These two samples have similar sampling 
methodology and protocols, and included participants within the same age range. This 
provided a great opportunity to examine the racial differences between Caucasians and Asians 
in the associations of body size and fatness with blood pressure, which, to my knowledge, had 
never been reported. The following text in this chapter has been published in the journal 
Hypertension Research. Following on from this publication, a letter was submitted to the 
journal and the author response was also published in the journal Hypertension Research 
2012; 35(9):961-2, which is presented in Appendix 3B. 
Introduction 
High blood pressure (BP) is strongly associated with an increased risk of cardiovascular 
disease (CVD), including heart disease and stroke, and is a major contributor to the total 
burden of death and disease worldwide.
1
  BP is affected by genetic and lifestyle factors and is 
increased in those who are physically inactive, smokers, overweight or obese, have high 
dietary salt intakes or high alcohol consumption.
2
 While much is known about the 
epidemiology of high BP in adults in developed countries, less is known about the prevalence 
and predictors of high BP in developing countries. In Vietnam, these issues have been 
investigated in a few published studies.
3-6
 Mirroring reasonably well the results of studies in 
Western countries, predictors of elevated BP identified in these studies include increasing age, 
male sex, tobacco smoking, and alcohol consumption, indicators of overweight or body 
fatness, markers of low socioeconomic status including education and occupation, and marital 
status. 
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Obesity has been a serious public health problem in Caucasian populations for years, and is 
now an emerging problem in Asian populations
7
 including the Vietnamese.
8
 Positive 
associations between obesity and BP have been well established in both developed and 
developing countries.
9
 Several studies have compared the relationship of body composition 
and BP in black and white racial groups
9
 or between African and Asian populations.
10
 
However, to our knowledge, no study has reported such relationship in population-based 
samples of Caucasian and Asian populations, which was the principal aim of the study. This 
is an important step to better understand the potential cardiovascular consequences of 
increasing overweight and obesity in Asian populations. 
Methods 
Study population 
The study used data from two population-based cross-sectional studies conducted using 
similar methodology: a survey by the Burnie Take Heart (BTH) project of residents of Burnie 
(Australia) in 1998–99 (n = 832 adults aged 25–64 years; 47% male; 69% response), and a 
survey of residents of Can Tho (CT) (Vietnam), conducted in 2005 (n = 1978 adults aged 25–
64 years; 46% male; 74% response). The population of Burnie is predominantly Australian-
born, Caucasian and English speaking. In 1996, when the BTH project commenced, only 
0.03% of the population of Burnie was born overseas in a non-English speaking country.
11
 
Can Tho is the biggest city in the Mekong Delta, which is the far southern region of Vietnam 
and contains 20% of the country’s population.12 The study participants of this survey 
comprised 92% Vietnamese and 8% were of Chinese, Khmer or another ethnicity.  
Sampling procedures and methods of data collection for the BTH and CT surveys have been 
presented elsewhere.
6, 13
 Both surveys had approximately equal numbers of participants within 
four age categories (25–34 years, 35–44 years, 45–54 years and 55–64 years). In BTH, 
participants were selected by age- and sex-stratified random sampling from among those on 
the Electoral Roll of registered voters in Tasmania who had an address within the Burnie 
municipalities. In CT, participants were randomly selected from permanent residents in 
Cantho, by multistage sampling with age, sex and urban/rural stratification. Health volunteers, 
who are responsible for providing basic health services for an assigned local area, maintain 
and update the lists of the residents of the area regularly.  
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All participants provided written informed consent. In CT, those who could not sign provided 
verbal consent. The studies had approval from ethics committees of the University of 
Tasmania (BTH) and the Can Tho University of Medicine and Pharmacy (CT). 
Measurements 
Trained staff obtained physical measurements of participants, including BP and 
anthropometry. In both surveys, BP was measured at the mid-point of right upper arm, in an 
upright sitting position, with feet flat on the ground, back supported and no talking, after 
participants had rested for at least 5 minutes. Correct cuff sizes were determined before 
measurement based on right upper arm circumference. Three readings, at least 30 seconds 
apart (after the cuff was completely deflated), were taken in BTH, whereas a third reading 
was taken in CT only if there was a difference of more than 25 mmHg for systolic blood 
pressure (SBP) or 15 mmHg for diastolic blood pressure (DBP) between the first two readings 
(in accordance with the STEPSwise approach to surveillance of non-communicable diseases 
(STEPS) manual
14
 in 2005). A mean of all measurements was used for analysis in both 
surveys. A Dinamap Vital Signs Monitor 1846SX (Critikon Company, Tampa, FL) was used 
in BTH. This device was calibrated against a mercury sphygmomanometer prior to each week 
of clinic use. An Omron T9P digital automatic blood pressure monitor was used in CT. This 
device was calibrated against a mercury sphygmomanometer prior to each day of clinic use. 
Anthropometric measurements included weight, height, waist circumference and hip 
circumference. Each participant’s weight was measured to the nearest 0.1kg, in bare feet 
without heavy clothing, using digital scales. Height was measured to the nearest 0.1cm, in 
bare feet without headwear, using a stadiometer. Waist circumference at the narrowest point 
between the lower costal border and the iliac crest, and hip circumference at the greatest 
posterior protuberance of the buttocks, were measured to the nearest 0.1cm using a non-
stretching constant tension tape. 
Total cholesterol and plasma glucose were measured via standard laboratory procedure in 
venous blood in participants who had fasted for at least nine hours (BTH) and in capillary 
blood in participants who had fasted for at least 12 hours using a Roche Diagnostics 
Accutrend Glucometer (CT). 
Participants in both surveys completed questionnaires on demographic characteristics, socio-
economic factors and cardiovascular behavioral risk factors (smoking, alcohol consumption, 
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diet and physical activity). In BTH, the questionnaire was based with minor modification on 
the questionnaire developed by the National Heart Foundation of Australia and Australian 
Institute of Health to determine the prevalence of cardiovascular risk factors in Australian 
adults.
15
 The standardised STEPS survey methodology developed by the World Health 
Organization
14
 was used in CT. Some locally relevant questions and response options were 
added to the STEPS questionnaire, in accordance with the STEPS protocols.
14
 Whilst similar 
in most other respects, the questionnaires differed in the items used to assess physical activity. 
The BTH questions addressed time spent on vigorous and less vigorous exercise, and on 
vigorous tasks at work and around the house, during the past two weeks. The STEPS 
questionnaire addressed time on moderate and vigorous activities in three domains (work, 
transport and leisure) during a typical week.  
Statistical analyses 
Linear regression models including covariates for age and (where necessary) the square of age 
were used to produce the trend lines. The differences by sex in mean levels of BP reported in 
Table 2 were assessed from a regression model that included a single covariate for sex, and 
the differences by sex in the association with age in Figure 1 and Figure 2 were assessed from 
a regression model that also included product terms formed from the covariates for sex and 
age. Mean values of SBP, DBP, pulse pressure (PP = SBP − DBP) and mean arterial pressure 
(MAP = ⅓SBP + ⅔DBP) were calculated and reported in Table 2. For these analyses, as in 
the regression analyses, the BP measurements were transformed prior to analyses to remove 
skewness but all results are presented in the original units. Rank correlations of BP with 
indices of overweight and fatness presented in Supplementary Table 1 were calculated by 
applying Pearson’s correlation coefficient to the ranks of the variables with age as a covariate. 
The trend lines presented in Figure 3 and Figure 4 were produced from linear regression 
models including as covariates linear predictors for age, body mass index (BMI) and the 
square of BMI (if required). The adjusted estimates reported in Supplementary Table 2 were 
produced by adding as covariates linear predictors for total years of smoking, weekly 
frequency of alcohol consumption, total metabolic equivalent (MET-minutes) of physical 
activity and the binary indicator of fruit and vegetable consumption (two or more servings of 
fruit and five or more servings of vegetable per day), and calculating the estimated effect of 
an additional one unit (1 kg/m
2
) of BMI in the adjusted model. Further analyses of cholesterol 
were undertaken by including as covariates linear predictors for cholesterol and the product of 
cholesterol and age. 
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The analyses reported in Table 1, Figure 1 and Figure 2 were unweighted. All other analyses 
were weighted to the World Standard Population
16
 to enable comparisons free of 
discrepancies due to the slight differences in the age distributions of the two samples. 
Specifically, this required us to attach a weight to each observation such that the age 
distribution of 25–34 year olds, 35–44 year olds, 45–54 year olds, and 55–64 year olds in 
each sample matched that of the World Standard Population. 
Hypertension was defined as an average BP ≥ 140/90 mmHg, or use of antihypertensive 
medication. BMI was calculated as weight (kg) divided by height squared (m²). All 
participants who were taking antihypertensive medication at the time of study clinics were 
excluded from the analyses. 
Results 
Characteristics of study participants are shown in Table 3.1. Participants were approximately 
equally distributed across age categories as a result of the sampling design. Mean ages were 
44.6 (SD = 11.6) and 45.8 (SD = 10.5) years in BTH and CT respectively. Most subjects in 
BTH had completed secondary school level of education, but the majority in CT either had 
primary school as the highest level of education or had no formal education. A greater 
proportion of participants in BTH than in CT had values of BMI in the overweight or obese 
categories. Greater proportions of men than women were in these categories in BTH whilst 
the reverse was true in CT. Mean values of BMI, for men and women respectively, were 27.6 
(SD = 3.9) and 27.4 (SD = 5.8) in BTH, and 21.0 (SD = 3.0) and 21.8 (SD = 3.3) kg/m² in 
CT.  The mean values of weight, waist circumference and waist-hip ratio mirrored these 
differences. Cigarette smoking was very common among men in CT, but rare among women 
there. Relatively more male than female participants consumed alcohol regularly, with 
consumption highest among BTH participants. 
  
Chapter 3 – Race, obesity and blood pressure  80 
 
Table 3.1. Characteristics of participants in Burnie Take Heart and Cantho 
surveys.  
 Burnie Take Heart 
(n=832) 
 Cantho 
(n=1978) 
 Male Female  Male Female 
Sample size 47.1% [392] 52.9% [440]  46.1% [911] 53.9% [1067] 
Age, y      
25-34 23.2% [91] 25.7% [113]  17.2% [157] 18.8% [201] 
35-44 25.8% [101] 24.4% [107]  26.9% [245] 27.4% [292] 
45-54 24.7% [97] 25.7% [113]  29.7% [270] 28.2% [301] 
>55 26.3% [103] 24.2% [106]  26.2% [239] 25.6% [273] 
Education      
No formal education 0.5% [2] 0% [0]  38.0% [346] 55.7% [593] 
Primary school 7.1% [28] 5.0% [22]  27.5% [250] 21.1% [225] 
Secondary school 58.2% [228] 60.4% [265]  17.8% [162] 11.9% [127] 
High school 8.7% [34] 12.3% [54]  10.9% [99] 7.2% [77] 
Tertiary institution 25.5% [100] 22.3% [98]  5.8% [53] 4.1% [44] 
Employment      
Student 0.5% [2] 0.5% [2]  0% [0] 0.1% [1] 
Employed 75.3% [295] 52.0% [229]  92.1% [839] 69.7% [743] 
Unemployed 6.4% [25] 1.6% [7]  1.9% [17] 1.7% [18] 
Home duties   2.0% [8] 38.0% [167]  0.8% [7] 25.5% [272] 
Retired 11.0% [43] 6.1% [27]  3.8% [35] 2.4% [26] 
Disabled 4.8% [19] 1.8% [8]  1.4% [12] 0.6 [6] 
BMI
*
, kg/m² 27.6 (3.9) 27.4 (5.9)  21.1 (3.0) 21.8 (3.3) 
Weight
*
, kg 84.3 (13.2) 71.5 (15.6)  55.4 (9.2) 50.7 (8.4) 
Waist
*
, cm 95.2 (11.5) 84.2 (14.2)  75.4 (9.1) 73.5 (9.1) 
Waist-hip ratio
*
 0.92 (0.06) 0.80 (0.05)  0.85 (0.06) 0.82 (0.06) 
Total cholesterol
*
, mmol/L 5.55 (1.50) 5.42 (1.08)  4.47 (0.71) 4.78 (0.85) 
Blood glucose
*
, mmol/L 4.55 (0.61) 4.36 (0.54)  3.54 (0.85) 3.51 (0.92) 
Smoker      
Never 49.1% [192] 54.2% [238]  16.4% [149] 98.2% [1047] 
Former 27.9% [109] 23.0% [101]  14.3% [130] 0.3% [3] 
Current 23.0% [90] 22.8% [100]  69.3% [631] 1.5% [16] 
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Drinker      
Never 13.3% [52] 29.5% [130]  13.9% [116] 90.0% [939] 
< once a week 31.4% [123] 42.1% [185]  44.7% [373] 8.8% [92] 
1-4 days a week 40.5% [159] 22.3% [98]  28.7% [239] 0.4% [4] 
5+ days a week 14.8% [58] 6.1% [27]  12.7% [106] 0.8% [3] 
Physical activity
†
      
Active hours/week      4(1.3, 8)    3(1, 6.5)    11.5(1, 36)     4.5(0, 28) 
Total MET.hour/week
‡
      24(8, 57.6) 18(6, 40)       56(4, 168)   18.6(0, 112) 
Active
§
, % 62.76 56.15  52.75 42.21 
The data displayed are in percentages and numbers, unless otherwise stated. 
*
Data shown are Mean (SD). 
†
Data shown are Median (Interquartile range). 
‡
Total Metabolic Equivalent Task unit (MET-hour) per week 
§
Active is defined as having at least equivalent 150 minutes of moderate activities per 
week. 
Figure 3.1 depicts associations of SBP and DBP with age, by sex and population. Younger 
women in these samples of 25–64 year-olds had lower mean levels of both SBP and DBP than 
their male counterparts (as shown in Table 3.2), but this difference was diminished among 
older participants. Figure 3.2 displays trend lines depicting the association of MAP and PP 
with age. In both samples, younger men had higher mean values of MAP and PP than their 
female counterparts, but this difference was progressively diminished among older 
participants (BTH p = 0.114 (MAP), p < 0.0001 (PP); CT p = 0.005 (MAP), p < 0.0001 (PP)). 
Mean values of four measures of BP are shown in Table 3.2, stratified by sex, age group and 
population. These sex and age groups were used in the stratified sampling design in each 
location. In each age group, mean SBP was higher among men in BTH than in CT whereas 
mean DBP was generally higher among men in CT than in BTH. This led to a higher mean 
level of PP among men in BTH than in CT. In general, men in BTH had marginally higher 
MAP than men in CT. Among women, a higher mean level of PP in BTH than in CT was also 
observed. While there were approximately equal mean levels of SBP among women in the 
two surveys, higher mean levels of DBP were observed in CT. Among women, mean levels of 
MAP were always higher for CT than for BTH participants in each of the four age groups. 
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Figure 3.1 Associations of age with blood pressure, by population and sex. In each 
figure, the higher set of points and trend lines represent systolic blood pressure and the 
lower set represent diastolic blood pressure. BTH (Burnie Take Heart); CT (Can Tho). 
 
5
0
1
0
0
1
5
0
2
0
0
2
5
0
m
m
H
g
20 30 40 50 60 70
Age, year
BTH males
5
0
1
0
0
1
5
0
2
0
0
2
5
0
20 30 40 50 60 70
Age, year
BTH females
5
0
1
0
0
1
5
0
2
0
0
2
5
0
m
m
H
g
20 30 40 50 60 70
Age, year
CT males
5
0
1
0
0
1
5
0
2
0
0
2
5
0
20 30 40 50 60 70
Age, year
CT females
Chapter 3 – Race, obesity and blood pressure  83 
 
 
Figure 3.2. Trend lines depicting the association of mean arterial pressure (at top) and 
pulse pressure (at bottom) with age for men and women in the Burnie Take Heart 
(BTH) study and Cantho (CT) survey. 
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Table 3.2. Mean values of blood pressure for subjects classified by sex and age 
group, by population 
 Age group, year 
 25-34  35-44  45-54  55-65 
 Mean (SD)  Mean (SD)  Mean (SD)  Mean (SD) 
BTH        
Male        
SBP 129.2 (12.6)  130.9 (14.5)    136.3 (18.7)  142.1 (19.9) 
DBP 71.7 (8.2)  77.5 (9.4)   83.3 (10.0)  82.3 (8.9) 
PP   56.8 (10.4)  52.5 (9.9)  52.1 (11.4)  59.7 (14.7) 
MAP 91.0 (8.6)  95.5 (10.3)  101.1 (12.4)  102.2 (11.7) 
Female        
SBP 112.8 (12.8)  116.8 (13.5)  130.6 (20.1)  143.0 (19.4) 
DBP 67.5 (8.6)  70.9 (8.8)  75.8 (11.1)  76.5 (9.8) 
PP 45.4 (8.8)  45.6 (8.4)  54.3 (14.2)  66.5 (16.0) 
MAP 82.6 (9.4)  86.4 (9.9)  94.1 (13.1)  98.6 (11.5) 
CT        
Male        
SBP 124.3 (12.9)  124.0 (15.2)  130.4 (19.4)  135.6 (22.4) 
DBP   75.5 (9.8)  77.4 (11.5)  83.9 (13.1)  83.2 (12.4) 
PP 48.1 (8.9)  46.0 (8.8)  47.4 (11.4)  51.7 (14.0) 
MAP   91.9 (10.1)  92.9 (12.0)  99.4 (14.7)  100.8 (15.0) 
Female        
SBP 113.9 (12.0)  115.9 (13.8)  127.1 (19.0)  135.5 (23.0) 
DBP 72.4 (8.3)  73.7 (9.9)  80.3 (11.9)  81.9 (12.5) 
PP   41.2 (7.3)  42.0 (7.6)  46.8 (10.9)  53.5 (15.3) 
MAP 86.4 (9.1)  87.9 (10.8)  95.9 (13.7)  99.9 (15.2) 
mmHg is the unit of blood pressure. 
Abbreviations: BTH (Burnie Take Heart), CT (Cantho), SBP (Systolic blood pressure), 
DBP (Diastolic blood pressure), PP (Pulse pressure), MAP (Mean arterial pressure), SD 
(Standard deviation). 
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Age-adjusted rank correlations of BP with various indices of overweight and fatness, stratified 
by sex and population, are shown in Table 3.A.1 (Appendix 3.A). There were moderate 
associations between body fatness and BP measures among men and women with the 
exception of PP among CT women, for which the associations were weak. The strength of 
correlations with BP was similar across body fatness measures and, in subsequent analyses we 
present data for BMI only, given that this is a commonly used index in research and clinical 
practice. 
Figure 3.3 illustrates the estimated relationships of SBP, DBP and MAP with BMI, by sex and 
population, after adjusting for age. In each population, the trends of the relationships were 
similar for men and women. MAP increased with BMI among BTH women, but declined at 
high and increasing levels of BMI among BTH men. For the CT sample, MAP increased with 
BMI because both SBP and DBP increased with BMI.  
 
Figure 3.3. Age-adjusted associations of three indices of blood pressure with body mass 
index, by population and sex. BTH (Burnie Take Heart), CT (Cantho), SBP (systolic 
blood pressure), DBP (diastolic blood pressure), MAP (mean arterial pressure), BMI 
(body mass index) 
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The values of PP plotted against BMI in Figure 3.4 showed that PP increased with BMI 
among the BTH samples, but not among the CT samples. These differing results for PP were 
not due to different distributions of BMI in the two populations. Restricting the analyses to 
the 95.9% of BTH men and 71.3% of CT men whose BMI fell in the 19.2 (BTH minimum) to 
34.9 (CT maximum) kg/m
2
 range, and to the 92.7% of BTH women and 87.5% of CT women 
whose BMI fell in the 18.2 (BTH minimum) to 37.2 (CT maximum) kg/m
2
 range, all 
relationships between PP and BMI were linear and positive for BTH participants (men p < 
0.001, women p < 0.001) but negative for CT participants (men p = 0.324, women p = 0.358). 
 
Figure 3.4. Age-adjusted associations of pulse pressure with body mass index, by 
population and sex. The trend lines are plotted over the range of overlapping BMI in 
the two populations: 19.2–34.9 kg/m2 for men, and 18.2–37.2 kg/m2 for women. 
Abbreviation: BTH (Burnie Take Heart), CT (Cantho), BMI (body mass index). 
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We investigated whether these relationships were independent of other factors that may be 
associated with BP, such as years of smoking, weekly frequency of alcohol intake, dietary 
consumption of fruit and vegetables, and physical activity. However, adjusting for these 
factors had little impact (as shown in Table 3.A.2 of Appendix 3.A). 
To determine whether differences in metabolic parameters could account for the different 
patterns of association between PP and BMI in the two populations, we adjusted the 
associations for fasting blood total cholesterol and glucose concentrations. Cholesterol was 
positively associated with PP among BTH women (p = 0.018) and negatively associated with 
PP among CT men (p = 0.04), but adjusting for it had only a marginal effect on the estimated 
association of PP with BMI in each population (data not shown). Glucose was not a 
significant predictor of BP among BTH participants, but was a significant positive predictor 
of MAP among CT participants (men p < 0.001, women p = 0.072). However, adjusting for 
glucose only marginally reduced the positive linear slope between MAP and BMI among CT 
participants (data not shown). 
Finally, whilst the proportion with hypertension among BTH men (37.1%, 95% confidence 
interval (CI): 32.7%, 42.0%) and BTH women (28.2%, 95% CI: 24.2%, 32.9%) exceeded the 
respective proportion among CT men (30.8%, 95% CI: 28.0%, 33.8%) and CT women 
(21.3%, 95% CI: 18.9%, 24.0%), only 13.8% of the hypertensives in CT reported taking 
antihypertensive medication compared to 33.1% in BTH. These subjects were excluded from 
analyses but, in the remaining sample, the proportion with non-medicated SBP > 180 mmHg 
and/or non-medicated DBP > 110 mmHg among CT subjects (3.7%) was more than twice that 
among BTH subjects (1.8%). Particularly for SBP, this can be observed in Figure 1. To 
investigate whether this greater proportion of high values among the CT sample had 
influenced our results, we repeated the analyses further excluding non-medicated subjects 
with SBP > 180 mmHg and/or DBP > 110 mmHg. No marked differences were found (data 
not shown). 
Discussion 
This study examined the associations of BP with age and body composition in population-
based samples of Caucasians and Asians. The main findings of the study were significant 
differences in the relationships between PP and body composition for Caucasians compared 
with Asians. The relationships between BP and age, and between other indices of BP and 
body composition, were generally similar between populations. Although further work is 
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required, these observations provide new information regarding race, body composition and 
BP that may help inform public health planning in the future. 
Whilst there were major discrepancies in the associations between PP and BMI, it was 
interesting to find similarities in the two populations for the age–BP relationships. The fall (or 
leveling off) of DBP together with the rise of SBP and PP with increasing age (particularly 
after the 5
th
 decade) among both BTH and CT participants in these cross-sectional 
associations is consistent with age-related abnormalities of the arterial wall resulting in large 
artery stiffness.
17, 18
 This effect has been demonstrated to increase cardiovascular risk,
19
 
probably owing to concomitant raised central BP. We also observed a lower mean PP in 
young women than young men, and this sex difference gradually narrowed and reversed at the 
fifth and sixth decade in BTH and CT respectively. These findings are consistent with results 
from other studies
18, 20
 and suggest that – regardless of differences in race, culture and 
demography – Caucasian and Asian people probably have similar physiology in relation to 
vascular aging. 
Increasing BMI was associated with significant increases in PP among participants in BTH, 
but not among participants in CT. The difference was not due to different distributions of 
BMI in the two populations, because around 80% of the men and 90% of the women in the 
two populations had BMI in the same range, and we estimated the relationships among 
participants in the same range of BMI. The difference in PP between the two populations in 
response to increasing body composition suggests the possibility of different pathophysiology 
related to hypertension in Caucasians and Asians. In BTH, higher PP with increasing BMI 
may be indicative of increased large artery stiffness, similar to the association between higher 
PP and increasing age after about 50 years. Conversely, in CT, we observed increases of both 
SBP and DBP with associated increase in MAP but not in PP. This type of hypertension in CT 
is more typical of essential hypertension, in which both SBP and DBP are raised. Although 
speculative, this may be a result of increased circulatory volume or peripheral vascular 
resistance, possibly due to high sodium intake,
21
 rather than being due to increased large 
artery stiffness per se. This conclusion is not necessarily consistent with some studies that 
have reported increased arterial stiffness in Asians compared with Caucasians.
22-25
 These 
studies included only participants of South Asian origin, who are known to have higher rates 
of diabetes and premature coronary artery disease
26, 27
 than the South-East Asian participants 
in this study. Other studies are required to elucidate causes of these racial differences in BP.  
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Some studies
28, 29
 have also shown that at any value of SBP, cardiovascular risk is higher with 
lower DBP. Whether there is any difference in overall cardiovascular risk associated with 
increased BMI and the consequent BP differences between populations is unknown. 
Importantly, adjustment for other potential confounders such as tobacco smoking, alcohol 
consumption, fruit and vegetable consumption and physical activity showed negligible effects 
on the relationship of BP and BMI. Whatever the reasons for the observed differences 
between these Caucasian and Asian populations, it is reasonable to conclude that these 
modifiable lifestyle behaviors did not play a major role. Of course the BMI–BP differences 
between Caucasians and Asians might be explained by genetic factors or other unmeasured 
lifestyle or environmental influences. 
A number of mechanisms by which obesity might contribute to vascular stiffness have been 
proposed. In obesity, macrophages accumulate in adipose tissue.
30
 This is believed to lead to 
the chronic state of low-grade inflammation (vascular and systemic) and endothelial 
dysfunction in obese people.
31
 Other artery-stiffening mechanisms of obesity may work 
through the functions of hormones such as insulin and leptin. An excess of circulatory insulin 
will promote sodium retention by increasing tubular reabsorption,
32
 stimulate sympathetic 
activity,
33
 proliferate vascular smooth muscle cells,
34
 promote endothelial dysfunction and 
impair vasodilator activity.
35
 Another possible mechanism of obesity-induced arterial stiffness 
is hyperleptinemia, which is also known to stimulate the sympathetic nervous system
36
 and 
induce endothelial dysfunction.
37
 
Hypercholesterolemia is also associated with increased large artery stiffness in Caucasians
38
 
and this is known to affect peripheral BP. In this study, fasting serum total cholesterol was a 
significant positive predictor of PP in BTH women, though adjusting for total cholesterol had 
negligible effects on the relationship of PP and BMI. Similarly, fasting blood glucose was 
positively associated with MAP among CT participants, but played a negligible role in the 
relationship of MAP and BMI. Therefore it seems reasonable to suggest that the difference in 
associations of BP and BMI between Caucasians and Asians observed in this study was not 
due to serum total cholesterol or glucose. 
A limitation of this study was the cross-sectional design. Also there was a lack of information 
on sodium intake which is known to be associated with hypertension and arterial stiffness. 
Whilst sodium consumption has been greatly reduced in western countries due to high 
awareness of cardiovascular risks, Asian countries generally have higher mean sodium 
intakes.
21
 This might help to explain the differences observed in this study between 
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Caucasians and Asians. Using different BP devices in the two surveys would be a limitation if 
there were systematic errors between the two devices in measuring SBP and/or DBP, but only 
if these errors influenced the estimated relationships between PP and BMI. With the effect of 
minimising this possibility, each BP device was calibrated against a standard mercury 
sphygmomanometer before each clinic examination for accuracy. 
Conclusions 
In conclusion, the principal finding in this study was that independent of conventional risk 
factors (e.g. age, smoking, alcohol, diet and physical inactivity), BMI was positively 
associated with PP (and possibly large artery stiffness) among Caucasians, but not among 
Asians. This may be an important observation because increased PP is an independent 
predictor of myocardial infarction, congestive heart failure and cardiovascular death, even in 
hypertensive patients undergoing successful antihypertensive drug therapy.
39
 Our findings 
provide additional evidence for the importance of weight reduction to improve cardiovascular 
risk. The difference in associations of BMI and BP between Caucasians and Asians suggests 
different pathophysiology related to hypertension, and the possibility of different approaches 
to prevention and treatment of hypertension might be applied to the two populations. Future 
studies could perhaps focus on genetic and environmental factors to answer this important 
question. 
Postscript 
The results of this chapter suggest that obesity-induced hypertension in Caucasians may be 
related to increased large artery stiffness. This finding led to the examination of the 
associations of body size and fatness in childhood and adulthood with adult arterial structure 
and function measured by ultrasound among young Caucasian adults, which are presented in 
Chapter 4. Rather than focus on pulse pressure, which is not a reliable indicator of arterial 
stiffness among young adults, carotid artery stiffness measured by ultrasound was used in 
analyses instead.
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Appendix 3.A. Additional tables 
Additional Table 3.A.1. Age-adjusted rank correlations of blood pressure and 
indices of overweight and fatness, by sex and population 
 Weight Weight 
adjusted 
for height 
and age 
Weight 
to height 
ratio 
BMI WC Waist 
adjusted 
for height 
and age 
WHR 
Males        
SBP        
BTH 0.276 0.314 0.323 0.331 0.278 0.307 0.207 
CT 0.221 0.242 0.250 0.256 0.253 0.257 0.233 
DBP        
BTH 0.219 0.236 0.234 0.228 0.238 0.262 0.218 
CT 0.208 0.203 0.244 0.248 0.276 0.272 0.262 
PP        
BTH 0.190 0.243 0.238 0.268 0.184 0.212 0.125 
CT 0.130 0.170 0.133 0.137 0.112 0.123 0.107 
MAP        
BTH 0.279 0.306 0.310 0.308 0.291 0.316 0.239 
CT 0.220 0.227 0.254 0.260 0.276 0.276 0.259 
Females        
SBP        
BTH 0.404 0.424 0.359 0.354 0.364 0.394 0.224 
CT 0.159 0.157 0.164 0.160 0.144 0.141 0.118 
DBP        
BTH 0.199 0.217 0.175 0.175 0.170 0.218 0.144 
CT 0.246 0.245 0.254 0.245 0.225 0.221 0.156 
PP        
BTH 0.394 0.402 0.368 0.359 0.363 0.371 0.241 
CT 0.014 0.012 0.013 0.015 0.012 0.011 0.040 
MAP        
BTH 0.312 0.334 0.273 0.271 0.275 0.316 0.159 
CT 0.216 0.215 0.223 0.216 0.197 0.193 0.146 
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Abbreviations: BTH (Burnie Take Heart), CT (Cantho), BMI (Body mass index), WC 
(Waist circumference), WHR (Waist to hip ratio), SBP (Systolic blood pressure), 
DBP (Diastolic blood pressure), PP (Pulse pressure), MAP (Mean arterial pressure).  
For BTH, 𝑟 ≥ 0.125 represent p < 0.05, 𝑟 ≥ 0.159 represent p < 0.01 and 𝑟 ≥ 1.90 
represent p < 0.001 
For CT, 𝑟 ≥ 0.107 represent p < 0.05, 𝑟 ≥ 0.117 represent p < 0.001  
 
 
 Additional Table 3.A.2. Differences in four measures of blood pressure per unit difference in body mass index (kg/m²) adjusted for 
smoking, alcohol intake, diet and physical activity, classified by population and sex 
 Adjusted for age Adjusted for age and  
smoking 
Adjusted for age and 
alcohol intake 
Adjusted for age and 
diet 
Adjusted for age and 
physical activity 
Males      
SBP      
BTH 1.69(1.09, 2.28) 1.69(1.09, 2.30) 1.65(1.05, 2.25) 1.66(1.06, 2.25) 1.62(1.02, 2.22) 
CT 1.58(1.14, 2.03) 1.65(1.18, 2.12) 1.57(1.13, 2.02) 1.59(1.15, 2.04) 1.64(1.19, 2.09) 
DBP      
BTH 0.77(0.40, 1.14) 0.79(0.42, 1.15) 0.76(0.38, 1.13) 0.78(0.40, 1.15) 0.77(0.39, 1.14) 
CT 1.43(1.05, 1.81) 1.47(1.08, 1.86) 1.39(1.01, 1.76) 1.43(1.05, 1.81) 1.42(1.04, 1.81) 
PP      
BTH 0.73(0.45, 1.00) 0.73(0.45, 1.01) 0.72(0.44, 0.99) 0.71(0.44, 0.99) 0.70(0.42, 0.98) 
CT −0.17(−0.49, 0.16) −0.15(−0.49, 0.18) −0.16(−0.49, 0.16) - 0.16(- 0.49, 0.16)  −0.09(−0.42, 0.23) 
MAP       
BTH 1.07(0.67, 1.47) 1.09(0.69, 1.48) 1.05(0.65, 1.45) 1.06(0.66, 1.47) 1.05(0.64, 1.45) 
CT 1.26(0.94, 1.59) 1.34(1.00, 1.68) 1.25(0.93, 1.57) 1.27(0.95, 1.60) 1.29(0.96, 1.61) 
Females      
SBP      
BTH 1.11(0.86, 1.35) 1.11(0.87, 1.35) 1.11(0.86, 1.35) 1.10(0.86, 1.34) 1.08(0.84, 1.32) 
CT 0.78(0.45, 1.12) 0.81(0.47, 1.14) 0.82(0.48, 1.15) 0.83(0.49, 1.16) 0.82(0.48, 1.15) 
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 DBP      
BTH 0.37(0.21, 0.54) 0.38(0.21, 0.55) 0.38(0.21, 0.55) 0.37(0.21, 0.54) 0.37(0.21, 0.54) 
CT 0.85(0.63, 1.07) 0.87(0.65, 1.09) 0.88(0.66, 1.10) 0.89(0.67, 1.11) 0.88(0.66, 1.10) 
PP      
BTH 0.74(0.56, 0.91) 0.72(0.55, 0.89) 0.73(0.55, 0.91) 0.73(0.55, 0.91) 0.71(0.54, 0.89) 
CT −0.10(−0.28, 0.08) −0.09(−0.27, 0.08) −0.08(−0.27, 0.09) −0.08(−0.27, 0.09) −0.08(−0.26, 0.09) 
MAP       
BTH 0.62(0.45, 0.80) 0.63(0.45, 0.81) 0.63(0.45, 0.81) 0.62(0.45, 0.80) 0.62(0.44, 0.79) 
CT 0.83(0.58, 1.09) 0.85(0.60, 1.10) 0.86(0.61, 1.11) 0.87(0.62, 1.12) 0.86(0.60, 1.11) 
Abbreviations: SBP (Systolic blood pressure), DBP (Diastolic blood pressure), PP (Pulse pressure), MAP (Mean arterial pressure), BTH 
(Burnie Take Heart), CT (Cantho). 
Smoking and alcohol intake were associated with BP (not PP) among CT men. Weighted to the standard population, the correlations among 
CT men were 𝑟 = 0.098 (SBP, p = 0.004), 𝑟 = 0.158 (DBP, p < 0.001) and 𝑟 = 0.140 (MAP, p < 0.001) for total years of smoking, and 
𝑟 = 0.071 (SBP, p = 0.038), 𝑟 = 0.135 (DBP, p < 0.001) and 𝑟 = 0.112 (MAP, p = 0.001) for weekly frequency of alcohol intake. Dietary 
consumption of fruit and vegetables was negatively associated with SBP (𝑟 = – 0.085, p = 0.008), DBP (𝑟 = − 0.098, p = 0.002) and MAP 
(𝑟 = − 0.093, p = 0.003) among CT women. Physical activity was inversely associated with SBP (𝑟 = − 0.147, p = 0.005) and PP (𝑟 = − 
0.167, p = 0.002) among BTH women.  
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Appendix 3.B. Elevated blood pressure in different populations: 
the role of dietary salt consumption 
Published in the journal Hypertension Research 2012; 35(9):961-2. 
Huynh L. Quan, Christopher L. Blizzard, Alison J. Venn and James E. Sharman 
Preface 
This invited correspondence was published in the journal Hypertension Research as a 
communication to Fujisawa and colleagues who commented on the paper presented above in 
this chapter. 
Content 
In a fascinating account of a natural experiment on the possible impacts of lifestyle on blood 
pressure (BP), Fujisawa et al
1
 report the relationship of BP with age and with body mass 
index (BMI) among people living in two regions of Papua, Indonesia. One study site was 
Soroba village in the central highlands where the indigenous inhabitants were reported by the 
authors to maintain a traditional way of life. The study sample from this village included 46 
men and 54 women with mean systolic and diastolic BP of 118mmHg and 73mmHg 
respectively. The other study site was the small mercantile town of Bade in the southern 
coastal lowlands where, it was reported by the authors, the residents practice a more modern 
lifestyle with increasing dietary intake of salt and sugar. The study sample from this town 
included 38 men and 50 women with mean systolic and diastolic BP of 144mmHg and 
80mmHg respectively. The prevalence of hypertension (systolic BP ≥ 140mmHg or diastolic 
BP ≥ 80mmHg or using anti-hypertensive medication) was 8% in the Soroba sample, and 
56% in the Bade sample.  
Probably contributing to these marked differences in BP, the subjects from Bade were about 
10 years older on average and were more often overweight or obese (26 persons in the Bade 
sample but only 3 persons in the Soroba sample had BMI > 25 kg/m², and median BMI was 
around 2 kg/m² greater for the Bade sample despite the slightly lesser proportion of males). In 
unadjusted analyses, Fujisawa et al
1
 found no association of blood pressure with age or BMI 
among the subjects from Soroba, but a positive association of BP with age and BMI in the 
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sample from Bade, and attribute their findings to the impact of social globalisation on human 
physiology.  
Although details of the sampling design were not provided, it seems clear that the population 
of Soroba contains individuals who, in adult life, have remained lean with low BP. As 
Fujisawa et al
1
 noted, the pathophysiological phenomenon of little or no BP rise with 
increasing age, and a low prevalence of hypertension, has been identified in other remote 
populations of the world. For those remote populations included in the INTERSALT study,
2
 
the favorable BP patterns among remote populations were attributed to their low salt intake
3, 4
 
rather than other lifestyle factors or unusual population genetics.
5, 6
 
In our population-based study,
7
 we studied samples of the Caucasian (Australian) and Asian 
(Vietnamese) populations selected by stratified multi-stage random sampling. The mean 
systolic BP in each sample was around 15 mm Hg higher than that in the similarly aged 
sample from Soroba, and the percentages with hypertension were 32.4% in the Caucasian 
sample and 25.7% in the Asian sample. The higher BP of the Vietnamese participants than of 
those from Soroba is apparent despite almost identical median BMI. Relative to the men and 
women in the Soroba sample, the Vietnamese women had higher mean systolic BP (126 mm 
Hg) and higher percentage with hypertension (21.3%) despite almost no exposure to personal 
tobacco smoking or alcohol, and similar body size. Higher salt intake is a possible culprit. 
In formal analyses, we found similar positive associations of BP with age in the Caucasian 
and Asian samples irrespective of sex. In both populations, there was a fall (or leveling off) of 
diastolic BP together with a rise of systolic BP and pulse pressure (PP) with increasing age 
particularly after the fifth decade. This is consistent with age-related abnormalities of the 
arterial wall resulting in large artery stiffness.
8, 9
 To examine the relationship between BP and 
BMI, we adjusted for age and restricted the analysis to the range of overlapping BMI in the 
two populations. We found that PP was positively associated with BMI among the 
Caucasians, but not among the Asians. This may be indicative of increased large artery 
stiffness among the Caucasians, similar to the positive association of PP with age after about 
50 years of age. Conversely, an increase in mean arterial pressure (arising from increases in 
both systolic and diastolic BP) with increasing BMI was observed among the Asians, 
suggesting a more typical type of essential hypertension rather than arterial stiffness induced 
hypertension. This may be a result of increased circulatory volume or peripheral vascular 
resistance, possibly due to higher salt intake among the Asians.
10
 These differences suggest 
different pathophysiology related to hypertension in Caucasians and Asians. 
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In summary, these data appear consistent with the hypothesis that high salt intake is a key 
factor in the development of elevated BP. Lowering dietary salt intake is strongly 
recommended to reduce cardiovascular risk associated with hypertension. 
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Chapter 4. Relative contributions of adiposity in childhood 
and adulthood to vascular heath of young adults 
Preface 
The findings presented in the previous chapter implicated that, for Caucasians, greater body 
size and fatness may be associated with hypertension through higher large artery stiffness. 
Using more direct and sophisticated measures of vascular health, this chapter aims to examine 
the associations of body size and fatness in both childhood and adulthood with arterial 
structure and function in adulthood, and to determine whether body size and fatness in 
adulthood have any effects on adult vascular health that are independent of adult body size 
and fatness. The following text of this chapter has been published in the journal 
Atherosclerosis. 
Introduction 
Vascular damage is suggested to have origins in childhood obesity,
1, 2
 but it is unclear 
whether this is a direct effect of childhood adiposity as suggested by recent studies
3, 4
 or an 
indirect effect arising from tracking of obesity from childhood to adulthood. A key research 
question is whether childhood adiposity influences adult vascular health independently of 
adult adiposity.  Some measures of vascular health associated with cardiovascular risk include 
carotid intima-media thickness (IMT) and three measures of large artery stiffness (LAS) 
including carotid distensibility (CD), stiffness index (SI) and Young’s elastic modulus 
(YEM).
5-7
 Whilst IMT
8-13
  and recently CD, SI and YEM14  have been reported to be 
associated with childhood body mass index (BMI), it is unclear whether these associations are 
independent of adult adiposity or indeed whether childhood BMI in this context is an 
appropriate measure of childhood adiposity.
15, 16
   
This study aimed to investigate the association of childhood body size or adiposity with adult 
vascular health. We hypothesised childhood body size or adiposity to have positive effects on 
adult IMT and LAS that are independent of adult body size or adiposity. Clarifying this matter 
will provide information critical for determining when and how clinical and public health 
interventions should be undertaken to reduce cardiovascular risk. 
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Methods 
Study population 
This study used data from the Childhood Determinants of Adult Health (CDAH) study, a 
prospective cohort study with baseline data collected in 1985 on a nationally representative 
sample of 8498 Australian schoolchildren aged 7-15 years.
17
 During 2001-2004, 5170 
(60.8%) of them enrolled in the follow-up study (CDAH). Of these, 2410 attended one of 34 
study clinics across Australia during May 2004–May 2006 when aged 26-36 years. In this 
study, analyses were restricted to 2328 non-pregnant subjects (49.4% male) with physical 
measurements at both time-points (1985, 2004-2006) and vascular ultrasound parameters at 
follow-up.  
Body size or adiposity  
 Weight, height, and waist and hip circumference were measured in childhood and 
adulthood.
16
 BMI was calculated as weight(kg)/height(m)
2
. Body surface area was measured 
as [weight(kg)height(cm)/3600]0.5. Waist-to-hip and waist-to-height ratios were calculated as 
waist(cm)/hip(cm) and waist(cm)/height(cm) respectively. While skinfolds at four locations in 
adulthood were measured for all clinic participants, skinfolds in childhood were measured 
only for those then aged 9, 12 and 15 years.
16
 The sum of four skinfolds was used in 
subsequent analyses. 
Carotid intima-media thickness 
B-mode ultrasound studies of carotid IMT were performed using a portable Acuson Cypress 
(Siemens Medical Solutions USA Inc., Mountainview, CA) ultrasound machine with a 
7.0MHz linear-array transducer by a single technician,
18
 following previously reported 
standardised protocol.
10
 (Please see Appendix 4.A for more details.) 
Blood pressure (BP) and LAS 
Brachial BP was measured supine during the ultrasound study using an Omron M4 Digital 
Automatic Blood Pressure Monitor (Omron Corporation, Kyoto, Japan) with a mean of two 
readings used in this study. Electrocardiogram-based end-systolic and end-diastolic diameters, 
which were maximum and minimum diameters during a cardiac cycle, were taken 10mm 
proximal from the carotid bulb. Three measures of LAS were calculated as follows:  
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CD = ([Dsbp−Ddbp]/Ddbp)/(SBP−DBP) 
SI = ln(SBP/DBP)/([Dsbp−Ddbp]/Ddbp) 
YEM = ([SBP−DBP)Ddbp)/([Dsbp−Ddbp]/IMT) 
where Dsbp is the end-systolic diameter, Ddbp is the end-diastolic diameter, SBP is brachial 
systolic BP, and DBP is brachial diastolic BP. CD measures passive expansion and 
contraction of the arterial wall with changes in pressure. SI is a measure of LAS designed to 
be relatively independent of BP. YEM is an estimate of LAS per mm of IMT.  
Covariates 
Covariates included socioeconomic status, smoking, alcohol consumption, female 
reproductive characteristics and fasting blood biochemistry. (Please see Appendix 4.A for 
details.) 
Statistical analyses 
Other than for the summary statistics reported in Table 4.1, all physical measurements, BP, 
and cardio-metabolic parameters were converted to z-scores specific to each sex and year of 
age by subtracting from each measurement the mean for that sex and age category and 
dividing by its standard deviation (SD). Spearman correlation coefficients (𝑟) are reported. 
For other analyses, the right-skewed outcome data (IMT, CD, SI and YEM) were 
appropriately transformed (by taking logarithms for example) prior to estimation of means or 
the estimation of associations using linear regression methods. The regression estimates 
reported are in original units of the outcomes for one-SD increase in the study factor.
19
 The 
IMT measurements were calibrated to eliminate the minor differences (< 1.2%) in means 
between the readers. All covariates were linearly scaled because careful checking did not 
reveal non-linear relationships. Age- and sex-specific linear regression analyses were 
conducted for childhood measures of body size or adiposity. Childhood obesity was classified 
as normal weight, overweight and obese using the International Obesity Taskforce (IOTF) 
BMI cut-points.
20
 Adulthood obesity was classified as normal weight (adult BMI < 25kg/m
2
), 
overweight (25 ≤ BMI < 30kg/m2) and obese (BMI ≥ 30kg/m2). Analyses using childhood 
BMI z-scores based on the IOTF reference population
20
 provided no marked differences (not 
shown). STATA 12.0 was used for analysis. 
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Results 
Table 4.1 shows participants’ characteristics at baseline and follow-up. Participants were aged 
7-15 years at baseline, and were of mean age 31.5 (SD = 2.6) years at follow-up. The men 
generally had higher carotid IMT and stiffer arteries than women (p<0.001).  
There were strong relationships among the three measures of LAS (CD, SI and YEM) with 
correlation coefficients in the range 0.84-0.96 (all p < 0.001) in absolute value. IMT was used 
in the calculation of YEM, and this measure of LAS was most strongly correlated with IMT 
(men 𝑟 = 0.372, women 𝑟 = 0.317; both p < 0.001).  
Among the measures of body size or adiposity, height had the greatest correlation between 
childhood and adulthood values (men 𝑟 = 0.659, women 𝑟 = 0.716), followed by weight (men 
𝑟 = 0.529, women 𝑟 = 0.565) and BMI (men 𝑟 = 0.530, women 𝑟 = 0.530). Of the 259 
overweight or obese participants in childhood, 53.3% (138/259) remained obese and 12.4% 
(32/259) were normal weight as adults. 
Table 4.2 shows that correlations of adult IMT and LAS with age- and sex-specific 
standardised measures of body size in childhood were marginally stronger for height than for 
weight (see Figure 4.B.1 of Appendix 4.B for age-stratified associations) and somewhat 
weaker for  waist-based measures. The correlations of IMT and LAS with child height-
adjusted-for-weight were only slightly different from those with child height not adjusted for 
weight (not shown). The correlations with adult measures were stronger than those with the 
corresponding childhood measures, and strongest with weight.    
 Table 4.1. Participants’ characteristics at baseline and follow-up 
 Baseline  Follow-up 
 7-9 years  10-12 years  13-15 years  26-36 years 
 Mean (SD)  Mean (SD)  Mean (SD)  Mean (SD) 
Male 341 (46.5%)*  408 (49.8%)*  401 (51.8%)*  1150 (49.4%)* 
Weight, kg 27.7 (4.7)  37.0 (6.9)  54.1 (10.6)  83.5 (13.8) 
Height, cm 131.3 (7.5)  145.7 (7.9)  165.7 (9.7)  179.5 (6.7) 
BMI, kg/m² 16.1 (1.5)  17.3 (2.0)  19.5 (2.4)  25.9 (3.8) 
Waist, cm 57.1 (4.3)  62.7 (5.9)  70.8 (6.2)  88.0 (9.7) 
Waist-hip ratio 0.86 (0.04)  0.85 (0.04)  0.83 (0.04)  0.84 (0.05) 
Waist-height ratio 0.44 (0.03)  0.43 (0.03)  0.43 (0.03)  0.49 (0.06) 
Sum of skinfolds†, mm 31.0 (9.5)  36.8 (15.8)  35.7 (12.3)  61.7 (25.9) 
Intima-media thickness, mm          0.61 (0.10) 
Carotid distensibility, %/10mmHg          1.94 (0.64) 
Stiffness index          5.29 (1.82) 
Young’s elastic modulus, mmHg.mm          293.3 (111.4) 
Female 393 (53.5%)*  412 (50.2%)*  373 (48.2%)*  1178 (50.6%)* 
Weight, kg 27.1 (5.0)  37.6 (7.8)  51.2 (8.0)  65.7 (12.9) 
Height, cm 129.7 (7.4)  146.4 (8.6)  160.8 (6.2)  165.6 (6.3) 
BMI, kg/m² 16.1 (1.7)  17.5 (2.2)  19.7 (2.4)  23.8 (4.2) 
Waist, cm 55.8 (5.0)  61.2 (6.4)  66.6 (6.5)  75.7 (9.6) 
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 Waist-hip ratio 0.84 (0.05)  0.81 (0.05)  0.78 (0.05)  0.74 (0.05) 
Waist-height ratio 0.43 (0.03)  0.42 (0.04)  0.42 (0.04)  0.46 (0.06) 
Sum of skinfolds†, mm 41.1 (15.9)  47.1 (17.6)  59.0 (20.3)  73.4 (30.8) 
Intima-media thickness, mm          0.58 (0.08) 
Carotid distensibility, %/10mmHg          2.35 (0.79) 
Stiffness index          4.83 (1.68) 
Young’s elastic modulus, mmHg.mm          230.3 (87.4) 
*Data are number (percentage). 
†Childhood skinfolds were available for 9, 12 and 15 year-olds only (males n=383, females n=403). 
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Table 4.2. Spearman correlations of age- and sex-specific standardised body 
size and adiposity in childhood and adulthood with adult carotid intima-media 
thickness and large artery stiffness 
 IMT CD SI YEM 
Childhood     
Male      
Weight 0.066* −0.067* 0.050 0.097** 
Height 0.075* −0.065* 0.049 0.099** 
BMI 0.074* −0.052 0.035 0.085** 
Weight adj. for height 0.023 −0.007 −0.005 0.022 
Waist 0.063* −0.077* 0.048 0.109*** 
Waist adj. for height 0.027 −0.055 0.029 0.075* 
Waist-hip ratio 0.024 −0.020 0.003 0.054 
Waist-height ratio 0.022 −0.051 0.025 0.069* 
Sum of skinfolds† 0.086 −0.080 0.027 0.107 
Female      
Weight 0.083** −0.029 −0.008 0.043 
Height 0.098** −0.055 0.020 0.081* 
BMI 0.051 −0.009 −0.016 0.017 
Weight adj. for height −0.004 0.014 −0.028 −0.023 
Waist 0.049 −0.020 −0.021 0.035 
Waist adj. for height 0.010 0.007 −0.036 0.001 
Waist-hip ratio −0.026 0.008 −0.025 −0.005 
Waist-height ratio 0.005 0.011 −0.038 −0.005 
Sum of skinfolds† 0.043 0.039 −0.096 −0.018 
Adulthood     
Male      
Weight 0.110*** −0.176*** 0.095** 0.207*** 
Height 0.078* −0.091** 0.090** 0.112*** 
BMI 0.097** −0.148*** 0.057 0.177*** 
Weight adj. for height 0.096** −0.152*** 0.062 0.180*** 
Waist 0.068* −0.169*** 0.074* 0.187*** 
Waist adj. for height 0.060 −0.158*** 0.063* 0.174*** 
Waist-hip ratio 0.046 −0.130*** 0.049 0.146*** 
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Waist-height ratio 0.049 −0.131*** 0.041 0.142*** 
Sum of skinfolds –0.010 −0.122*** 0.051 0.100** 
Female      
Weight 0.090** −0.118*** 0.044 0.128*** 
Height 0.043 −0.054 0.035 0.062 
BMI 0.082** −0.118*** 0.042 0.123*** 
Weight adj. for height 0.081** −0.118*** 0.046 0.123*** 
Waist 0.082** −0.114*** 0.034 0.118*** 
Waist adj. for height 0.079* −0.106*** 0.034 0.113*** 
Waist-hip ratio 0.066* −0.114*** 0.062 0.129*** 
Waist-height ratio 0.073* −0.095** 0.027 0.100** 
Sum of skinfolds 0.032 −0.094** 0.023 0.087** 
Abbreviation: IMT (intima-media thickness), CD (carotid distensibility), SI 
(stiffness index), YEM (Young’s elasticity modulus), and BMI (body mass index). 
*p < 0.05; **p < 0.01; ***p < 0.001. 
†Data were available for 9, 12 and 15 year-olds only. 
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We next investigated whether childhood body size or adiposity were associated with adult 
IMT and LAS independently of adult adiposity. Increases in childhood body size were 
associated with age-specific increases in adult IMT of 1.0–1.5µm (male) and 0.9–1.1µm 
(female) per cm increase in height, 0.9–2.9µm (male) and 0.6–1.5µm (female) per kg increase 
in weight, and 3.3–5.7 (male) and 0.8–1.5µm (female) per kg/m2 increase in BMI. Table 4.3 
presents the estimated response of adult IMT and LAS to one-SD increase in body size or 
adiposity. Where the childhood measure was significantly associated with LAS (any of CD, 
SI and YEM), adjusting for the adult measure substantially attenuated its estimated 
coefficients. Adjustment for adult height, BMI or body surface area also substantially 
attenuated the estimated effects of its childhood antecedents on LAS.  Typically, the effect of 
adjustment was to reverse the sign of the childhood measure. In age-stratified analyses (not 
shown), this crossover in signs was most pronounced and consistent for those of pre-pubertal 
age in 1985 (men then aged 7–11 years, women then aged 7–9 years).  For IMT, adjustment 
for adult weight reduced the coefficients of child weight by 46% (male) and 70% (female) and 
of child height by 44% (male) and 27% (female). Adjusted for adult BMI, one SD of child 
height was associated with increases in adult IMT of 7.0µm (1.0–13.3) among males and 
6.0µm (1.0–11.0) among females. The association of child height with adult IMT was also 
independent of adult height (not shown). Adjusted for age and sex, one SD of child BMI and 
body surface area was associated with 4.7µm (0.8–8.6) and 7.5µm (0.4–11.1) increase in adult 
IMT respectively. Further adjustment for adult BMI or body surface area reduced the effects 
of child BMI or body surface area on adult IMT by 60% and 53% respectively. 
Table 4.4 shows mean values of IMT and LAS for participants cross-classified as normal 
weight or overweight/obese in childhood and as non-obese or obese in adulthood. Participants 
who were obese as adults had the greatest LAS and this was most pronounced for those of 
them who were normal in childhood. In contrast, the relative weight gain between childhood 
and adulthood was not as consequential for IMT.  
 Table 4.3. Regression of adult carotid intima-media thickness and three measures of large artery stiffness on age- and sex-specific 
standardised measures of body size and adiposity in childhood when aged 7–15 years and as adults aged 26–36 years  
 IMT CD SI YEM 
Study factor β  (95% CI) β  (95% CI) β  (95% CI) β  (95% CI) 
Male        
Child weight and adult weight       
Child weight only  0.89 (0.20, 1.50) −4.22 (−8.06, −0.38) 7.65 (−3.01, 18.41) 11.07 (4.40, 17.75) 
Adult weight only  1.04 (0.41, 1.67) −10.85 (−14.71, −6.99) 16.16 (4.79, 27.53) 22.46 (15.26, 29.65) 
Child adjusted for adult  0.48 (−0.25, 1.21) 2.54 (−2.12, 7.20) −1.47 (−14.13, 11.18) −1.16 (−8.66, 6.34) 
Adult adjusted for child  0.75 (−0.01, 1.51) −12.28 (−16.93, −7.63) 17.06 (3.28, 30.84) 23.21 (14.48, 31.94) 
Child height and adult weight        
Child height only  0.80 (0.17, 1.43) −3.63 (−7.61, 0.35) 7.32 (−3.79, 18.44) 9.76 (2.89, 16.64) 
Adult weight only  1.04 (0.41, 1.67) −10.85 (−14.71, −6.99) 16.16 (4.79, 27.53) 22.46 (15.26, 29.65) 
Child adjusted for adult  0.45 (−0.23, 1.14) 1.04 (−3.32, 5.41) 1.00 (−10.97, 12.97) 1.02 (−6.11, 8.14) 
Adult adjusted for child  0.84 (0.15, 1.53) −11.19 (−15.43, −6.95) 15.45 (2.99, 27.92) 21.75 (13.88, 29.62) 
Female          
Child weight and adult weight        
Child weight only  0.48 (−0.02, 0.97) −0.29 (−5.18, 4.60) −5.96 (−15.61, 3.69) 1.64 (−3.48, 6.76) 
Adult weight only  0.68 (0.18, 1.18) −8.23 (−13.05, −3.41) 2.14 (−7.87, 12.14) 10.24 (4.81, 15.68) 
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 Child adjusted for adult  0.14 (−0.46, 0.74) 6.73 (0.68, 12.77) −10.65 (−22.28, 0.98) −6.00 (−11.96, −0.05) 
Adult adjusted for child  0.60 (−0.01, 1.21) −12.02 (−17.85, −6.19) 8.55 (−3.92, 21.02) 14.11 (7.29, 20.93) 
Child height and adult weight        
Child height only  0.66 (0.17, 1.14) −3.58 (−8.35, 1.19) 2.45 (−7.28, 12.18) 5.83 (0.68, 10.97) 
Adult weight only  0.68 (0.18, 1.18) −8.29 (−13.09, −3.48) 2.37 (−7.59, 12.34) 10.24 (4.81, 15.68) 
Child adjusted for adult  0.48 (−0.04, 1.00) −0.69 (−5.83, 4.45) 1.84 (−8.60, 12.29) 2.51 (−2.90, 7.91) 
Adult adjusted for child  0.49 (−0.05, 1.02) −8.03 (−13.20, −2.86) 1.68 (−9.02, 12.38) 9.21 (3.41, 15.00) 
Abbreviation: IMT (intima-media thickness), CD (carotid distensibility), SI (stiffness index) and YEM (Young’s elastic modulus). 
Outcome variables were IMT, CD, SI and YEM. The covariates were mean-corrected standard deviation scores of child weight, adult weight and 
child height, and with adult age as an additional covariate. 
β (95% CI) denotes regression coefficient (95% confidence interval) multiplied by 100 for better display. 
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 Table 4.4. Intima-media thickness and three measures of large artery stiffness in participants cross-classified by childhood and 
adulthood obesity 
 IMT (mm)  CD (%/10mmHg)  SI  YEM (mmHg.mm) 
 n Mean (SD)  Mean (SD)  Mean (SD)  Mean (SD) 
Male             
Normal child – Not obese adult 906 0.607 (0.098)  1.98 (0.63)  5.23 (1.76)  286.4 (105.5) 
Overweight/Obese child – Not obese adult 55 0.637 (0.103)  1.89 (0.61)  5.42 (1.98)  315.2 (109.8) 
Normal child – Obese adult 117 0.622 (0.106)  1.77 (0.62)  5.61 (2.02)  325.7 (145.2) 
Overweight/Obese child – Obese adult 72 0.614 (0.110)  1.80 (0.65)  5.43 (2.04)  318.2 (123.7) 
Female             
Normal child – Not obese adult 944 0.576 (0.080)  2.36 (0.77)  4.84 (1.64)  229.4 (83.9) 
Overweight/Obese child – Not obese adult 66 0.567 (0.067)  2.55 (0.66)  4.60 (1.20)  209.8 (61.4) 
Normal child – Obese adult 101 0.582 (0.084)  2.11 (0.89)  5.27 (2.27)  258.6 (124.5) 
Overweight/Obese child – Obese adult 66 0.582 (0.094)  2.38 (0.87)  4.45 (1.60)  235.5 (98.8) 
Abbreviations: IMT (intima-media thickness), CD (carotid distensibility), SI (stiffness index) and YEM (Young’s elastic modulus). 
Childhood obesity was classified as normal or overweight/obese by using the International Obesity Taskforce BMI cut-points. Adulthood obesity 
was classified as not obese (adult BMI<30kg/m
2) or obese (adult BMI≥30kg/m2). 
All models were adjusted for adult age. 
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Finally, we investigated whether these relationships were independent of potential 
confounders or altered by potential effect modifiers. Adjusting for childhood exposure to 
parental smoking, alcohol consumption in childhood, adult smoking, parity and oral 
contraceptive use did not appreciably alter the coefficient of the adult body size or adiposity 
measures (not shown). Adjustment for childhood BP (a potential mediator measured for 9, 12 
and 15 year-olds only) and age of menarche (found to be negatively associated with adult 
IMT in girls) reduced the estimated effects of child height on adult IMT by around 30% and 
15% respectively (not shown). Adjustment for BP, lipids, insulin and glucose substantially 
reduced the estimated effects of adulthood adiposity (ranging from 50–70%) on adult IMT 
(not shown).  
Discussion 
This study examined the relationships of body size or adiposity in childhood (7–15 years) and 
20 years later in adulthood (26–36 years) with adult IMT and LAS on a large population-
based sample of Australians. LAS was found to depend primarily on current adiposity and 
was greatest for those who were normal weight in childhood but obese as adults, whereas 
IMT was positively associated with body size or adiposity in both childhood and adulthood.  
For LAS, adjusting for the adult measure of adiposity almost eliminated the estimated effect 
of its childhood antecedents. This suggests that increases in body size or adiposity after 
childhood influence LAS in early adulthood, and that the importance of larger size in 
childhood is primarily that larger children are very likely to become larger adults with greater 
LAS on average. Of those who were overweight or obese in childhood in our study, only 
12.4% were normal weight adults. The coefficient of the childhood measure was greatly 
attenuated, and in some cases the diminution of effect was so comprehensive that all that 
remained was a weak association of reverse sign, when adjusted for its adult value. This 
change in sign is interpreted in life-course epidemiology as evidence that changes in the 
explanatory factor during the intervening period have affected the outcome of interest.
21, 22
 In 
other words, it was the magnitude of adiposity gain from childhood to adulthood that was 
associated with LAS. This is consistent with our results because LAS appeared to be greatest 
in obese adults, and this was most pronounced for those of them who were normal weight in 
childhood. In our study this reverse in sign was most pronounced for those of pre-pubertal age 
at baseline, suggesting that subsequent growth spurts and fat deposition during puberty may 
influence LAS. Alternatively, or in unison, the action of sex hormones may modify (by 
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magnifying) the effect of growth in body size or adiposity. This could explain why 
correlations of childhood adiposity with CD, SI and YEM found in this study were weaker 
than those reported in an analysis of the Young Finns cohort.
14
 The participants in that study 
had a wider range of ages (3–18 years) and included older subjects. However, it might also be 
explained by other differences in methodology, including lack of adjustment for baseline age 
of participants in that study. 
In contrast, greater body size or adiposity in both childhood and adulthood were associated 
with thickened IMT. This was also found in a pooled analysis of our data with data from three 
other cohorts.
23
 This is consistent with recent evidence showing increased IMT in overweight 
and obese children.
3, 4
 The stronger association of adult IMT with child height than with other 
childhood measures of body size argues against the use of height-for-weight indices such as 
child BMI to predict adult IMT. Our results also suggest that in the relationship between 
childhood body size and IMT, height is the most relevant measure of body size for 
participants of pre-pubertal age and weight becomes relatively more important thereafter 
commencing in the pubertal years. This may be due to higher BP and earlier sexual 
maturation in taller children.
24
 Our study revealed a reduced effect of childhood height on 
adult IMT after adjustment for childhood BP, and for age of menarche in girls. Our study also 
revealed BP, lipids, insulin, and glucose to be possible intermediary factors in the relationship 
of adiposity with IMT. This finding suggests that childhood obesity, which predisposes to 
obesity in adulthood, contributes to increases in these cardio-metabolic risk factors for obese 
adults, and thereby influences adult IMT 20 years later. Among the same persons in young 
adulthood, weight and weight-for-height indices captured the relationship better than height. 
This study was a follow-up of a large nationally-representative sample of Australian 
schoolchildren on whom standardised measurements were made of an extensive range of 
study factors. Loss to follow-up has occurred, with non-participants at follow-up having 
higher mean BMI in childhood than the participants,
16
 but this was an analytical investigation 
of a large sample from a well-characterised study population for which the distributional 
range of confounders and effect modifiers was not restricted by sampling or diminished by 
attrition. Threats to external validity are less of an issue in these circumstances.
25
 An 
additional strength of this study was its relatively contemporary cohort with childhood 
anthropometric measurements made in 1985. Most other studies have followed historical 
cohorts of children lacking the upper extremes of body size or adiposity observed more 
recently. Although the prevalence of childhood overweight and obesity in this study was not 
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as extreme as that reported for present-day Australian children,
26
 participants in our study 
were fully exposed to the risk factors that have subsequently led to dramatic increases in 
overweight and obesity in contemporary young adults. 
The limitations of this study need to be recognised. Whilst a recent meta-analysis has 
questioned the prognostic value of IMT,
27
 several studies have reported carotid artery stiffness 
to be an independent predictor of cardiovascular events and all-cause mortality in kidney 
disease patients,
28
 and the measures of carotid artery stiffness used in this study were 
recognised by expert consensus.
28
 Anthropometric measurements at additional time-points 
would have better discerned the critical periods of exposure. Using an ultrasound machine 
with a higher transducer frequency
29
 and automatic border detection software may have 
provided better accuracy in IMT measurements. However, the coefficient of variation 
(calculated as SD/mean) in our IMT measurements was 0.1639 (male) and 0.1379 (female), 
which were very similar to those of the Cardiovascular Risk Factors of Young Finns study
10
 
that used a 13MHz transducer (male 0.1606, female 0.1376). Our IMT measurements were 
also sensitive enough to detect siginificant associations of adult IMT with childhood body 
size or adiposity 20 years earlier. Transducer compression due to limited ultrasound 
penetrance in obese participants may have occurred. However, our data suggests that 
transducer compression (if any) was not sufficient to mask associations because adjustment 
for it did not change our results. Another potential limitation of this study was the use of 
brachial pulse pressure in calculation of carotid LAS when it is preferable to use the carotid 
pressure itself. With one exception,
8
 studies of childhood adiposity and adult vascular health
9-
14
 have not followed-up beyond early adult years. Atherosclerosis develops very slowly 
throughout life and, possibly, an independent relationship of childhood adiposity with adult 
IMT will be better discerned at a later stage.   
Conclusions 
In summary, whilst LAS depended primarily on current adiposity and was worst for those 
who gained their excess weight after childhood, carotid IMT was positively influenced by 
body size in both childhood and adulthood. This suggests that accumulation of IMT occurs 
slowly from childhood to adulthood, whereas LAS is more dynamic and dependent on current 
adiposity and magnitude of adiposity gain between childhood and adulthood. Our findings 
demonstrate direct (IMT) and indirect (LAS) consequences of childhood body size or 
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adiposity on adult vascular health, and efforts to achieve a healthy weight to reduce 
cardiovascular risk should be started early in life and maintained through adulthood. 
Postscript 
The findings from this chapter showed detrimental effects of greater body size and fatness in 
both childhood and adulthood on adult vascular health. The association of another important 
physical health metric (physical fitness) with vascular health is examined in Chapter 5. 
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Appendix 4.A. Additional Methods 
Carotid intima-media thickness (IMT) 
The left common carotid artery and left carotid bifurcation were traced longitudinally so that 
the distal 10-30mm of the artery was imaged with focus on the posterior (far) wall. A real-
time image of three consecutive cardiac cycles was recorded. From the best-quality cardiac 
cycle, a total of 12 measurements at two positions were taken approximately 10mm proximal 
from the bulb at the end-diastolic phase. The mean and maximum of each of six 
measurements were calculated, and they were averaged to derive mean and maximum IMT. 
The measurements of IMT were made by three readers. The mean maximum IMT 
measurements of the three readers were 0.588 mm ± 0.093 (n=769), 0.595 mm ± 0.103 
(n=702), and 0.590 mm ± 0.074 (n=512).  The measurements of the three readers were 
calibrated to have the same mean adjusted for factors that differed between the groups of 
subjects measured by each reader. This procedure is necessary to preserve the associations of 
IMT with the same independent variables used in the main analysis. For example, the 
association of maximum IMT with childhood weight z-scores adjusted for age and sex was 
𝑟=0.080 (pre-calibration) and 𝑟=0.079 (post-calibration). Intra-reader reproducibility was 
assessed in a random subsample of 30 participants. The average absolute difference and 
standard deviation for replicate IMT measurements was 0.02±0.04mm.
1
 
Covariates 
Socioeconomic status based on residential postcodes in childhood was derived using the 
Australian Bureau of Statistics Index of Relative Socioeconomic Disadvantage.
2
 Information 
on smoking, alcohol consumption, and female reproductive characteristics (including 
menstrual cycle regularity, age at menarche, parity and hormonal contraceptive use) was 
obtained by self-administered questionnaire. Childhood age and age of menarche (for girls) 
were used to approximate likely pre-, peri- and post-pubertal status of participants in 1985. 
Alcohol consumption at follow-up was calculated from a food frequency questionnaire using 
a frequency grid.
3
 Glucose, high-density lipoprotein cholesterol and triglyceride 
concentrations were measured in 12-hour overnight fasting blood samples using an Olympus 
AU5400 automated analyzer (Olympus Optical, Tokyo, Japan). Low-density lipoprotein 
cholesterol concentration was calculated using the Friedewald formula.
4
 Fasting plasma 
insulin was measured by a microparticle enzyme immunoassay kit (AxSYM, Abbot 
Laboratories, Abbot Park, IL, USA) and by electrochemiluminescence immunoassay (Elecsys 
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Modular Analystics E170; Roche Diagnostics, Manheim, Switzerland) with interassay 
standardization.
5
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Appendix 4.B. Additional figure 
 
Figure 4.B.1. Semi-partial correlations of adult intima-media thickness with child 
weight and child height. 
The figure shows semi-partial correlations of IMT with weight-adjusted-for-height and 
with height-adjusted-for-weight. In the context of association with IMT, childhood size 
appeared to be better represented by height than by weight in the middle years of the age 
range studied (7-15 years) with weight becoming more important in the later years. There 
were similar age-specific patterns of association with CD, SI and YEM (not shown). 
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Chapter 5. Resting heart rate and the association of 
physical fitness with carotid artery stiffness 
Preface 
The previous chapter shows that greater body size and fatness in both childhood and 
adulthood have detrimental effects on adult vascular health. This chapter aims to study the 
associations of physical fitness – another important health metric – with vascular health 
among young adults, and to investigate the possible mechanisms involved. The following text 
in this chapter has been published in the journal American Journal of Hypertension. 
Introduction 
Stiffening of the large arteries (carotid and aorta) independently predicts future cardiovascular 
events and all-cause mortality.
1-3
 Fully understanding the determinants of arterial stiffness 
may lead to methods for reducing cardiovascular risk. Currently, there are no pharmacological 
agents targeted at reducing arterial stiffness. Improvements in lifestyles including regular 
exercise to increase cardiorespiratory fitness (CRF) have been shown to be associated with 
reduced arterial stiffness through a variety of mechanisms that remain unproven.
4
 Strength 
training, however, has been reported to increase arterial stiffness.
5, 6
 
Elevated resting heart rate (RHR) is an independent cardiovascular risk factor
7
 that is 
positively associated with arterial stiffness.
8, 9
 High RHR, possibly due to sympathetic 
hyperactivity, may directly increase arterial stiffness through greater cyclic mechanical shear-
stress on the arterial wall.
10
 Regular exercise to improve CRF reduces RHR,
11
 and this could 
be a pathway by which arterial stiffness is reduced. In contrast, the relationship between 
arterial stiffness and strength training, which increases muscular strength and may also reduce 
RHR, remains controversial. Contrary to evidence from intervention studies showing an 
acute
12, 13
 or chronic
5, 6
 increase in arterial stiffness induced by strength training, some studies 
have shown no change
14, 15
 or a decrease in arterial stiffness.
16
 Despite the uncertain 
implication for arterial stiffness, strength training is recommended to improve general 
health.
17, 18
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The aim of this study was to investigate the associations of CRF and muscular strength with 
arterial stiffness in young adults, and to determine whether RHR had an intermediary role in 
any associations.    
Methods 
Study population 
The Childhood Determinants of Adult Health (CDAH) study collected baseline data in 1985 
on a nationally-representative sample of 8498 Australian schoolchildren aged 7–15 years.19 In 
this study, the analyses were restricted to 2328 non-pregnant subjects (49.4% male) who 
attended clinics in the first follow-up during 2004–2006.20 The CDAH study was approved by 
the local Ethics Committee. 
Cardiorespiratory fitness and muscular strength 
CRF was estimated as physical work capacity at a heart rate of 170bpm (PWC170). PWC170 
was measured using a bicycle ergometer (Monark Exercise AB, Vansbro, Sweden) pedaled at 
60rpm.
21
 Because the absolute workload achieved is a function of muscle mass,
22
 CRF was 
calculated as PWC170 adjusted for lean body mass to create an index uncorrelated with lean 
body mass (see Appendix 5.A for more details).  
Five measures of strength (left and right grip, shoulder push and pull, and leg strength) were 
measured using appropriate dynamometers (Smedley’s Dynamometer, TTM, Tokyo, Japan). 
Detailed procedure is reported in Appendix 5.A. Principal components analysis was used to 
estimate the first principal component of the five measures of strength for men and women 
separately.
23
 The first principal component was then adjusted for body weight to create an 
index uncorrelated with weight. This was the indicator of muscular strength used in this study. 
Blood pressure and arterial stiffness 
B-mode ultrasound studies of arterial stiffness were performed using a portable Acuson 
Cypress (Siemens Medical Solutions USA Inc., Mountainview, CA) platform with a 7.0MHz 
linear-array transducer by a single technician,
24
 following standardized protocols.
25
 Intima-
media thickness (IMT), and end-systolic and end-diastolic diameters (with intra-class 
correlations of repeated measurements 𝑟=0.99) were measured from the posterior wall of the 
left common carotid artery.
20
 Brachial systolic blood pressure (SBP) and diastolic blood 
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pressure (DBP) were measured supine during the ultrasound study.
20
 Carotid distensibility 
(CD), the inverse of stiffness, was measured as:  
CD = ([Dsbp−Ddbp]/Ddbp)/(SBP−DBP)  
where Dsbp is the end-systolic diameter, Ddbp is the end-diastolic diameter. CD is defined as 
the ability of the arterial wall to expand and contract passively with the changes in pressure.  
Covariates 
RHR was measured using an Omron HEM907 Digital Automatic Blood Pressure Monitor 
(Omron Corporation, Kyoto, Japan) after five-minute rest. A mean of three readings was used. 
RHR was also measured by electrocardiogram during the ultrasound procedure; analyses 
using this value of RHR provided the same results. Body mass index (BMI) was calculated as 
weight(kg)/height(m
2
). Mean arterial pressure (MAP) was calculated (MAP = ⅓SBP+⅔DBP). 
Socio-economic status, smoking, alcohol consumption, and data on resistance-type activities 
(including work-related vigorous activities and strength training) were obtained by 
questionnaire.
20
 Total minutes/week leisure-time physical activity was obtained using the 
International Physical Activity Questionnaire.
26
 High-density lipoprotein cholesterol (HDL-
C), low-density lipoprotein cholesterol (LDL-C), insulin, triglycerides and glucose were 
measured using 12-hour overnight fasting blood samples.
20
 
Statistical analyses 
Muscular strength and CRF were standardized z-scores for men and women separately. 
Values reported in Table 5.2 were calculated by applying Pearson’s correlation coefficients to 
the ranks of the variables. For other analyses, right-skewed outcomes were transformed prior 
to analysis. The regression estimates reported are in original units of the outcomes for one 
standard deviation (SD) increase in the study factor.
27, 28
 Direct and indirect associations (via 
RHR) of CRF and muscular strength with arterial stiffness were estimated by structural 
equation model analysis. Three levels of participation in resistance-type activities were 
defined as reporting no activities at all, either reporting strength training or occupational 
exposure to vigorous activities, or reporting both. For analyses, these ordered levels were 
graded by consecutive integer scores. Of the 2328 participants, 28 participants (1.2%) were on 
antihypertensive medication, two participants (0.08%) had had a heart attack, and three 
participants (0.13%) had had a stroke. Excluding these participants from analyses did not 
change our findings (not shown). The fit of all final models were assessed as being adequate. 
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Results 
Table 5.1 displays participants’ characteristics. Males had higher values of PWC170 and 
measures of strength, and greater body sizes (weight, height, BMI, waist circumference, and 
lean body mass) but smaller skinfolds than females. Males also had lower mean values of CD 
reflecting stiffer carotid arteries. Other than having lower RHR than women, the men 
generally had higher values of cardiovascular risk factors.  
Table 5.2 shows correlations of CRF and muscular strength with CD that were almost 
unchanged after mutual adjustment. CRF was positively correlated with CD, but this 
correlation was almost eliminated after adjusting for RHR (men 𝑟=0.01, women 𝑟=0.04). 
Leisure-time physical activity was correlated (all p<0.001) with both CRF (men 𝑟=0.30, 
women 𝑟=0.33) and RHR (men 𝑟=−0.20, women 𝑟=−0.19). Men and women with strength 
training had lower CD on average than those without (p=0.05). The correlation between 
muscular strength and CD was much weaker among women who undertook strength training 
than women who did not (p=0.021). Muscular strength was not correlated with CD before 
adjusting for RHR among men, and among women with strength training (𝑟=−0.01), but was 
negatively correlated with CD after adjusting for RHR (men 𝑟=−0.06, women with strength 
training 𝑟=−0.06). The correlation of muscular strength with participation in resistance-type 
activities (see Methods) was stronger for men (𝑟=0.19 p<0.001) than for women (𝑟=0.06 
p=0.053). Among participants undertaking strength training, total time spent on training was 
more strongly correlated with muscular strength among men (𝑟=0.16 p=0.02) than among 
women (𝑟=0.08 p=0.237). 
RHR was positively associated with arterial stiffness (Additional Figure 5.B.1 in Appendix 
5.B) and was negatively associated with the difference between Dsbp and Ddbp (men 𝑟=−0.29, 
women 𝑟=−0.25, both p<0.001) but was not associated with carotid IMT (men 𝑟=−0.04 
p=0.217, women 𝑟<0.01 p=0.877). Adjustment for blood pressure did not change the 
association of RHR with either CD or the difference between Dsbp and Ddbp (not shown).  
We next examined which other factors might be associated with CRF and muscular strength 
to better understand the possible causal pathways in the associations of CRF and muscular 
strength with arterial stiffness. Additional Table 5.B.1 (Appendix 5.B) presents age-adjusted 
associations of CRF and muscular strength with RHR and with MAP, BMI, insulin, HDL-C, 
LDL-C and triglycerides, which are known to be associated with arterial stiffness. Among 
these factors, RHR was most strongly correlated with CRF (men 𝑟=−0.36, women 𝑟=−0.30) 
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and muscular strength (men 𝑟=−0.14, women 𝑟=−0.15). The associations of CRF and 
muscular strength with RHR were slightly reduced after mutual adjustment (not shown). 
Table 5.1. Participants’ characteristics 
 Men  Women  
 Mean  (SD)  Mean  (SD) p-values 
Age (years) 31.6 (2.6)  31.3 (2.6) 0.044 
PWC170 (watts) 193.7 (45.1)  127.9 (30.5) <0.001 
Right grip (kg) 48.8 (7.7)  29.5 (5.2) <0.001 
Left grip (kg) 46.9 (7.7)  27.9 (5.1) <0.001 
Shoulder push (kg) 49.1 (13.0)  25.6 (7.6) <0.001 
Shoulder pull (kg) 40.0 (13.0)  20.9 (7.1) <0.001 
Leg strength (kg) 167.9 (38.9)  89.6 (28.2) <0.001 
Weight (kg) 83.5 (13.9)  65.8 (12.9) <0.001 
Height (cm) 179.5 (6.8)  165.6 (6.3) <0.001 
Body mass index (kg/m
2
) 25.9 (3.9)  23.9 (4.2) <0.001 
Waist circumference (cm) 88.0 (9.8)  75.7 (9.6) <0.001 
Sum of four skinfolds (mm) 61.7 (25.9)  73.4 (30.8) <0.001 
Lean body mass (kg) 63.6 (7.7)  43.9 (6.1) <0.001 
Resting heart rate (beats/minute) 68.3 (9.9)  73.2 (9.7) <0.001 
Systolic pressure (mmHg) 124.7 (10.7)  110.5 (10.1) <0.001 
Diastolic pressure (mmHg) 74.5 (8.9)  69.8 (8.6) <0.001 
Mean arterial pressure (mmHg) 91.3 (8.7)  83.4 (8.5) <0.001 
Insulin (mU/L) 6.3 (4.0)  6.0 (3.4) 0.001 
HDL-cholesterol (mmol/L) 1.26 (0.25)  1.51 (0.33) <0.001 
LDL-cholesterol (mmol/L) 3.04 (0.83)  2.74 (0.74) <0.001 
Triglycerides (mmol/L) 1.03 (0.65)  0.81 (0.42) <0.001 
Carotid distensibility (%/10mmHg) 1.94 (0.64)  2.35 (0.80) <0.001 
Stiffness index 5.29 (1.82)  4.83 (1.68) <0.001 
Young’s elastic modulus (mmHg.mm) 293.3 (111.5)  230.3 (87.4) <0.001 
Abbreviations: SD (standard deviation); PWC170 (physical work capacity at a heart 
rate of 170bpm); HDL (high-density lipoprotein); LDL (low-density lipoprotein). 
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Table 5.2. Rank correlations of cardiorespiratory fitness and muscular strength 
with carotid distensibility. 
 Men Women 
Cardiorespiratory fitness† 0.121 *** 0.103 ** 
Muscular strength‡ −0.002 −0.108 ** 
Partial correlations§   
Cardiorespiratory fitness 0.128 *** 0.119 *** 
Muscular strength −0.020  −0.112 ** 
**p<0.01; ***p<0.001. 
†Sex-specific z-scores of cardiorespiratory fitness, which was PWC170 adjusted for 
lean body mass. 
‡The first principal component of five measures of strength that was then adjusted 
for body weight and expressed as a sex-specific z-score. 
§Correlations of cardiorespiratory fitness with carotid distensibility adjusting for 
muscular strength, and of muscular strength with carotid distensibility adjusting for 
cardiorespiratory fitness. 
Table 5.3 shows the estimated change in CD with a one-SD increase of CRF and muscular 
strength after adjustment for relevant factors. For muscular strength, the regression 
coefficients were changed slightly-to-moderately by controlling for BMI or insulin, HDL-C, 
LDL-C and triglycerides, but the largest changes occurred on adjustment for RHR revealing a 
substantially stronger association. The direct and indirect effects (via RHR) of one-SD 
increase in muscular strength on CD were −0.03%/10mmHg (−0.07, −0.00) and 
0.03%/10mmHg (0.02, 0.05) for men, and were −0.10%/10mmHg (−0.16, −0.05) and 
0.03%/10mmHg (0.01, 0.04) for women. For CRF, adjustment for RHR reduced the 
association with CD by 93.7% (men) and 67.6% (women). The direct and indirect effects (via 
RHR) of one-SD increase in CRF on CD were 0.01%/10mmHg (−0.03, 0.05) and 
0.07%/10mmHg (0.05, 0.09) for men, and were 0.01%/10mmHg (−0.05, 0.06) and 
0.05%/10mmHg (0.03, 0.07) for women. Additional adjustment for MAP, BMI or blood 
biomarkers after adjustment for RHR slightly changed the coefficients produced by 
adjustment for RHR. There was no interaction of RHR with blood pressure and other factors 
(not shown). Further adjustment for socio-economic status, smoking and alcohol consumption 
did not alter these findings (not shown). 
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Table 5.3. Regression of carotid distensibility on cardiorespiratory fitness and muscular 
strength with adjustment for resting heart rate and other relevant factors. 
 Men  Women 
 β (95% CI)* R2  β (95% CI)* R2 
Cardiorespiratory fitness        
Unadjusted 7.7 (3.4, 12.0) 0.03  6.5 (1.1, 12.0) 0.02 
Adjusted for        
Age 7.9 (3.6, 12.2) 0.03  7.4 (2.0, 12.8) 0.03 
Age, MAP 6.4 (2.1, 10.8) 0.04  6.3 (1.0, 11.7) 0.05 
Age, BMI 6.7 (2.3, 11.0) 0.04  5.8 (0.4, 11.3) 0.04 
Age, Biomarkers† 6.4 (1.9, 10.8) 0.04  5.4 (−0.1, 11.0) 0.04 
Age, RHR 0.5 (−3.8, 4.8) 0.12  2.4 (−3.1, 7.9) 0.10 
Age, RHR, MAP 0.3 (−4.0, 4.6) 0.12  2.2 (−3.3, 7.7) 0.10 
Age, RHR, BMI −0.4 (−4.8, 3.9) 0.12  0.8 (−4.8, 6.4) 0.10 
Age, RHR, Biomarkers† −0.5 (−4.9, 3.9) 0.12  0.4 (−5.3, 6.1) 0.09 
Muscular strength        
Unadjusted −0.8 (−5.2, 3.5) 0.03  −8.2 (−13.4, −3.1) 0.04 
Adjusted for        
Age −0.4 (−4.8, 3.9) 0.03  −8.4 (−13.5, −3.2) 0.05 
Age, MAP −0.6 (−4.9, 3.7) 0.05  −8.9 (−14.0, −3.9) 0.06 
Age, BMI −1.2 (−5.9, 3.1) 0.04  −9.0 (−14.1, −3.9) 0.05 
Age, Biomarkers† −1.5 (−5.9, 2.9) 0.04  −9.0 (−14.1, −3.9) 0.06 
Age, RHR −3.6 (−7.7, 0.5) 0.13  −11.1 (−16.1, −6.2) 0.12 
Age, RHR, MAP −3.5 (−7.6, 0.6) 0.13  −11.2 (−16.1, −6.2) 0.13 
Age, RHR, BMI −4.1 (−8.2, −0.0) 0.14  −11.6 (−16.5, −6.6) 0.12 
Age, RHR, Biomarkers† −4.5 (−8.6, −0.3) 0.14  −11.4 (−16.4, −6.4) 0.12 
Abbreviation: MAP (mean arterial pressure), BMI (body mass index), RHR (resting heart 
rate). 
*Regression coefficient (95% confidence interval) multiplied by 100 for better display. 
†Including adjustment for insulin, HDL-C, LDL-C, and triglycerides. 
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Whilst these cross-sectional data are silent about attribution of causation, Figure 5.1 shows 
hypothesised pathways through which CRF and muscular strength could affect arterial 
stiffness. An increase in CRF might reduce arterial stiffness mainly through reducing RHR. 
There are two possible pathways through which an increase in muscular strength may affect 
arterial stiffness. First, muscular strength may influence arterial stiffness directly, and 
possibly more so for women. Second, muscular strength may exert its influence indirectly by 
reducing RHR. If these pathways exist as postulated, our results suggest they are roughly 
counter-balanced for men. 
 
Figure 5.1. The pathways illustrate postulated direct and indirect effects of 
cardiorespiratory fitness and muscular strength on arterial stiffness.  
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Discussion 
We found that arterial stiffness was negatively associated with CRF, but positively associated 
with muscular strength. Greater CRF and muscular strength were independently associated 
with lower RHR, and thereby, lower arterial stiffness. While the negative association of CRF 
with arterial stiffness appeared to be mediated by RHR, adjustment for RHR revealed a 
stronger positive association of muscular strength with arterial stiffness because the offsetting 
beneficial effects via lower RHR were removed. Adjustment for BMI, MAP or blood 
biomarkers did not change these findings. These results suggest that lower RHR is a key 
intermediary factor in the beneficial effect of CRF on arterial stiffness, and that the 
deleterious effect of greater muscular strength on arterial stiffness is partially offset by its 
indirect effect via lower RHR.  If correct, these pathways enhance understanding of the 
mechanisms involved and clarify the controversial findings on strength training and 
cardiovascular health. 
Women in this age range had lower carotid stiffness than men. This is consistent with 
previous findings.
25, 29
 Whilst the relationship of CRF with arterial stiffness was similar for 
men and women, there were differences for muscular strength. Arterial stiffness was more 
strongly associated with muscular strength for women than for men and, for men, an 
association was revealed only after adjusting for RHR. The different ways in which men and 
women acquire muscular strength may play a part in this. Muscular strength was greater for 
men, and was associated with time spent on strength training and occupational exposure to 
vigorous activities. This suggests men are more likely to acquire muscular strength from 
participation in resistance-type activities. This is the mechanism proposed by which 
acquisition of muscular strength leads to increased arterial stiffness.
5
 Results from sub-group 
analyses for women with strength training support this inference. The relationship between 
muscular strength and arterial stiffness was weaker for women with strength training than 
those without, and more like that of the men. Again, like the men, adjusting for RHR 
strengthened the relationship markedly. 
The intermediary role of RHR may help explain previous inconsistent findings about strength 
training and arterial stiffness. Our findings are inconsistent with those from Fahs et al
30
 that 
showed an inverse association of muscular strength with arterial stiffness among 79 men. 
While we adjusted our measures of strength for body weight to create an index uncorrelated 
with weight as recommended,
31
 Fahs et al
30
 divided muscular strength by body weight. Cole 
et al
31
 indicated that this may produce a spurious association. Using our data, we noted that 
Chapter 5 – Resting heart rate and arterial stiffness 140 
the effect of dividing muscular strength by body weight was to reverse the sign of the 
correlations with CD, changing them from negative to positive. A spurious association arising 
in this way will be reduced by adjusting for weight and, consistent with this, adjusting for 
body weight or BMI eliminated the negative association in our data (not shown).  
For CRF, its inverse association with arterial stiffness was mostly eliminated by controlling 
for RHR. This suggests RHR mediates the relationship between CRF and arterial stiffness.  It 
might be argued that RHR may be a marker of CRF, so adjusting for RHR would eliminate 
any association of CRF with any outcomes. However, this was not true in our study. Findings 
from intervention studies suggest RHR to be an outcome of endurance training to improve 
CRF.
11
 In our data, RHR could not be considered as a marker of CRF because the correlation 
between them was only weak-to-moderate. Furthermore, the results of adjusting for CRF and 
RHR are very different. For example, the association of muscular strength with arterial 
stiffness was substantially increased after adjusting for RHR (Table 5.3) but was slightly 
changed after adjusting for CRF (Table 5.2). Also suggesting they are associated with 
outcomes via different pathways, adjustment for RHR eliminated the association of CRF with 
arterial stiffness, but only weakly-to-moderately reduced the associations of CRF with other 
cardiovascular risk factors such as blood pressure, metabolic syndrome or fatness (not 
shown). 
Our findings show physical fitness is associated with arterial stiffness even among young and 
generally-healthy adults with low levels of arterial stiffness, which is consistent with 
associations between physical activity and arterial stiffness among children and young adults 
reported in other studies.
32, 33
 Because the association of CRF with arterial stiffness was 
independent of muscular strength and the association of muscular strength was independent of 
CRF, the effects on arterial stiffness for those who undertake both endurance and strength 
training may be the net effect from the two types of training. Although the direct detrimental 
effect of high muscular strength due to training on arterial stiffness may be partially offset by 
its indirect beneficial effect via RHR, individuals who do strength training might also benefit 
from endurance training to further minimise the adverse effects on arterial stiffness from 
strength training, as previously suggested.
34
 
Though not completely understood, high RHR may increase mechanical load on the arterial 
wall and expose it to greater pressure and shear stress by shortening the diastolic period. This 
might lead to greater arterial wall stiffness possibly by promoting vascular smooth muscle cell 
growth and collagen deposition.
10, 35
 Changes in heart rate can change the computed value of 
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CD. However, distinction needs to be drawn between the acute versus chronic exposure to 
changes in heart rate and the corresponding response in CD. In the acute setting,
36
 the increase 
in blood pressure that accompanies the rise in heart rate will result in a functional increase in 
arterial stiffness. That is, there is temporary recruitment of collagenous fibres in the arterial 
wall to ‘stiffen’ the vessel against increased distending pressure.37 On the other hand, chronic 
exposure to high RHR and blood pressure results in arterial wall remodelling and a structural 
increase in stiffness. Our study measured heart rate at rest and, the estimated relationship with 
arterial stiffness is likely to represent a chronic effect. The associations of RHR with either 
CD or carotid diameters remained unchanged after adjusting for blood pressure, which 
suggests that the relationship between RHR and CD was not due to an acute change in 
pressure. We therefore believe that the relationship between RHR and arterial stiffness 
observed in our study was due to structural changes in the arterial wall and not from artefact 
related to computation of CD. 
It is well-known that blood pressure can influence arterial stiffness and independently predicts 
mortality.
38
 Thus, any studies of arterial stiffness predicting mortality should account for 
blood pressure.
3
 RHR independently predicts mortality
7
 and is positively associated with 
arterial stiffness,
8, 9
 but is generally not considered in studies of arterial stiffness. These data 
together suggest that future studies of arterial stiffness predicting mortality need to take 
account of RHR.  
This study used a large nationally-representative sample of young Australians on whom 
standardized measurements were made of an extensive range of study factors. The few other 
studies of muscular strength and arterial stiffness have either used small samples or compared 
normal, sedentary controls with high-intensity trained athletes. A limitation of our study was 
the use of brachial, instead of carotid, pulse pressure to calculate CD. This is likely to have 
resulted in underestimation of the association between RHR and CD because the fittest people 
(with higher CD and lower RHR) would also be more likely to have the greatest systolic and 
pulse pressure amplification (higher brachial compared with central systolic and pulse 
pressure). The higher estimated values for SBP may therefore underestimate the calculated 
CD. The cross-sectional design limits the causal inference that can be drawn about the 
relationship of RHR with arterial stiffness. However, given evidence that endurance training 
to improve CRF reduces arterial stiffness,
4
 we discount the possibility of reverse causation in 
our data (where greater arterial stiffness leading to higher RHR) because adjusting the 
association between CRF (an antecedent of arterial stiffness) and RHR by arterial stiffness 
had only the most minor impact in our data (not shown). This is consistent with recent 
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findings that CD and aortic distensibility decreased with increasing RHR.
9, 39
 Because our 
study included data on young adults only, we cannot generalise our findings to older 
population.   
Conclusions 
In conclusion, our findings attribute a key intermediary role for RHR in the relationship 
between physical fitness and arterial stiffness. Higher CRF may reduce arterial stiffness by 
reducing RHR and while higher muscular strength is associated with greater arterial stiffness, 
the association is partially offset by reduced RHR. An indirect association of muscular 
strength with arterial stiffness via RHR would help reconcile the inconsistent evidence on the 
response of arterial stiffness to strength training, and provide some support for the inclusion 
of strength training in recommendations and guidelines for exercise to improve general health. 
Postscript 
This chapter examines the associations of physical fitness with arterial stiffness, and attributes 
a key intermediary role of RHR in those relationships. The next chapter studies the 
associations of different types of physical activity with arterial stiffness, and determines 
whether RHR also plays a key role. 
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Appendix 5.A. Additional Methods 
Carotid artery stiffness 
The other two measures of carotid artery stiffness that were measured in our study were 
stiffness index (SI) and Young’s elastic modulus (YEM). 
SI = ln(SBP/DBP)/([Dsbp−Ddbp]/Ddbp) 
YEM = ([SBP−DBP)Ddbp)/([Dsbp−Ddbp]/IMT) 
SI is a measure of carotid artery stiffness designed to be relatively independent of blood 
pressure. YEM is an estimate of carotid artery stiffness per mm of carotid intima-media 
thickness (IMT). Using these two measures of carotid artery stiffness for analyses provided 
similar results as those of using carotid distensibility. 
Lean body mass 
Lean body mass was calculated from body density and percent body fat equations that used 
measures of skinfold thickness. Skinfolds were measured to the nearest 0.5mm at the biceps, 
triceps, iliac crest and subscapularis. Skinfold measures >40mm were truncated due to caliper 
limitations and estimated values were imputed from body mass index (BMI) and waist 
circumference using Tobit regression.
1
  Body density was estimated from the log of the sum 
of four skinfolds using age-specific regression equations.
2, 3
 Calculations of body fat were 
made from density using the Siri formula,
4
 and lean body mass was estimated by subtracting 
fat mass from total body mass. 
Estimation of body density using age-specific regression equations
2, 3
: 
Males: Body density = 1.1765 − (0.0744 × (log10(sum of four skinfolds))) 
Females: Body density = 1.1567 − (0.0717 × (log10(sum of four skinfolds))) 
Calculation of the percentage of body fat using the Siri formula
4
: 
Body fat percentage = (495/body density) – 450 
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Calculation of lean body mass 
Lean body mass = body weight × ((100 – body fat percentage)/100) 
Muscular strength 
Five measures of strength were measured in different types of large muscles using hand-grip, 
shoulder-arm and leg-back dynamometers (Smedley’s Dynamometer, TTM, Tokyo, Japan). 
Each measure was repeated twice with at least 1-minute rest apart. The maximum of the two 
attempts was used in analysis. Grip strength (left and right) was measured as participants held 
the dynamometer with one hand, supported it on the opposite shoulder, and gripped with 
maximum force. Shoulder strength (pull and push) was measured as participants held the 
dynamometer in front of their chest so that their arms and elbows were parallel to the ground, 
and then pulled or pushed with maximum force. For leg strength, participants were asked to 
stand on the dynamometer with a straight back, flat against the wall, holding a hand bar with 
an overhand grip. Knees were flexed until an angle of 115º was obtained, at which position 
the bar was attached to the dynamometer by a chain. Participants then pulled the bar upward 
as far as possible. Other than leg strength that was measured to the nearest 1kg, the other four 
measures of muscular strength were measured to the nearest 0.5kg. Before testing in each 
Australian state or territory, the dynamometers were calibrated by either a private company 
accredited by the National Association of Testing Authorities, Australia, or by a hospital-
based biomedical engineering department, through the entire range of measurement of the 
device.  
 
  
Chapter 5 – Resting heart rate and arterial stiffness 149 
References 
1. Dwyer T, Magnussen CG, Schmidt MD, Ukoumunne OC, Ponsonby AL, Raitakari 
OT, Zimmet PZ, Blair SN, Thomson R, Cleland VJ, Venn A. Decline in physical fitness from 
childhood to adulthood associated with increased obesity and insulin resistance in adults. 
Diabetes Care. 2009 Apr;32(4):683-7. 
2. Durnin JV, Rahaman MM. The assessment of the amount of fat in the human body 
from measurements of skinfold thickness. Br J Nutr. 1967 Aug;21(3):681-9. 
3. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation 
from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br 
J Nutr. 1974 Jul;32(1):77-97. 
4. Siri W. Gross composition of the body. In: Lawrence J, Hamilton J, editors. Advances 
in Biological and Medical Physics. New York: Academic Press; 1956. 
 
 
  
Chapter 5 – Resting heart rate and arterial stiffness 150 
Appendix 5.B. Additional table and figure 
Additional Table 5.B.1. Regression of resting heart rate and relevant 
cardiovascular risk factors on sex-specific z-scores of cardiorespiratory fitness 
and muscular strength. 
 Muscular strength  Cardiorespiratory fitness 
 β (95% CI)  β (95% CI) 
Men      
Resting heart rate −1.38 (−1.99, −0.78)  −3.56 (−4.10, −3.01) 
Mean arterial pressure 0.16 (−0.37, 0.70)  −1.53 (−2.03, −1.02) 
Body mass index −0.17 (−0.40, 0.05)  −0.63 (−0.84, −0.42) 
Insulin −0.56 (−0.78, −0.34)  −0.97 (−1.16, −0.77) 
HDL-cholesterol 0.02 (0.01, 0.03)  0.03 (0.01, 0.04) 
LDL-cholesterol 0.02 (−0.03, 0.08)  −0.12 (−0.17, −0.07) 
Triglycerides −0.05 (−0.09, −0.01)  −0.10 (−0.13, −0.07) 
Women      
Resting heart rate −1.25 (−1.94, −0.76)  −2.94 (−3.51, −2.38) 
Mean arterial pressure −0.34 (−0.86, 0.17)  −0.82 (−1.32, −0.31) 
Body mass index −0.14 (−0.38, 0.09)  −0.67 (−0.89, −0.45) 
Insulin −0.13 (−0.34, 0.07)  −0.77 (−0.95, −0.59) 
HDL-cholesterol 0.01 (−0.01, 0.03)  0.06 (0.04, 0.08) 
LDL-cholesterol −0.05 (−0.10, −0.01)  −0.10 (−0.14, −0.05) 
Triglycerides −0.03 (−0.06, −0.01)  −0.04 (−0.07, −0.02) 
All models were adjusted for age. 
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Additional Figure 5.B.1. The associations of resting heart rate with three measures of 
carotid artery stiffness. 
Abbreviations: CD (carotid distensibility), SI (stiffness index), and YEM (Young’s elastic 
modulus). 
 
 
Chapter 6 – Physical activity and arterial stiffness 153 
 
 
Chapter 6 
 
 
Vigorous physical activity and carotid distensibility 
in young and mid-aged adults 
 
 
Currently under consideration with the journal 
Medicine and Science in Sports and Exercise 
(Manuscript submitted in 11/11/2013) 
Huynh L. Quan, Christopher L. Blizzard, Olli Raitakari, James E. Sharman, 
Costan G. Magnussen, Terence Dwyer, Markus Juonala, Mika Kähönen, and 
Alison J. Venn
Chapter 6 – Physical activity and arterial stiffness 155 
Chapter 6. Vigorous physical activity and carotid 
distensibility in young and mid-aged adults 
Preface 
The previous chapter shows the relationships of cardiorespiratory fitness and muscular 
strength – two important components of physical fitness – with arterial stiffness, and for the 
first time suggest the possible mechanisms involved in these relationships. This chapter aims 
to investigate the relationships of different types of physical activity (PA) – a means to 
improve fitness – with arterial stiffness, and the possible mechanisms involved in these 
relationships. 
Introduction 
Large arteries such as the carotid and aorta stiffen with age even in healthy individuals.
1
 
Decreased distensibility (or increased stiffness) of large arteries can independently predict 
cardiovascular events and all-cause mortality,
2-4
 and is one of the most important contributors 
to the increased cardiovascular risk with ageing.
5
 Given that there are currently no 
pharmacological agents that are targeted at reducing arterial stiffness, any lifestyle factors that 
can delay this process hold promise for reducing age-associated cardiovascular disease. 
Intervention studies have reported light-to-moderate PA to increase arterial distensibility 
among older adults.
6, 7
 However, it is unclear whether these results can be extrapolated to 
younger adults and there is limited information on the type of PA that exerts the most 
beneficial effect on arterial distensibility. Current guidelines
8
 reflect the thinking that 
reduction in cardiovascular risks can be achieved by participating in either vigorous PA or 
light-to-moderate PA (with longer time required). Walking, assessed by questionnaire or by 
motion sensors such as pedometers or accelerometers, has been shown to have a range of 
cardio-metabolic benefits
9-11
 but its association with arterial distensibility is less clear. Recent 
evidence suggests that vigorous PA may provide cardioprotective benefits that are beyond 
those achieved through light-to-moderate PA
12, 13
 but associations of objectively measured 
steps/day with arterial distensibility have not been previously investigated.  Clarifying this 
matter is important for informing advice on PA to promote cardiovascular health. 
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In this study, using data on 4503 young to mid-aged adults from two large population-based 
cohorts in Australia and Finland, we examined the relationship of different types of PA, 
including pedometer measured steps/day, with carotid artery distensibility and, for 
comparison, other cardiovascular risk factors. We sought to determine whether the association 
varied by type of PA and aimed to investigate the possible mechanisms. 
Methods 
This study included data from two large population-based prospective cohort studies in 
Australia and Finland. Each study was approved by local ethics committees. All participants 
provided written informed consent. 
Australia: the Childhood Determinants of Adult Health study (CDAH) 
Study population 
The CDAH study  collected baseline data in 1985 on a nationally-representative sample of 
8498 Australian schoolchildren aged 7–15 years.14 In this study, we included 2328 non-
pregnant participants aged 26–36 years (49.4% male) who attended one of 34 study clinics 
across Australia at follow-up during May 2004–May 2006.15 Of these participants, 1787 
(76.8%) had their arterial distensibility measured. 
Physical activity 
Daily steps were recorded using Yamax Digiwalker SW-200 pedometers for seven days.
9
 
Average steps/day was calculated for participants wearing pedometers at least eight hours/day 
for at least four days,
16
 consistent with other studies.
17
 PA in previous week was self-reported 
using the International Physical Activity Questionnaire.
18
 Minutes/week spent on work-
related, domestic and recreational PA at moderate and vigorous intensity was recorded 
together with time spent in active transport (classified as moderate intensity). These were 
summed to obtain total minutes of moderate-to-vigorous PA, and moderate and vigorous 
activities were weighted – by assigning metabolic equivalent of task (MET) values of four 
and eight respectively – to obtain total energy expenditure.  
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Arterial distensibility and blood pressure 
End-systolic and end-diastolic diameters, and intima-media thickness (IMT) of the left 
common carotid artery were measured using a portable Acuson Cypress (Siemens Medical 
Solutions USA Inc., Mountainview, CA) platform with a 7.0MHz linear-array transducer by a 
single technician, following a standardized protocol.
15, 19
 Before its inclusion in the CDAH 
study, the ultrasound measures derived from this portable Acuson Cypress were validated 
against those from a routinely-used clinic-based ultrasound machine like that used in the 
Cardiovascular Risk in Young Finns study (Acuson Sequoia 512, Siemens Medical Solutions 
USA Inc., Mountainview, CA).
20
 Brachial systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) were measured during the ultrasound with a mean of two readings used in this 
study.
15
 Carotid distensibility (CD), the inverse of stiffness, was calculated as follows
15, 21
: 
CD = ([Dsbp−Ddbp]/Ddbp)/(SBP−DBP)  
where Dsbp and Ddbp are the end-systolic and end-diastolic diameters.  
Other cardiovascular risk factors 
Body mass index (BMI) was calculated as weight(kg)/height(m
2
). Mean arterial pressure 
(MAP) was calculated as MAP = ⅓ SBP + ⅔ DBP. Resting heart rate (RHR) was measured 
while sitting after at least five-minute rest using an Omron HEM907 Blood Pressure Monitor 
(Omron Corporation, Kyoto, Japan). Concentrations of high-density lipoprotein cholesterol 
(HDL-C), triglycerides, insulin, and glucose were measured in 12-hour overnight fasting 
blood samples.
15
 Low-density lipoprotein cholesterol (LDL-C) concentration was calculated 
using the Friedewald formula.
22
 Because the absolute workload achieved is partly a function 
of muscle mass,
23
 physical working capacity measured by a bicycle ergometer
24
 at a heart rate 
of 170 beats per min was adjusted for lean body mass to create an index of cardiorespiratory 
fitness that is uncorrelated with lean body mass. This was previously described elsewhere.
21
 
The first principal component
25
 of five measures of strength (left and right grip, shoulder push 
and pull, and leg strength) was measured by appropriate dynamometers (Smedley’s 
Dynamometer, TTM, Tokyo, Japan) and adjusted for body weight to create an index of 
muscular strength that is uncorrelated with weight.
21
 Data on socio-economic status, smoking 
and alcohol consumption were obtained by questionnaire.
15
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Finland: the Cardiovascular Risk in Young Finns study 
Study population 
The Young Finns study collected baseline data in 1980 on 3596 Finnish children and 
adolescents aged 3–18 years.26 In this study, we included 2175 non-pregnant participants aged 
30–45 years (45.8% male) who attended a clinic in Finland during the follow-up in 2007. Of 
these participants, 2169 (99.7%) had their arterial distensibility measured. 
Physical activity 
In 2007, participants of Young Finns study wore Omron Walking Style One (HJ-152R-E) 
pedometers to record daily steps for seven days.
27
 Average steps/day was calculated for 
participants wearing pedometers at least eight hours/day for four days, consistent with other 
studies including CDAH.
9, 17
 Leisure-time and transport PA were obtained by questionnaire, 
and a value of MET.hour/week was calculated based on these two subdomains of PA for 
Young Finns participants.
28
 Vigorous leisure-time PA per usual week was reported by 
choosing one of the six response categories: “none”, “approximately 30 minutes”, “1 hour”, 
“2–3 hours”, “4–6 hours” and “7 hours or more”.  
Arterial distensibility and blood pressure 
Using similar a standardized protocol as in CDAH,
15, 19
 end-systolic and end-diastolic 
diameters, and IMT were measured from the left common carotid artery by Sequoia 512 
ultrasound mainframes (Acuson) with 13.0MHz linear-array transducers, together with 
concomitant brachial blood pressure. CD was calculated using the same formula as in 
CDAH.
15, 19
 
Other cardiovascular risk factors 
Using similar standardized protocols and formulas as in CDAH, BMI and MAP were 
calculated, RHR was measured while sitting after at least five-minute rest, 12-hour overnight 
fasting concentrations of HDL-C, triglycerides, insulin, and blood glucose were measured,
19
 
LDL-C concentration was calculated using the Friedewald formula,
22
 and data on socio-
economic status, smoking and alcohol consumption were obtained by a questionnaire.
29
 
Cardiorespiratory fitness was objectively estimated in a random subsample of 538 participants 
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(47.8% male) by a bicycle ergometer using hypothetical maximal workload sustainable for six 
minutes measured on the basis of age, sex, height, and weight.
30
 
Statistical analyses 
Spearman correlations and relative risks (by log binomial regression) are reported in Table 6.2 
and Table 6.3 respectively. For other analyses, right-skewed outcome data (CD and other risk 
factors) were transformed prior to estimation of their means or linear regression. The 
regression estimates reported are in the original units of the outcomes for one unit increase in 
the study factor.
31
 Participants of each sex in each sample were classified as spending no time, 
<2hours/week, 2–3hours/week or >3hours/week in vigorous leisure-time PA. For estimation 
of trend, these ordered levels were graded by consecutive integer scores. For estimation of 
relative risk, low arterial distensibility was defined by having CD<10
th
 percentile specific for 
each sample, each sex and each year of age. Based on the concept of “vascular age” for 
IMT,
32
 we used linear regression to estimate sample- and sex-specific rate of decreasing CD 
per year of age after adjusting for BMI, PA, socio-economic status, smoking, and alcohol 
consumption. We then calculated the mean difference in “vascular age” of participants who 
spent at least one hour/week in vigorous PA, as in guidelines,
8
 compared with that of those 
who did not by dividing the difference in CD by the rate of decreasing CD per year of age. 
The percentage by which RHR explained the relationship of PA with CD was calculated by 
subtracting the direct effect (adjusting for RHR and age) from the total effect (adjusting for 
age only), and then dividing by the total effect. The percentage was set at 100% if adjusting 
for RHR reversed the sign of the association. 
Results 
Characteristics of participants in the two samples are shown in Table 6.1. On average, the 
Young Finns participants were 6 years older than the CDAH participants. Other than having 
lower RHR, the men in each sample had lower CD and greater BMI, MAP, insulin, glucose, 
LDL-C and triglycerides, and lower HDL-C, than the women (all p<0.001). The risk factor 
profile of the Young Finns reflected their slightly older age. 
Cardiorespiratory fitness was positively correlated with steps/day (CDAH men 𝑟=0.15, 
women 𝑟=0.21; Young Finns men 𝑟=0.33, women 𝑟=0.25; all p<0.001), and was more 
strongly correlated with self-reported vigorous leisure-time PA (CDAH men 𝑟=0.36 women 
𝑟=0.35, Young Finns men 𝑟=0.41 women 𝑟=0.40, all p<0.001). 
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Table 6.1. Characteristics of participants in the two samples 
 Men   Women  
 Mean (SD)  Mean (SD) 
CDAH (n=2328) a 49.4% (1150)  50.6% (1178) 
Age (year) 31.6 (2.6)  31.3 (2.6) 
Body mass index (kg/m
2
) 25.9 (3.9)  23.9 (4.2) 
Average steps/day 8819 (3426)  8575 (2932) 
Total active hours/week 11.3 (8.7)  10.8 (7.9) 
Total physical activity (MET.hour/week) 52.6 (44.1)  42.2 (33.3) 
Vigorous physical activity      
Any vigorous physical activity
a
 71.4% (703)  49.2% (536) 
Average hours/week
b
 3.37 (3.41)  2.23 (2.32) 
Any vigorous work-related activity
a
  39.9% (393)  16.2% (176) 
Average hours/week
b
 3.40 (3.39)  2.32 (2.91) 
Any vigorous domestic activity
a
 40.0% (394)  22.2% (242) 
Average hours/week
b
 1.93 (1.83)  1.67 (1.58) 
Any vigorous leisure-time activity
a
 48.7% (479)  40.0% (436) 
Average hours/week
b
 2.13 (2.13)  1.83 (1.66) 
Carotid distensibility (%/10mmHg) 1.94 (0.64)  2.35 (0.79) 
Stiffness index 5.29 (1.82)  4.83 (1.68) 
Young’s elastic modulus (mmHg.mm) 293.3 (111.5)  230.3 (87.4) 
Heart rate at rest (bpm) 68.3 (9.9)  73.2 (9.7) 
Systolic pressure (mmHg) 124.6 (10.7)  110.5 (10.1) 
Diastolic pressure (mmHg) 74.5 (8.9)  69.8 (8.6) 
Insulin (mU/L) 6.33 (4.0)  5.96 (3.35) 
Glucose (mmol/L) 5.14 (0.42)  4.84 (0.40) 
HDL-cholesterol (mmol/L) 1.26 (0.25)  1.51 (0.33) 
LDL-cholesterol (mmol/L) 3.04 (0.84)  2.74 (0.74) 
Triglycerides (mmol/L) 1.03 (0.65)  0.81 (0.42) 
Young Finns (n=2175) a 45.8% (996)  54.2% (1179) 
Age (year) 37.6 (5.1)  37.8 (4.9) 
Body mass index (kg/m
2
) 26.1 (4.0)  24.5 (4.3) 
Average steps/day 6729 (2732)  7509 (2811) 
Leisure-time, commuting activity (MET.hour/week) 9.9 (19.2)  12.1 (17.9) 
Any vigorous leisure-time activity
a
 67.5% (667)  76.7% (895) 
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Carotid distensibility (%/10mmHg) 1.71 (0.62)  1.97 (0.72) 
Stiffness index 5.71 (2.14)  5.28 (1.95) 
Young’s elastic modulus (mmHg.mm) 372 (168.9)  306.5 (135.5) 
Heart rate at rest (bpm) 66.7 (9.9)  68.9 (9.2) 
Systolic pressure (mmHg) 125.2 (12.8)  115.2 (13.5) 
Diastolic pressure (mmHg) 78.8 (10.9)  73.0 (10.9) 
Insulin (mU/L) 7.54 (6.24)  7.00 (5.69) 
Glucose (mmol/L) 5.38 (0.54)  5.08 (0.51) 
HDL-cholesterol (mmol/L) 1.18 (0.28)  1.41 (0.32) 
LDL-cholesterol (mmol/L) 3.22 (0.82)  2.89 (0.72) 
Triglycerides (mmol/L) 1.33 (0.77)  1.01 (0.47) 
Abbreviations: CDAH, the Childhood Determinants of Adult Health study; Young Finns, 
the Cardiovascular Risk in Young Finns study. 
a
Data are percentage (number). 
b
Data are reported only for participants who reported some vigorous physical activity of the 
corresponding subdomain. 
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Table 6.2 shows Spearman correlations of steps/day, and of self-reported PA, with CD and 
other cardiovascular risk factors. Steps/day and total PA in both studies, and total vigorous 
PA in CDAH, were negatively associated with RHR, insulin and triglycerides and positively 
associated with HDL-C, but not with CD. Among CDAH participants, self-reported time 
spent on walking was also not associated with CD (men p=0.431, women p=0.968). In each 
sample, although the associations of outcomes with total PA or total vigorous PA remained 
significant, they were largely reduced after adjustment for the vigorous leisure-time 
component of PA (not shown). Only vigorous leisure-time PA was positively associated with 
CD.  
Because only vigorous leisure-time PA was associated with CD, we further investigated this 
association. Additional Table 6.A.1 shows that, other than CDAH women, participants with 
greater vigorous leisure-time PA had greater mean values of CD. Whereas light-to-moderate 
PA was not associated with CD, participants spending at least one hour/week in vigorous 
leisure-time PA had a lower vascular age of approximately 6.6 years (CDAH men), 1.0 year 
(CDAH women), 2.7 years (Young Finns men), and 3.2 years (Young Finns women) than 
those who did not. Based on consistent findings from parallel analyses, Table 6.3 shows 
pooled-data analyses adjusting for cohort and age, which presents associations of greater 
levels of vigorous leisure-time PA with lower risk of having low arterial distensibility (see 
Methods). In contrast, greater steps/day was not associated with risk of having low arterial 
distensibility (CDAH men p=0.868, women p=0.254; Young Finns men p=0.883, women 
p=0.161). Adjustment for socio-economic status, smoking and alcohol consumption, and 
muscular strength (CDAH only), did not change our findings (not shown). 
Compared with BMI, MAP and blood biomarkers, RHR was most strongly correlated with 
CD (CDAH men 𝑟=−0.33 women 𝑟=−0.24; Young Finns men 𝑟=−0.30 women 𝑟=−0.30; 
p<0.001). To investigate the possible pathways by which participation in vigorous leisure-
time PA may influence CD, Table 6.4 presents the estimated effects of participation in 
vigorous leisure-time PA on CD with adjustment for RHR and other relevant factors. While 
adjustment for MAP, BMI or insulin, HDL-C, LDL-C and triglycerides reduced slight-to-
moderately the estimated effect of vigorous leisure-time PA on CD, adjustment for RHR 
substantially reduced this association by 88% (CDAH men), 100% (CDAH women, Young 
Finns men) or  80% (Young Finns women). Additional adjustment for MAP, BMI or blood 
biomarkers after adjustment for RHR provided small additional changes to the regression 
coefficients produced by adjustment for RHR.  
 Table 6.2. Spearman correlation of different measures of physical activity with carotid artery distensibility and other cardiovascular 
risk factors 
 CD HR MAP Insulin Glucose HDL-C LDL-C Triglycerides 
CDAH                 
Men                 
Steps/day −0.02  −0.10 ** 0.01  −0.17 *** 0.06  0.09 ** 0.04  −0.06  
Total PA
a
 −0.04  −0.09 ** 0.02  −0.15 *** 0.03  0.12 *** 0.05  −0.05  
Total vig. PA
b
 0.01  −0.12 *** −0.03  −0.14 *** 0.01  0.10 ** 0.01  −0.05  
Leisure vig. PA
b
 0.07 * −0.23 *** −0.06  −0.17 *** −0.03  0.11 *** −0.12 *** −0.08 * 
Women                
Steps/day 0.03  −0.14 *** −0.02  −0.13 *** −0.01  0.12 *** −0.07 * −0.09 ** 
Total PA
a
 −0.02  −0.05  −0.01  −0.00  0.03  −0.02  0.04  −0.00  
Total vig. PA
b
 0.02  −0.16 *** 0.04  −0.04  0.02  0.07 * −0.04  −0.03  
Leisure vig. PA
b
 0.02  −0.19 *** 0.05  −0.09 ** 0.02  0.11 *** −0.05  −0.04  
Young Finns               
Men               
Steps/day 0.04  −0.15 *** −0.05  −0.22 *** −0.04  0.15 *** −0.02 −0.23 *** 
Total PA
a
 0.04  −0.14 *** −0.02  −0.18 *** −0.17 *** 0.11 *** −0.10 ** −0.15 *** 
Leisure vig. PA
c
 0.07 * −0.20 *** 0.00  −0.17 *** −0.17 *** 0.09 ** −0.08 * −0.10 ** 
Women                
Steps/day 0.05  −0.11 *** 0.01  −0.14 *** −0.04  0.06 * −0.03 −0.09 ** 
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 Total PA
a
 0.04  −0.12 *** 0.01  −0.15 *** −0.09 ** 0.06 * 0.00 −0.09 ** 
Leisure vig. PA
c
 0.08 ** −0.13 *** 0.00  −0.16 *** −0.09 ** 0.06 * −0.05 −0.10 ** 
Abbreviations: CD, carotid distensibility; HR, heart rate; MAP, mean arterial pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, 
low-density lipoprotein cholesterol; CDAH, the Childhood Determinants of Adult Health study; Young Finns, the Cardiovascular Risk in 
Young Finns study; and PA, physical activity. 
*p<0.05; **p<0.01; ***p<0.001. 
a
Total MET.hour/week. 
b
Minutes/week spent on different types of vigorous physical activities. 
c
Levels of participation in vigorous leisure-time physical activities. 
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Table 6.3. Relative risks of having low arterial distensibility by levels of participation 
in vigorous leisure-time physical activity in the two samples (pooled-data analysis). 
 Men  Women 
 n/N RR (95% CI)  n/N RR (95% CI) 
Vigorous leisure-time PA        
None 93/744 1.00 Ref  103/881 1.00 Ref 
Any 83/1047 0.62 (0.46, 0.82)  115/1284 0.73 (0.56, 0.96) 
Vigorous leisure-time PA      
None 93/744 1.00 Ref  103/881 1.00 Ref 
<2 hours/week 33/351 0.73 (0.50, 1.07)  54/533 0.83 (0.60, 1.15) 
2-3 hours/week 31/404 0.60 (0.40, 0.88)  36/486 0.60 (0.40, 0.87) 
>3 hours/week 19/292 0.51 (0.32, 0.83)  25/265 0.73 (0.50, 1.06) 
 Ptrend=0.003  Ptrend=0.03 
Abbreviations: RR, relative risk; PA, physical activity. 
Low arterial distensibility was defined by having carotid distensibility<10
th
 percentile 
specific for each sample, each sex and each year of age. 
All models were adjusted for age and cohort. 
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Table 6.4. Regression of carotid distensibility on levels of participation in vigorous 
physical activity during leisure time, with adjustment for heart rate and other 
relevant factors 
 Carotid distensibility (%/100mmHg) 
 Men  Women 
 β (95% CI)  β (95% CI) 
CDAH      
Unadjusted 0.47 (0.07, 0.87)  0.24 (−0.29, 0.76) 
Adjusted for      
Age 0.43 (0.03, 0.83)  0.16 (−0.36, 0.68) 
Age, MAP 0.41 (0.02, 0.80)  0.20 (−0.32, 0.71) 
Age, BMI 0.41 (0.01, 0.80)  0.05 (−0.48, 0.57) 
Age, Biomarkers
a
 0.28 (−0.12, 0.69)  0.06 (−0.45, 0.58) 
Age, RHR 0.05 (−0.32, 0.44)  −0.25 (−0.76, 0.26) 
Age, RHR, MAP 0.07 (−0.31, 0.45)  −0.18 (−0.70, 0.33) 
Age, RHR. BMI 0.06 (−0.32, 0.44)  −0.34 (−0.86, 0.18) 
Age, RHR, Biomarkers
a
 −0.00 (−0.39, 0.38)  −0.28 (−0.79, 0.23) 
Young Finns      
Unadjusted 0.31 (0.03, 0.59)  0.42 (0.09, 0.75) 
Adjusted for      
Age 0.29 (0.02, 0.56)  0.35 (0.03, 0.67) 
Age, MAP 0.29 (0.02, 0.56)  0.37 (0.06, 0.67) 
Age, BMI 0.21 (−0.06, 0.48)  0.18 (−0.14, 0.50) 
Age, Biomarkers
a
 0.15 (−0.12, 0.42)  0.22 (−0.09, 0.53) 
Age, RHR −0.03 (−0.30, 0.23)  0.07 (−0.22, 0.37) 
Age, RHR, MAP 0.03 (−0.23, 0.29)  0.12 (−0.17, 0.41) 
Age, RHR. BMI −0.04 (−0.31, 0.21)  −0.03 (−0.33, 0.27) 
Age, RHR, Biomarkers
a
 −0.09 (−0.36, 0.17)  0.03 (−0.27, 0.32) 
Abbreviations: CI, confidence intervals; CDAH, the Childhood Determinants of Adult 
Health study; MAP, mean arterial pressure; BMI, body mass index; RHR, resting 
heart rate; Young Finns, the Cardiovascular Risk in Young Finns study. 
a
Including adjustment for insulin, HDL-cholesterol, LDL-cholesterol and triglycerides. 
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Discussion 
Our principal findings were as follows. First, vigorous leisure-time PA, but not total PA or 
less intensive forms of PA, were associated with greater CD. Second, participation in 
vigorous leisure-time PA may increase CD (or delay age-related arterial stiffening) by 
reducing RHR. Third, greater steps/day was associated with lower risk factors such as RHR, 
insulin, HDL-C, LDL-C and triglycerides, but not with CD. These findings were independent 
of age, MAP, BMI, biochemical markers, socio-economic status, smoking, and alcohol 
consumption. 
Our study included only young to mid-aged adults who did not have the low levels of arterial 
distensibility typically found among older people. Light-to-moderate PA has been found to 
increase arterial distensibility among old adults,
33
 but more vigorous PA may be required to 
increase the higher levels of arterial distensibility among younger adults as shown in our 
study. This is consistent with a study by van de Laar et al.
13
 showing an association of self-
reported vigorous PA with arterial distensibility among 373 young adults. The same logic 
may explain the weaker association found for CDAH women in our study. Women in this age 
range have higher CD than men. This was observed in both the CDAH and Young Finns 
samples, and in another study.
34
 In our study, CDAH women had the highest mean level of 
CD and, as shown in Additional Table 6.A.1, the CDAH women who did not do any vigorous 
leisure-time PA had greater CD than the CDAH men who spent more than three hours/week 
on vigorous leisure-time PA. Thus, participation in vigorous PA may benefit these young 
women by reducing other cardiovascular risk factors, but not by directly improving CD. 
Current recommendations for PA
8
 reflect the evidence that cardiovascular risk can be reduced 
by either vigorous PA or light-to-moderate PA such as walking but with longer time required 
for light-to-moderate PA to achieve the same benefits. In our study, the benefits of PA in 
respect of greater CD were confined to vigorous leisure-time PA, and improvements in RHR 
and cardiorespiratory fitness were greater for this type of PA as well. Whereas light-to-
moderate PA was not associated with greater CD, participants who spent at least one 
hour/week on vigorous PA as described by the guideline
8
 had younger vascular age than those 
who did not. Although our findings do not contradict the benefits of light-to-moderate PA 
such as walking for cardiovascular health, they suggest that an increase in arterial 
distensibility among young to mid-aged adults may be best achieved by participation in 
vigorous PA and, are consistent with other evidence of vigorous PA being associated with 
greater cardioprotective benefits.
12
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In this study, RHR clearly mediated the positive relationship of vigorous leisure-time PA with 
CD. This is consistent with findings on the positive relationship of cardiorespiratory fitness 
with CD, which was also mediated by RHR.
21
 Though not completely understood, high RHR 
may increase mechanical load on the arterial wall by exposure to higher mean pressure and 
increase cyclic shear stress by shortening the diastolic period.
35
 This might lead to greater 
arterial wall stiffness possibly by promoting vascular smooth muscle cell growth and collagen 
deposition.
35
 Using the same data from CDAH, we found that stroke volume was negatively 
associated with RHR, but was not related to CD. This again suggests that the lower arterial 
distensibility associated with high RHR may be due to remodelling of the arterial wall.  
This study used two large population-based samples of adults in Australia and Finland on 
whom standardized measurements were made of an extensive range of study factors. Despite 
many cultural and environmental differences in the two countries, the very consistent results 
from the two populations strengthened the external validity of our findings. Using similar 
standardized protocols for physical measurements (including CD) in the two cohorts was 
another strength of this study. Although transducers with different frequencies were used, the 
coefficients of variation between these methods were very similar,
15
 suggesting comparable 
accuracy. Combining data on both self-reported and objectively-measured PA helps to clarify 
the beneficial effects of PA at different intensities for cardiovascular health. The validity of 
self-reported PA in our study was confirmed by its strong association with objectively-
measured cardiorespiratory fitness. We were able to somewhat differentiate endurance 
training from strength training, which may have adverse effects on arterial distensibility,
36
 by 
accounting for muscular strength (in the CDAH sample). A limitation of our study was the 
use of brachial, instead of carotid, pulse pressure to calculate CD. This is likely to have 
resulted in underestimation of the association between RHR and CD because the most 
physically-active people (with higher CD and lower RHR) would also be more likely to have 
the greatest systolic and pulse pressure amplification (higher brachial compared with central 
systolic and pulse pressure). The higher estimated values for SBP may therefore 
underestimate the calculated CD. The cross-sectional design of this study, however, limits the 
causal inferences concerning the relationship of vigorous PA with CD. We cannot rule out the 
possibility of reverse causation whereby participants with stiffer arteries might do less 
vigorous PA. However, our findings on these generally-healthy individuals who were 
unaware of their levels of arterial distensibility link well with previous findings to suggest that 
young and mid-aged adults may acquire additional benefits of increased arterial distensibility 
by participation in vigorous leisure-time PA; a benefit mediated via lower RHR.  
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Conclusions 
In conclusion, our findings provide further evidence to support the recommendation of 
vigorous PA for cardiovascular health benefits beyond those achieved through light-to-
moderate PA such as walking in young to mid-aged adults and, for the first time, suggest that 
participation in vigorous physical activity may increase arterial distensibility through lower 
RHR. 
Postscript 
The research in this chapter investigated the relationship of different types of PA with arterial 
stiffness, and showed that only vigorous PA at leisure time was associated with arterial 
stiffness. The next chapter aims to examine the relationship of sedentary behaviour with 
arterial stiffness and to determine whether this relationship (if any) is independent of PA. 
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Appendix 6.A. Additional Table 
Additional Table 6.A.1. Mean values of carotid distensibility by levels of 
participation in vigorous physical activity during leisure time 
 Men  Women 
 n Mean (SD)  n Mean (SD) 
CDAH      
None 427 1.89 (0.65)  601 2.32 (0.78) 
<2 hours/week 110 1.98 (0.61)  178 2.33 (0.81) 
2-3 hours/week 156 2.00 (0.57)  105 2.38 (0.85) 
>3 hours/week 124 2.00 (0.60)  86 2.36 (0.74) 
 Ptrend=0.036  Ptrend=0.439 
Young Finns      
None 317 1.66 (0.60)  280 1.89 (0.73) 
<2 hours/week 241 1.70 (0.63)  355 1.98 (0.74) 
2-3 hours/week 248 1.74 (0.63)  381 2.05 (0.68) 
>3 hours/week 168 1.77 (0.58)  179 2.03 (0.76) 
 Ptrend=0.045  Ptrend=0.013 
Abbreviations: CDAH (the Childhood Determinants of Adult Health study), Young Finns 
(the Cardiovascular Risk in Young Finns study). 
All models were adjusted for age. 
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Chapter 7. The association of sitting time with carotid 
artery stiffness in young adults 
Preface 
Chapter 5 and 6 of this thesis show negative associations of cardiorespiratory fitness and 
vigorous physical activity with arterial stiffness and, for the first time, shed light on the 
possible mechanisms involved in these relationships. This chapter aims to investigate the 
association of sedentary behaviour with arterial stiffness and the possible mechanisms 
involved in any association, and to determine whether the relationship of sedentary behaviour 
with arterial stiffness (if any) is independent of physical activity and cardiorespiratory fitness. 
Introduction 
Physical activity is widely accepted as an important means to improve cardiovascular health. 
Indeed, lack of physical activity is the second leading behavioural cause of death in the 
United States, following tobacco use.
1
 Many studies have reported participation in physical 
activity to be negatively associated with cardio-metabolic risk factors including arterial 
stiffness.
2, 3
 Although the benefits of physical activity are well-known, recent data show that 
levels of participation in moderate-to-vigorous physical activity decline from childhood to 
adulthood and are low for adults.
4
  
Sedentary behaviour such as sitting, watching television and computer use are ubiquitous in 
contemporary society and have become a new focus for research in health and physical 
activity. They are defined by both their posture (sitting or reclining) and their low levels of 
energy expenditure (typically in the range of 1.0 to 1.5 multiples of the basal metabolic rate).
5, 
6
 Recent findings suggest such activities should not be viewed as a replacement for moderate-
to-vigorous physical activity but as a distinct cardiovascular risk factor.
7
 Indeed, several 
studies have reported sedentary behaviour to independently predict greater cardio-metabolic
8-
10
 and mortality risk.
11-15
 That is, even for individuals who meet guideline recommendation on 
physical activity, being sedentary for prolonged periods may still compromise their health. 
The relationship between sedentary behaviour and arterial stiffness, which is considered as 
one of the most important contributors to the increased cardiovascular risk associated with 
ageing,
16
 is however poorly understood. In this study of young adults, we examined the 
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association of sedentary behaviour with arterial stiffness and with other cardio-metabolic risk 
factors as a means to investigate the possible mechanisms. We hypothesised that sedentary 
behaviour is positively associated with arterial stiffness. 
Methods 
Study population 
This cross-sectional study used data from the Childhood Determinants of Adult Health 
(CDAH) study, which collected baseline data in 1985 on a nationally-representative sample of 
8498 Australian schoolchildren aged 7–15 years.17 In this study, we included 2328 non-
pregnant participants aged 26–36 years (49.4% male) who attended one of 34 study clinics 
across Australia at follow-up during May 2004–May 2006.18 The CDAH study was approved 
by the local ethics committees. 
Sedentariness, physical activity and physical fitness  
Participants reported how much time (hours and minutes) they spent sitting on a weekday 
(Monday to Friday) and weekend day (Saturday and Sunday) during the last seven days using 
the long version of the International Physical Activity Questionnaire (IPAQ).
19
 Time spent 
watching television, using computers and playing video games were also recorded in the same 
manner. Physical activity during the last seven days was also reported using the long version 
of the IPAQ.
19
 Specifically, minutes/week spent on work-related, domestic and leisure 
physical activity at moderate and vigorous intensity were recorded together with time spent on 
active transport (classified as moderate intensity). These were summed to obtain total minutes 
of moderate-to-vigorous physical activity, and moderate and vigorous activities were 
weighted by their energy cost – by assigning metabolic equivalent of task (MET) values of 
four and eight respectively – to obtain total energy expenditure. The associations of self-
reported measures of sedentary behaviour and physical activity with a range of demographic 
and cardio-metabolic factors in our study have been reported elsewhere.
20, 21
 Daily steps were 
recorded by Yamax Digiwalker SW-200 pedometers for seven days as previously described.
21
 
Cardiorespiratory fitness was estimated as physical work capacity at a heart rate of 170bpm 
(PWC170) by bicycle ergometry.
22
 Because the absolute workload achieved is partly a function 
of muscle mass,
23
 PWC170 was adjusted for lean body mass
24
 to create an index of 
cardiorespiratory fitness that is uncorrelated with lean body mass.
25
 For participants who were 
currently involved in strength training, total time spent on strength training was calculated 
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from self-reported information on average duration of each workout, number of workouts per 
week, and the total years and months of training. 
Arterial stiffness and other cardio-metabolic risk factors 
Arterial stiffness was measured in the left common carotid artery using a portable Acuson 
Cypress (Siemens Medical Solutions USA Inc., Mountainview, CA) platform with a 7.0MHz 
linear-array transducer by a single technician.
26
 Brachial systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) were measured during the ultrasound study with a mean of 
two readings used in this study.
18
 Three indices of carotid artery stiffness
18, 25
 were calculated 
as follows: 
CD = ([Dsbp−Ddbp]/Ddbp)/(SBP−DBP)  
SI = ln(SBP/DBP)/([Dsbp−Ddbp]/Ddbp) 
YEM = ([SBP−DBP)Ddbp)/([Dsbp−Ddbp]/IMT) 
where Dsbp and Ddbp  are the end-systolic and end-diastolic diameters respectively, and IMT is 
carotid intima-media thickness. Carotid distensibility (CD), the inverse of stiffness, measures 
the passive expansion and contraction of the arterial wall with changes in blood pressure. 
Stiffness index (SI) is a measure of stiffness that is relatively independent of pressure. 
Young’s elastic modulus (YEM) is an estimate of stiffness per mm of IMT. 
Resting heart rate (RHR) was measured while sitting after at least a five-minute rest. Weight, 
height and waist circumference were measured.
18
 Body mass index (BMI) was calculated as 
weight(kg)/height(m)
2
. Sum of skinfolds at biceps, triceps, iliac crest and supraspinale was 
used.
27
 Glucose, high-density lipoprotein cholesterol (HDL-C), triglyceride and insulin 
concentrations were measured in 12-hour overnight fasting blood samples.
18
 Low-density 
lipoprotein cholesterol (LDL-C) concentration was calculated using the Friedewald formula.
28
 
Metabolic syndrome status was determined by using the 2009 harmonized definition proposed 
jointly by the International Diabetes Federation, National Heart, Lung and Blood Institute, 
American Heart Association, World Heart Federation, International Atherosclerosis Society, 
and the International Association for the Study of Obesity.
29
 A continuous metabolic 
syndrome score was calculated using the method described by Wijndaele et al
30
 as previously 
reported.
27
 Briefly, the score was calculated by applying sex-specific principal component 
analysis to the normalized metabolic syndrome risk factors (including waist circumference, 
SBP, DBP, HDL-C, triglycerides and glucose). Two principal components that explained 
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34% and 26% of the variance in men and 31% and 25% of the variance in women were 
identified. These principal components were then summed, weighted according to the relative 
proportion of variance explained, to compute the continuous metabolic syndrome score. 
Covariates 
Data on smoking (never-smoker, ex-smoker and current-smoker), alcohol consumption 
(g/week), diet (whether dietary guidelines on various types of food were met), highest 
education and parity were obtained by questionnaire.
18, 31
  
Statistical analyses 
Right-skewed outcome data were appropriately transformed before estimation of means. The 
rank correlations were estimated by applying Pearson’s correlation to the rank of variables. 
The associations of time spent watching television, and of time using a computer or playing 
video games, per weekday and weekend day with the outcomes were similar to, but somewhat 
weaker than those of total sitting time per weekday and weekend day with the outcomes (not 
shown). For brevity, we reported the associations of total sitting time. Because only leisure-
time vigorous physical activity but not less intensive forms of physical activity were 
associated with arterial stiffness among the young participants included in our study (not 
shown), the correlations presented in Table 7.3 were adjusted for leisure-time vigorous 
physical activity. Adjustment for total physical activity provided similar results (not shown). 
There was no difference in self-reported moderate-to-vigorous physical activity in childhood 
between the participants at follow-up and the non-participants who dropped out from the 
baseline sample (p=0.62). However, the non-participants had lower socio-economic status, 
lower levels of school academic performance, higher BMI, greater waist circumference and 
lower cardiorespiratory fitness in childhood in 1985 than the participants included in this 
study (all p<0.05). Using these characteristics, we calculated the probability of participation at 
follow-up for each subject at baseline. We then weighted the associations of sitting time with 
the outcomes among the participants using inverse probability weighting; this gave estimates 
of the association of interest with the inclusion of non-participants at follow-up represented by 
those similar to them at baseline in terms of socio-economic status, school performance, BMI, 
waist and fitness. The weighted results were very similar to those presented in this manuscript 
(not shown), and thus give us confidence that the drop-outs did not influence our results. 
STATA 12 (Statacorp, College Station, Texas, USA) was used for analyses. 
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Results 
Characteristics of participants are shown in Table 7.1. Of the 2328 participants included in the 
analysis, 1246 (54%) of them spent at least five hours sitting per weekday whereas 900 (39%) 
of them spent at least five hours sitting per weekend day. On average, the male participants 
spent more time sitting and watching television or using computers or video games (all 
p<0.05), but had greater steps/day and greater self-reported moderate-to-vigorous physical 
activity, than their female counterparts (p<0.05). Computer use in this study included time 
using a computer at work and home. 91% (2122/2328) of our participants had a job or were 
students, and were likely to use a computer frequently. This may explain the large proportion 
of total sitting time in our study attributed to watching television, using computers and 
playing video games. The men had lower mean value of CD and higher mean values of SI and 
YEM (that is, stiffer arteries) than the women (all p<0.001). With the exception of RHR and 
skinfolds, all other cardio-metabolic risk factors were greater among the men than the women 
(all p<0.001).  
Table 7.1. Characteristics of participants 
 Men (n=1150)  Women (n=1178) 
 Mean (SD)  Mean (SD) 
Age (year) 31.6 (2.6)  31.3 (2.6) 
Sitting time      
Per week (hour) 39.9 (21.1)  37.1 (18.7) 
Per weekday (hour) 6.1 (3.6)  5.7 (3.2) 
Per weekend day (hour) 4.9 (2.7)  4.5 (2.6) 
Television, computer, video games      
Per week (hour) 32.4 (22.1)  27.1 (18.8) 
Per weekday (hour) 4.9 (3.8)  4.3 (3.4) 
Per weekend day (hour) 4.0 (3.1)  2.8 (2.1) 
Average steps per day 8819 (3426)  8575 (2932) 
Total active hours/week‡ 11.3 (8.7)  10.8 (7.9) 
Total MET.hour/week‡ 52.6 (44.1)  42.2 (33.3) 
Vigorous leisure-time activity (hour/week) 1.5 (2.5)  1.0 (1.9) 
Carotid distensibility (%/10mmHg) 1.94 (0.64)  2.35 (0.79) 
Stiffness index 5.29 (1.82)  4.83 (1.68) 
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Young’s elastic modulus (mmHg.mm) 293.3 (111.5)  230.3 (87.4) 
Resting heart rate (bpm) 68.3 (9.9)  73.2 (9.7) 
PWC170 (watts) 193.7 (45.1)  127.9 (30.5) 
Total time of strength training* (hour) 205.0 (614.9)  52.8 (153.4) 
Body mass index (kg/m
2
) 25.9 (3.9)  23.9 (4.2) 
Waist circumference (cm) 88.0 (9.8)  75.7 (9.6) 
Skinfolds (mm) 61.7 (25.9)  73.4 (30.8) 
Systolic pressure (mmHg) 124.6 (10.7)  110.5 (10.1) 
Diastolic pressure (mmHg) 74.5 (8.9)  69.8 (8.6) 
Insulin (mU/l) 6.33 (4.0)  5.96 (3.35) 
Glucose (mmol/l) 5.14 (0.42)  4.84 (0.40) 
HDL-cholesterol (mmol/l) 1.26 (0.25)  1.51 (0.33) 
LDL-cholesterol (mmol/l) 3.04 (0.84)  2.74 (0.74) 
Triglycerides (mmol/l) 1.03 (0.65)  0.81 (0.42) 
Continuous metabolic syndrome score 0.00 (0.71)  0.00 (0.71) 
Metabolic syndrome† 11.8% (136)  5.1% (60) 
Abbreviations: PWC170 (physical work capacity at a heart rate of 170 beats per minute). 
*Data are for those who were doing strength training only (men n=256, women n=245). 
†Data are percentage (number). 
‡Including moderate-to-vigorous physical activity. 
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Levels of education were positively correlated with sitting time per weekday, and with time 
using a computer per weekday and weekend day, but was negatively associated with time 
watching television per weekday and weekend day (all p<0.001 for each sex). Among 
women, both sitting time per weekday and per weekend day were negatively correlated with 
parity (p<0.001). Sitting time was strongly correlated with time spent watching television or 
using computers or video games per week (men 𝑟=0.50, women 𝑟=0.56), per weekday (men 
𝑟=0.50, women 𝑟=0.57) and per weekend day (men 𝑟=0.49, women 𝑟=0.39) respectively (all 
p<0.001).  
Table 7.2 shows rank correlations of sitting time with cardiorespiratory fitness, self-reported 
physical activity and average steps/day. While total MET.hour/week and average steps/day 
were negatively correlated with sitting time per weekday and per weekend day, 
cardiorespiratory fitness and self-reported time spent on vigorous physical activity were 
negatively correlated with sitting time per weekend day only. Among men and women who 
were currently doing strength training, sitting time per weekend day but not per weekday was 
negatively correlated with total training time (p<0.05). Similarly to sitting time, time spent 
watching television, using computers and playing video games per weekend day, but not per 
weekday, was inversely correlated with cardiorespiratory fitness (men 𝑟=−0.15, women 
𝑟=−0.15) and self-reported leisure-time vigorous physical activity (men 𝑟=−0.08, women 
𝑟=−0.05). 
Table 7.3 shows rank correlations of sitting time with arterial stiffness, RHR, skinfolds and 
continuous metabolic syndrome scores. In general, sitting time per weekend day was more 
strongly correlated with arterial stiffness and other cardio-metabolic risk factors than sitting 
time per weekday. These correlations, with an exception of the correlation between sitting 
time and continuous metabolic syndrome scores among women, were not substantially altered 
after adjusting for either self-reported physical activity or objectively-measured steps/day, and 
for other potential confounders (p<0.05). Further adjustment for cardiorespiratory fitness did 
not change our findings either (not shown). The change in the correlations between sitting 
time and continuous metabolic syndrome score among women was due to adjustment for 
parity that was negatively correlated with sitting time and positively correlated with metabolic 
syndrome scores. In these cross-sectional data, one additional sitting hour per weekend day 
was associated with 5.6% (men p=0.046) and 8.6% (women p=0.05) higher risk of metabolic 
syndrome. Adjusting for RHR moderately reduced the correlation of sitting time with arterial 
stiffness among men (p<0.05), and adjusting for fatness (BMI or waist or skinfolds), and 
either the continuous metabolic syndrome score or individual components of metabolic 
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syndrome, only slightly reduced the correlation of sitting time with arterial stiffness (not 
shown).  
Table 7.2. Rank correlations of sitting time with measures of cardiorespiratory 
fitness and physical activity 
Sitting time CRF VLPA Total PA† Average steps/day 
Men         
Per week −0.07 * −0.01  −0.42 *** −0.37 *** 
Per weekday −0.05  0.01  −0.43 *** −0.38 *** 
Per weekend day −0.14 *** −0.10 ** −0.19 *** −0.21 *** 
Women         
Per week 0.03  0.03  −0.29 *** −0.20 *** 
Per weekday 0.05  0.04  −0.31 *** −0.19 *** 
Per weekend day −0.08 * −0.07 * −0.13 *** −0.18 *** 
Abbreviations: CRF (cardiorespiratory fitness), VLPA (vigorous leisure-time physical 
activity, hour/week), Total PA (total MET.hour/week). 
*p<0.05; **p<0.01; ***p<0.001 
†Including moderate-to-vigorous physical activity. 
 Table 7.3. Rank correlations of sitting time with arterial stiffness and other cardio-metabolic risk factors 
Sitting time CD SI YEM RHR Skinfolds cMetS 
Men             
Un-adjusted correlation             
Per weekday −0.05  0.08 * 0.02  0.08 ** 0.05  −0.00  
Per weekend day −0.12 ** 0.12 *** 0.09 ** 0.13 *** 0.06  0.08 ** 
Adjusted correlation
a
             
Per weekday −0.05  0.08 * 0.03  0.08 ** 0.05  0.01  
Per weekend day −0.11 ** 0.11 ** 0.10 ** 0.11 *** 0.06 * 0.07 * 
Women             
Un-adjusted correlation             
Per weekday −0.01  −0.01  0.01  −0.03  0.04  −0.00  
Per weekend day −0.07 * 0.06  0.05  0.00  0.10 ** 0.08 * 
Adjusted correlation
a
             
Per weekday −0.01  0.00  0.03  0.01  0.06  0.04  
Per weekend day −0.09 * 0.08 * 0.08 * 0.02  0.11 ** 0.12 ** 
Abbreviations: CD (carotid distensibility), SI (stiffness index), YEM (Young’s elastic modulus), RHR (resting heart rate) and cMetS (continuous 
metabolic syndrome score).  
*p<0.5; **p<0.01; ***p<0.001 
a
Adjusted for vigorous leisure-time physical activity, time spent on strength training, age, education, smoking, diet and alcohol, and for parity 
(women only). 
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Discussion 
This study showed positive associations of sitting time per weekend day, but not per weekday, 
with arterial stiffness and other cardio-metabolic risk factors. These associations were 
independent of self-reported and objectively-measured physical activity, cardiorespiratory 
fitness and other potential confounders. The association of sitting time with arterial stiffness 
was not fully explained by RHR, fatness or metabolic syndrome, which are considered as 
potential mediators in this association. 
Confidence in the reliability of our measures of sedentary behaviour in our study is 
strengthened by their plausible associations with sex, levels of education, and self-reported 
and objectively-measured physical activity. The greater role of sitting time per weekend day 
in prediction of arterial stiffness and cardio-metabolic risks than that of sitting time per 
weekday may be due to better discrimination of discretionary sitting behaviour. Sedentary 
behaviours are ubiquitous in contemporary society, and many occupations require a person to 
remain sedentary during weekdays.
32
 An obvious example is office-based workers who have 
to spend many hours sitting during weekdays, and have more freedom to be physically active 
during non-working days that are usually weekends. This is consistent with our results 
because 54% of the participants in our study reported sitting at least five hours per weekday 
whereas 39% of them reported sitting at least five hours per weekend day, and objectively-
measured cardiorespiratory fitness was negatively associated with sitting time per weekend 
day but not with sitting time per weekday.  
A recent review suggests that prolonged sitting may be an independent cardiovascular risk 
factor.
7
 In this study, we have shown a positive association of sitting time with arterial 
stiffness and, consistently with previous findings of adverse health effects of being sedentary 
that were independent of physical activity,
7
 adjusting for physical activity made little 
difference to the association of sitting time with arterial stiffness in our study. Because arterial 
stiffness independently predicts mortality,
33
 this relationship between sitting time and arterial 
stiffness may be a possible pathway through which sedentary behaviours are associated with 
mortality as reported in other studies.
11, 12, 14
 Although Moreau et al
34
 have suggested the 
greater carotid artery compliance in habitually exercising than sedentary postmenopausal 
women is mediated by an absence of oxidative stress, the mechanisms through which 
sedentary behaviour may influence arterial stiffness remain poorly understood. Unlike 
associations of physical activity or cardiorespiratory fitness with arterial stiffness, which we 
found to be mediated by RHR in our study,
25
 the association of sitting time with arterial 
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stiffness was not mediated by RHR, fatness, metabolic syndrome or individual components of 
metabolic syndrome. Future studies are needed to explore the physiological mechanisms 
underlying the association of sitting time with arterial stiffness. 
This study used a large national sample of young Australians on whom standardised 
measurements were made of an extensive range of study factors. To our knowledge, this is the 
first study that shows a positive association of sitting time with arterial stiffness in such a 
large population-based sample. The use of sitting time from self-report, rather than from 
objective measurements by accelerometers, is a limitation of our study. However, the self-
reported sitting time in our study was well correlated with physical activity objectively-
measured by pedometers and cardiorespiratory fitness objectively-measured by bicycle 
ergometry. The cross-sectional design of this study limits the causal inferences concerning the 
relationships of sitting time with arterial stiffness. We cannot rule out the possibility of a 
reverse causation whereby participants with greater arterial stiffness might be more sedentary 
in consequence. However, our findings on these young, generally-healthy adults who were 
unaware of their levels of arterial stiffness link well with previous findings on the deleterious 
effects of sedentary behaviour on health, and may suggest a possible pathway through which 
too much sitting may lead to higher risk of mortality. 
Conclusions 
In conclusion, our study shows positive associations of sitting time with arterial stiffness and 
other cardio-metabolic risk factors, independently of physical activity, and attributes a greater 
predictive value of these health outcomes to sitting time per weekend day than sitting time per 
weekday among young adults. This may be due to greater capability of sitting time during 
weekends in reflecting discretionary sitting behaviour of an individual, whereas sitting time 
during weekdays is probably more determined by occupational requirements. The association 
of sitting time with arterial stiffness was not fully explained by RHR, fatness or metabolic 
syndrome.  
Postscript 
The findings presented in the current and previous chapters demonstrated the relationships of 
fatness, fitness, vigorous physical activity and sedentary behavior with vascular health. The 
next chapter will summarise all these findings, and discuss their public health implications 
and future directions of research.  
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Chapter 8. Summary, implications, future directions and 
conclusions 
Summary of background  
Cardiovascular disease (CVD) is the leading cause of death worldwide,
1
 and is predicted to 
remain so in the next couple of decades.
2
 It is suggested that CVD has a long process of 
development through the life course and has origins from very early periods in life, and even 
from childhood.
3-5
 This evidence implicates the need to understand the determinants of early 
stages of CVD for long-term reduction of CVD risk. Because cardiovascular events do not 
typically occur until older ages, studies of the early stages of CVD among young people 
previously had to rely on autopsy studies or required invasive methods. The advancement of 
novel non-invasive techniques such as ultrasound during the 1990s opened a new era of using 
subclinical markers of CVD among young and apparently healthy individuals for large 
population-based studies, which had not been possible before. These markers, including 
measures of the structure (intima-media thickness – IMT) and stiffness of the carotid artery, 
are strong predictors of major cardiovascular events and mortality,
6-9
 and can be used to 
predict early stages of CVD. Improved understanding of the determinants of these measures 
among young people may therefore lead to targeted early interventions to reduce CVD risk. 
This research examined the associations of the lifestyle factors – including fatness, fitness, 
physical activity and sedentary behaviour – with arterial structure and stiffness among young 
and mid-aged adults, and aimed to shed light on the possible mechanisms involved. The novel 
findings from this research make important contributions to improved understanding of the 
lifestyle determinants of vascular health among young adults. 
The following sections summarise the principal findings of the studies presented in this thesis 
and discuss their strengths and limitations, public health implications and directions for future 
research. 
 
 
 
Chapter 8 – Summary, implications, future directions and conclusions 196 
Summary of results 
The key findings from this thesis are summarised as follows:  
First, large artery stiffness appears to play a more prominent role in the pathophysiology of 
obesity-induced hypertension for Caucasians than for Asians. In a comparison of the 
relationship of body size and fatness with blood pressure in population-based samples of 
Australian and Vietnamese people, the positive association of body size and fatness with 
pulse pressure found in the Caucasian sample may be indicative of increased large artery 
stiffness. The positive associations of body size and fatness with both systolic and diastolic 
blood pressure in the Asian sample were more typical of essential hypertension. This is 
possibly due to increased circulatory volume and/or increased peripheral vascular resistance. 
These associations were independent of years of smoking, alcohol consumption, consumption 
of fruit and vegetables, self-reported physical activity, and fasting blood total cholesterol and 
glucose. 
Second, carotid artery stiffness and carotid IMT (measured by carotid ultrasound) in 
adulthood were associated with body size and fatness in both childhood and adulthood. While 
arterial stiffness depended primarily on adult body size and fatness and was greatest for obese 
adults who were normal weight in childhood, carotid IMT appeared to be influenced by body 
size and fatness in both childhood and adulthood. These findings add to evidence suggesting 
that CVD has origins from obesity in childhood. 
Third, carotid artery stiffness among young adults was negatively associated with 
cardiorespiratory fitness (CRF), but was positively associated with muscular strength, both 
independently of adult body size and fatness. While greater CRF may reduce arterial stiffness 
mainly through lower resting heart rate (RHR), greater muscular strength may have 
deleterious effects on arterial stiffness that are partially offset by lower RHR. These results, 
for the first time, attribute a key intermediary role to RHR in the association of physical 
fitness with arterial stiffness. 
Fourth, carotid artery stiffness among young and mid-aged adults in samples of the Australian 
and Finnish populations was negatively associated with vigorous physical activity, but not 
with less intensive forms of physical activity or number of steps per day. Similar to the 
relationship between CRF and arterial stiffness, participation in vigorous physical activity 
may also reduce arterial stiffness through lower RHR, independently of body size and fatness. 
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These findings, for the first time, shed light on the possible mechanisms involved in the 
relationship between vigorous physical activity and arterial stiffness, and strengthen the 
evidence of the potential cardioprotective benefits of vigorous physical activity that are 
beyond those achieved by less intensive forms of physical activity.  
Fifth, carotid artery stiffness was positively associated with sitting time per weekend day, but 
not with sitting time per weekday, independent of physical activity and CRF. For the first 
time, these findings show a detrimental association of sitting time with arterial stiffness, and 
suggest that sitting time during weekends rather than weekdays predict arterial stiffness and 
other cardio-metabolic risk factors in this population of young adults. This may be due to 
greater capacity of recollection of sitting time during weekends than weekdays to accurately 
reflect discretionary sedentary behaviour of young adults in this population. These novel 
findings advance our knowledge in relation to the possibly harmful effects of prolonged 
sitting periods on health. Unlike CRF and vigorous physical activity that may reduce arterial 
stiffness through lower RHR, the relationship of sitting time with arterial stiffness was not 
mediated by RHR, body size and fatness, and metabolic syndrome. Further research is needed 
to investigate the possible mechanisms involved. 
Strengths and limitations of this research 
This research has several strengths. First, all the participants included in the five studies were 
from large population-based samples that were each selected by multi-stage random sampling. 
Second, an extensive range of study factors were measured using standardised protocols in 
each study included in this research. These factors included potential mediators, effect 
modifiers and confounders that were able to be investigated in the analytical process. This 
approach not only contributed to shedding light, for the first time, on the possible mechanisms 
involved in the relationship of physical activity and fitness with arterial stiffness, but also 
made the findings from this research more likely to be free of confounding bias. Third, most 
of the participants included in this research were young adults. While many studies of 
vascular health have focused on adults at older age, less information is available for younger 
adults. Thus the findings of this research help to fill one of the evidence gaps, and improve 
our knowledge of the determinants of vascular health among younger adults. Fourth, the 
consistent findings on the relationship between vigorous physical activity and arterial stiffness 
among Australians and Finns, despite their cultural and environmental differences, 
strengthened the confidence that can be placed in the external validity of the results from this 
research. 
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There are also a number of limitations that need to be considered when interpreting the 
findings from this research. First, the cross-sectional analysis in four out of five studies 
included in this research is a limitation. This limits the causal inferences that can be drawn 
about the relationship between the exposures and the outcomes of those studies. For example, 
the possibility of a reverse causation in the relationship of physical activity and fitness, and of 
sedentary behaviours, with carotid artery stiffness (where individuals with higher arterial 
stiffness may tend to be less physically active and more sedentary) cannot be ruled out. 
However, the findings from this research link well to previous findings of intervention studies 
making the possibility of a reverse causation less likely.  
Second, although the Burnie Take Heart project and the Can Tho survey had good response 
rates (69% and 74% respectively), the loss to follow-up in the Childhood Determinants of 
Adult Health study and the Cardiovascular Risk in Young Finns study is another limitation. 
This may have caused selection bias if the association of the exposure with the outcome was 
different among participants and non-participants. However, this research was an analytical 
investigation using large population-based samples from well-characterised study populations 
for which the distributional range of confounders and effect modifiers was not restricted by 
sampling or diminished by attrition. Threats to external validity are therefore less of an issue 
in these circumstances.
10
 In addition, the probability of participation at follow-up was 
calculated for each subject at baseline. This information was used in sensitivity analyses to 
weight the association of interest by using inverse probability weighting. This estimated the 
association with non-participants at follow-up represented by participants who had similar 
characteristics to them at baseline. The results were very similar to those presented in this 
thesis. Therefore it is unlikely that the results were influenced by loss to follow-up. Reporting 
bias was also unlikely because the studies used data from large population-based samples, and 
included young and apparently healthy adults who were not aware of their levels of arterial 
stiffness.  
Third, unmeasured potential confounders may be another potential limitation of this research. 
An example is sodium intake, which may influence arterial stiffness.
11, 12
 Fourth, using 
accelerometers may have minimised measurement errors on participants’ physical activity and 
sedentary behaviour compared with using pedometers and a self-reported questionnaire. 
However, the high cost of accelerometers greatly reduces their feasibility in such large 
population-based studies. In addition, confidence in the reliability of the self-reported 
measures of physical activity in this research is strengthened by their plausible associations 
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with demographic measures, socio-economic status, physical measures (including objectively-
measured CRF, fatness, RHR and blood biomarkers) and pedometer-measured steps per day. 
Public health implications 
The research findings presented in this thesis show the associations of different lifestyle risk 
factors with vascular health. Given that there are currently no medications that are specifically 
targeted at improving arterial structure and stiffness, any lifestyle modifications that can do so 
may have heightened importance as potential targets of interventions to reduce cardiovascular 
risk. The findings from this research not only show the possible benefits of early lifestyle 
interventions to improve vascular health among young persons, but also, for the first time, 
shed light on the possible mechanisms involved. These findings have several important public 
health implications that are discussed in the following text. 
A different pathophysiology related to obesity-induced hypertension has, for the first time, 
been suggested among Caucasians in comparison to Asians and is presented in Chapter 3 of 
this thesis. The findings suggest a pathway involving increased large artery stiffness among 
Caucasians, but increased circulatory volume and/or increased peripheral vascular resistance 
that may be related to higher salt intake among Asians.
13
 These findings may suggest a 
possibility of different approaches to treatment of hypertension in the two populations, and 
underline the importance of interventions to reduce obesity (probably through diet and 
physical activity) in prevention of hypertension. Our findings are also consistent with 
evidence suggesting a restriction in salt intake, particularly among Asians, to prevent 
hypertension.  
Using more direct measures of vascular health assessed by ultrasound examination, the 
findings from Chapter 4 of this thesis demonstrated that obesity in both childhood and 
adulthood may influence adult vascular health. While child obesity may influence adult 
carotid IMT independently of adult obesity, weight gain from childhood to adulthood may be 
important in determining arterial stiffness in adulthood because the obese adult participants 
who were normal weight in childhood had the greatest arterial stiffness. Our data show that 
children as young as seven years of age who have greater body size and fatness than their 
counterparts may have thicker carotid IMT and greater arterial stiffness in adulthood because 
they are more likely to become overweight or obese adults. These findings not only strengthen 
the evidence of childhood origins of adult CVD, but also emphasise that early interventions to 
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reduce obesity and maintain healthy weight from childhood to adulthood are needed to reduce 
CVD risk. 
As discussed, reduction of obesity in both childhood and adulthood is needed to reduce CVD 
risk. However, obesity clearly has many behavioural and genetic determinants that are not 
easy to address. Although obesity is now widely accepted as a major CVD risk factor,
14
 and 
despite actions that have been undertaken at individual and population levels to reduce 
obesity, many overweight or obese people remain overweight or obese for many years.
15
 In 
the contemporary population-based sample of young Australians included in this research, of 
those who were classified as overweight or obese in childhood (7–15 years, n=259), 88% 
(n=227) remained overweight or obese as adults 20 years later when they were aged 26–36 
years. It is therefore encouraging for these people that doing physical activity and improving 
CRF may reduce CVD mortality independently of the effects on weight loss.
16, 17
 The findings 
presented in Chapter 5 strengthen this evidence by showing that, independently of body size 
and fatness, having greater CRF was negatively associated with arterial stiffness – which 
independently predicts mortality
18
 – even among young and apparently healthy adults with 
low levels of arterial stiffness. In line with this, the findings presented in Chapter 6 point out 
that young and mid-aged adults who participate in vigorous physical activity have lower 
arterial stiffness. These findings are very consistent with each other because CRF was more 
strongly associated with vigorous physical activity than with light-to-moderate physical 
activity, and are consistent with findings from other studies showing greater reduction in 
blood pressure and glucose produced by vigorous physical activity than produced by light-to-
moderate physical activity even when the total energy expenditure is held equivalent.
19
 The 
evidence on the potential extra benefits of vigorous physical activity should be emphasised 
more strongly as it is in the National Physical Activity Guidelines for Australians.
20
 This is 
necessary to encourage people to achieve greater health benefits from vigorous physical 
activity, and to change the thinking that similar benefits can be achieved by either vigorous or 
moderate physical activity, but with longer time required for moderate physical activity.
21
  
For the first time, the findings from this research suggest the possible mechanisms involved in 
the associations of vigorous physical activity and CRF with arterial stiffness, and attribute a 
key intermediary role to RHR in these relationships. These findings contribute to filling the 
evidence gap in the relationship of exercise training with vascular health. They also 
strengthen the evidence on the positive association of high RHR with increased arterial 
stiffness.
22, 23
 Because both high RHR and arterial stiffness are reported to independently 
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predict greater mortality,
18, 24
 any future studies of arterial stiffness predicting mortality 
should take account of RHR, which has never been done before. 
Muscular strength, on the other hand, was positively associated with arterial stiffness among 
young adults. This finding is consistent with those of many intervention studies that show 
detrimental effects of strength training on arterial stiffness.
25-28
 It is nevertheless inconsistent 
with some other studies showing no change
29
 or even a decrease in arterial stiffness
30
 
following strength training. For the first time, the findings from this research propose two 
offsetting pathways that may be involved in the relationship of muscular strength with arterial 
stiffness. They include one pathway with a positive association of muscular strength with 
arterial stiffness, and one pathway with a negative association of muscular strength with 
arterial stiffness that is mediated by lower RHR. The total effect of increased muscular 
strength on arterial stiffness is the net effect of these two pathways. These findings not only 
help to reconcile the previous inconsistent findings on the effect of strength training on 
arterial stiffness, but also strengthen the evidence for strength training to improve general 
health in physical activity guidelines.
22, 23
 
The research reported in Chapter 7 of this thesis examined the relationship of a recently 
recognised lifestyle risk factor – sedentary behaviour – with arterial stiffness and, for the first 
time, shows a positive relationship of sitting time with arterial stiffness that was independent 
of physical activity, CRF, and body size and fatness. These findings advance our knowledge 
of the possible detrimental effects of sedentary behavior on health, and demonstrate the 
importance of minimising prolonged periods of being sedentary, in addition to doing physical 
activity and improving CRF, to reduce CVD risk. 
Future directions 
Longitudinal studies are needed to confirm the cross-sectional findings reported in this thesis, 
and to examine the long-term effects of doing vigorous physical activity and reducing 
sedentary time on vascular health. This will be possible with future follow-ups of the 
Childhood Determinants of Adult Health (CDAH) study and the Cardiovascular Risk Factor 
in Young Finns study. 
Longitudinal studies with multiple follow-up time-points from childhood to adulthood are 
needed to investigate whether there are particularly sensitive periods of exposure to obesity 
that are associated with vascular health in adulthood. Reducing obesity and maintaining 
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healthy weight from childhood to adulthood are important but not easy to achieve. Thus 
understanding the most sensitive periods of exposure may help to set up more effective 
interventions to reduce CVD risk through reducing obesity. Having multiple follow-up time-
points is also necessary to investigate the effects of changing lifestyles (for example, from 
being sedentary to being physically active or vice versa) on vascular health. This may be 
possible using data from the Cardiovascular Risk in Young Finns study that collected physical 
measurements at multiple time-points from childhood to adulthood and, together with the 
CDAH study, is a member cohort of the International Childhood Cardiovascular Cohort (i3C) 
consortium. 
Longitudinal studies with follows-up into old ages are needed to investigate the relationship 
of childhood risk factors with major CVD events in late adulthood, and to confirm whether 
modifications of childhood risk factors to improve vascular health in young adulthood can 
translate to lower risk of major CVD events. Because CVD events are rare in young 
adulthood, it requires a long-term follow-up of the CDAH study before these findings can be 
confirmed. This research is possible using currently-held data from the i3C consortium that 
includes several cohort studies similar to the CDAH study and constitutes a very large number 
of participants that can be used to investigate rare events. 
In addition to observational studies, intervention studies may be needed to confirm the effects 
of physical activity at different levels of intensity on vascular health among people of 
different age groups. This will be helpful in recommending physical activity for specific age 
groups of the population. Intervention studies are also needed to confirm the intermediary role 
of RHR in the relationship of exercise training to improve CRF with arterial stiffness. Novel 
indicators of arterial stiffness (such as arterial reservoir
31, 32
) may also be used to strengthen 
our findings on carotid artery stiffness. 
Although the findings from this research suggest the associations of fatness and fitness with 
vascular health to be independent of each other, more research is needed to examine the 
vascular health of persons who are consistently obese but physically fit. As shown in this 
research, the majority of obese participants remain obese for many years. It is therefore 
important to confirm the effects of improving CRF on vascular health among people who are 
consistently obese from childhood to adulthood. Because the number of those who are obese 
but fit is apparently small, it will require either cohort studies with a very large sample (such 
as collectively the i3C consortium) or intervention studies to confirm the findings. 
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Conclusions 
Taken together, the findings from this research highlight the importance of lifestyle risk 
factors in predicting vascular health among young to mid-aged adults. They suggest that 
efforts to improve vascular health, and thereby to reduce CVD risk, among these younger 
adults should be simultaneously targeted at reducing obesity, encouraging vigorous physical 
activity, improving CRF and reducing sedentary behaviour to maximise the total beneficial 
effects on vascular health. 
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